Allstate Life Insurance Co Of New York POS AM 1 Apr 20 Prospectus update (post-effective amendment) Financial data

Document and Entity Information

Document and Entity Information	12 Months Ended
	Dec. 31, 2019
Entity Information [Line Items]
Document Type	POS AM
Amendment Flag	false
Entity Registrant Name	ALLSTATE LIFE INSURANCE CO OF NEW YORK
Entity Central Index Key	0000839759
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false

Statements of Operations and Co

Statements of Operations and Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Revenues
Premiums (net of reinsurance ceded of $10,600, $11,054, and $11,481)	$ 108,452	$ 103,447	$ 90,941
Contract charges	77,314	77,194	76,171
Net investment income	256,006	287,883	310,695
Realized capital gains and losses:
Total other-than-temporary impairment ("OTTI") losses	(1,202)	(68)	(6,263)
OTTI losses reclassified to (from) other comprehensive income	1,033	(217)	893
Net OTTI losses recognized in earnings	(169)	(285)	(5,370)
Sales and valuation changes on equity investments and derivatives	106,796	(20,269)	71,702
Total realized capital gains and losses	106,627	(20,554)	66,332
Total revenues	549,585	449,384	545,063
Costs and expenses
Contract benefits (net of reinsurance ceded of $13,687, $11,016, and $8,055)	259,013	237,578	230,493
Interest credited to contractholder funds (net of reinsurance ceded of $4,307, $4,533, and $4,805)	86,464	91,482	97,377
Amortization of deferred policy acquisition costs	30,396	16,299	16,992
Operating costs and expenses	45,162	45,964	42,753
Total costs and expenses	421,035	391,323	387,615
Income from operations before income tax expense (benefit)	128,550	58,061	157,448
Income tax expense (benefit)	30,926	12,827	(46,735)
Net income	97,624	45,234	204,183
Other comprehensive income (loss), after-tax
Change in unrealized net capital gains and losses	67,612	(50,575)	(66,210)
Change in unrealized foreign currency translation adjustments	(3,131)	98	2,409
Other comprehensive income (loss), after-tax	64,481	(50,477)	(63,801)
Comprehensive income (loss)	162,105	(5,243)	140,382
Product and Service, Other [Member]
Revenues
Contract charges	$ 1,186	$ 1,414	$ 924

Statements of Operations and _2

Statements of Operations and Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Premiums ceded	$ 10,600	$ 11,054	$ 11,481
Contract charges, reinsurance ceded	7,945	8,279	7,954
Contract benefits ceded	13,687	11,016	8,055
Interest credited ceded	$ 4,307	$ 4,533	$ 4,805

Statements of Financial Positio

Statements of Financial Position - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Investments
Fixed income securities, at fair value (amortized cost $4,023,107 and $4,375,110)	$ 4,434,362	$ 4,530,344
Mortgage loans	733,258	696,062
Equity securities, at fair value (cost $233,118 and $177,229)	274,133	184,970
Limited partnership interests	386,310	382,853
Short-term, at fair value (amortized cost $224,111 and $88,552)	224,098	88,548
Policy loans	38,583	39,374
Other	5,237	653
Total investments	6,095,981	5,922,804
Cash	9,273	8,479
Deferred policy acquisition costs	124,118	155,887
Reinsurance recoverable	229,759	234,733
Accrued investment income	46,846	50,219
Current income taxes receivable		3,944
Other assets	399,126	191,373
Reinsurance receivable from parent	1,218
Separate Accounts	265,546	241,710
Total assets	7,171,867	6,809,149
Liabilities
Contractholder funds	2,547,968	2,681,300
Reserve for life-contingent contract benefits	2,411,809	2,232,136
Current income taxes payable	31,713	0
Deferred income taxes	154,849	143,606
Other liabilities and accrued expenses	188,362	99,387
Payable to affiliates, net	4,973	6,312
Reinsurance payable to parent		156
Separate Accounts	265,546	241,710
Total liabilities	5,605,220	5,404,607
Commitments and Contingent Liabilities (Note 11)
Shareholder's Equity
Common stock, $25 par value, 100 thousand shares authorized, issued and outstanding	2,500	2,500
Additional capital paid-in	140,529	140,529
Retained income	1,299,868	1,202,244
Unrealized net capital gains and losses:
Unrealized net capital gains and losses on fixed income securities with OTTI	664	1,185
Other unrealized net capital gains and losses	324,055	121,407
Unrealized adjustment to DAC, DSI and insurance reserves	(200,010)	(65,495)
Total unrealized net capital gains and losses	124,709	57,097
Unrealized foreign currency translation adjustments	(959)	2,172
Total accumulated other comprehensive income ("AOCI")	123,750	59,269
Total shareholder's equity	1,566,647	1,404,542
Total liabilities and shareholder's equity	$ 7,171,867	$ 6,809,149

Statements of Financial Posit_2

Statements of Financial Position (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Fixed income securities, amortized cost	$ 4,023,107	$ 4,375,110
Equity securities, at cost	233,118	177,229
Short-term, amortized cost	$ 224,111	$ 88,552
Common stock, par value	$ 25	$ 25
Common stock, shares authorized	100,000	100,000
Common stock, shares issued	100,000	100,000
Common stock, shares outstanding	100,000	100,000

Statements of Shareholder's Equ

Statements of Shareholder's Equity - USD ($) $ in Thousands	Total	Common Stock	Additional capital paid-in	Retained income	Accumulated other comprehensive income
Balance at Dec. 31, 2016				$ 938,217	$ 181,640
Change in unrealized net capital gains and losses	$ (66,210)				(66,210)
Net income	204,183			204,183
Change in unrealized foreign currency translation adjustments	2,409				2,409
Reclassification of tax effects due to change in accounting principle				(25,380)	25,380
Balance at Dec. 31, 2017	1,403,268	$ 2,500	$ 140,529	1,117,020	143,219
Change in unrealized net capital gains and losses	(50,575)				(50,575)
Net income	45,234			45,234
Change in unrealized foreign currency translation adjustments	98				98
Balance at Dec. 31, 2018	1,404,542	2,500	140,529	1,202,244	59,269
Cumulative effect of change in accounting principle				39,990	(33,473)
Change in unrealized net capital gains and losses	67,612				67,612
Net income	97,624			97,624
Change in unrealized foreign currency translation adjustments	(3,131)				(3,131)
Balance at Dec. 31, 2019	$ 1,566,647	$ 2,500	$ 140,529	$ 1,299,868	$ 123,750

Statements of Cash Flows

Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities
Net income	$ 97,624	$ 45,234	$ 204,183
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization and other non-cash items	(27,136)	(27,152)	(30,014)
Realized capital gains and losses	(106,627)	20,554	(66,332)
Interest credited to contractholder funds	86,464	91,482	97,377
Changes in:
Policy benefits and other insurance reserves	(29,174)	(46,890)	(17,780)
Deferred policy acquisition costs	13,625	(3,278)	(7,530)
Income taxes	29,817	(3,424)	(53,734)
Other operating assets and liabilities	14,996	15,481	(28,736)
Net cash provided by operating activities	79,589	92,007	97,434
Proceeds from sales
Fixed income securities	295,930	292,026	192,227
Equity securities	141,893	165,147	125,416
Limited partnership interests	25,195	31,337	77,017
Investment collections
Fixed income securities	345,540	334,019	298,852
Mortgage loans	76,582	50,627	65,183
Investment purchases
Fixed income securities	(411,139)	(421,643)	(477,765)
Equity securities	(190,441)	(171,271)	(68,002)
Limited partnership interests	(41,881)	(56,986)	(67,015)
Mortgage loans	(113,712)	(116,996)	(78,783)
Change in short-term investments, net	(46,116)	12,231	3,104
Change in policy loans and other investments, net	1,228	576	1,440
Net cash provided by investing activities	83,079	119,067	71,674
Cash flows from financing activities
Contractholder fund deposits	95,390	96,954	97,287
Contractholder fund withdrawals	(257,264)	(304,412)	(274,887)
Other			(2,400)
Net cash used in financing activities	(161,874)	(207,458)	(180,000)
Net increase (decrease) in cash	794	3,616	(10,892)
Cash at beginning of year	8,479	4,863	15,755
Cash at end of year	$ 9,273	$ 8,479	$ 4,863

General

General	12 Months Ended
	Dec. 31, 2019
General	1. General Basis of presentation The accompanying financial statements include the accounts of Allstate Life Insurance Company of New York (the “Company”), a wholly owned subsidiary of Allstate Life Insurance Company (“ALIC”), which is wholly owned by Allstate Insurance Company (“AIC”). AIC is wholly owned by Allstate Insurance Holdings, LLC, a wholly owned subsidiary of The Allstate Corporation (the “Corporation”). These financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. The Company operates as a single segment entity based on the manner in which the Company uses financial information to evaluate business performance and to determine the allocation of resources. On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (“Tax Legislation”) became effective, permanently reducing the U.S. corporate income tax rate from 35% to 21% beginning January 1, 2018. As a result, the corporate tax rate is not comparable between periods. Nature of operations The Company offers traditional, interest-sensitive and variable life insurance and voluntary accident and health insurance products to customers in the State of New York. The Company distributes its products through Allstate exclusive agencies and exclusive financial specialists, and workplace enrolling independent agents and benefits brokers. The Company previously offered and continues to have in force fixed annuities such as deferred and immediate annuities. The Company also previously offered variable annuities and all of this business is reinsured. The following table summarizes premiums and contract charges by product. ($ in thousands) 2019 2018 2017 Premiums Traditional life insurance $ 61,980 $ 59,185 $ 55,996 Accident and health insurance 46,472 44,262 34,945 Total premiums 108,452 103,447 90,941 Contract charges Interest-sensitive life insurance 77,324 76,931 76,103 Fixed annuities (10 ) 263 68 Total contract charges 77,314 77,194 76,171 Total premiums and contract charges $ 185,766 $ 180,641 $ 167,112

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2019
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Investments Fixed income securities include bonds, asset-backed securities (“ABS”) and mortgage-backed securities (“MBS”). MBS includes residential and commercial mortgage-backed securities that were previously disclosed separately. Fixed income securities, which may be sold prior to their contractual maturity, are designated as available-for-sale pay-downs Mortgage loans are carried at unpaid principal balances, net of unamortized premium or discount and valuation allowances. Valuation allowances are established for impaired loans when it is probable that contractual principal and interest will not be collected. Equity securities primarily include common stocks, exchange traded funds, non-redeemable Investments in limited partnership interests are primarily accounted for in accordance with the equity method of accounting (“EMA”) and include interests in private equity funds, real estate funds and other funds. Investments in limited partnership interests purchased prior to January 1, 2018 where the Company’s interest is so minor that it exercises virtually no influence over operating and financial policies are accounted for at fair value primarily utilizing the net asset value (“NAV”) as a practical expedient to determine fair value. Short-term investments, including money market funds, commercial paper, U.S. Treasury bills and other short-term investments, are carried at fair value. Policy loans are carried at unpaid principal balances. Other investments consist of derivatives. Derivatives are carried at fair value. Investment income primarily consists of interest, dividends, income from limited partnership interests, and income from certain derivative transactions. Interest is recognized on an accrual basis using the effective yield method and dividends are recorded at the ex-dividend pay-downs, Realized capital gains and losses include gains and losses on investment sales, write-downs in value due to other-than-temporary declines in fair value, adjustments to valuation allowances on mortgage loans, valuation changes of equity investments, including equity securities and certain limited partnerships where the underlying assets are predominately public equity securities, and periodic changes in fair value and settlements of certain derivatives including hedge ineffectiveness. Realized capital gains and losses on investment sales are determined on a specific identification basis. Derivative and embedded derivative financial instruments Derivative financial instruments include equity futures, options, interest rate caps, foreign currency forwards and a reinvestment related risk transfer reinsurance agreement with ALIC that meets the accounting definition of a derivative (see Note 4). Derivatives required to be separated from the host instrument and accounted for as derivative financial instruments (“subject to bifurcation”) are embedded in equity-indexed life contracts and reinsured variable annuity contracts. All derivatives are accounted for on a fair value basis and reported as other investments, other assets, other liabilities and accrued expenses or contractholder funds. The income statement effects of derivatives, including fair value gains and losses and accrued periodic settlements, are reported either in realized capital gains and losses or in a single line item together with the results of the associated asset or liability for which risks are being managed. Embedded derivative instruments subject to bifurcation are also accounted for on a fair value basis and are reported together with the host contract. The change in fair value of derivatives embedded in life and annuity product contracts and subject to bifurcation is reported in contract benefits or interest credited to contractholder funds. Cash flows from embedded derivatives subject to bifurcation are reported consistently with the host contracts within the Statements of Cash Flows. Cash flows from other derivatives are reported in cash flows from investing activities within the Statements of Cash Flows. Securities loaned The Company’s business activities include securities lending transactions, which are used primarily to generate net investment income. The proceeds received in conjunction with securities lending transactions can be reinvested in short-term investments or fixed income securities. These transactions are short-term in nature, usually 30 days or less. The Company receives cash collateral for securities loaned in an amount generally equal to 102% and 105% of the fair value of domestic and foreign securities, respectively, and records the related obligations to return the collateral in other liabilities and accrued expenses. The carrying value of these obligations approximates fair value because of their relatively short-term nature. The Company monitors the market value of securities loaned on a daily basis and obtains additional collateral as necessary under the terms of the agreements to mitigate counterparty credit risk. The Company maintains the right and ability to repossess the securities loaned on short notice. Recognition of premium revenues and contract charges, and related benefits and interest credited Traditional life insurance products consist principally of products with fixed and guaranteed premiums and benefits, primarily term and whole life insurance products. Voluntary accident and health insurance products are expected to remain in force for an extended period and therefore are primarily classified as long-duration contracts. Premiums from these products are recognized as revenue when due from policyholders. Benefits are reflected in contract benefits and recognized over the life of the policy in relation to premiums. Immediate annuities with life contingencies, including certain structured settlement annuities, provide benefits over a period that extends beyond the period during which premiums are collected. Premiums from these products are recognized as revenue when received at the inception of the contract. Benefits are recognized in relation to premiums with the establishment of a reserve. The change in reserve over time is recorded in contract benefits and primarily relates to accumulation at the discount rate and annuitant mortality. Profits from these policies come primarily from investment income, which is recognized over the life of the contract. Interest-sensitive life contracts, such as universal life and single premium life, are insurance contracts whose terms are not fixed and guaranteed. The terms that may be changed include premiums paid by the contractholder, interest credited to the contractholder account balance and contract charges assessed against the contractholder account balance. Premiums from these contracts are reported as contractholder fund deposits. Contract charges consist of fees assessed against the contractholder account balance for the cost of insurance (mortality risk), contract administration and surrender of the contract prior to contractually specified dates. These contract charges are recognized as revenue when assessed against the contractholder account balance. Contract benefits include life-contingent benefit payments in excess of the contractholder account balance. Contracts that do not subject the Company to significant risk arising from mortality or morbidity are referred to as investment contracts. Fixed annuities, including market value adjusted annuities and immediate annuities without life contingencies, are considered investment contracts. Consideration received for such contracts is reported as contractholder fund deposits. Contract charges for investment contracts consist of fees assessed against the contractholder account balance for maintenance, administration and surrender of the contract prior to contractually specified dates, and are recognized when assessed against the contractholder account balance. Interest credited to contractholder funds represents interest accrued or paid on interest-sensitive life and investment contracts. Crediting rates for certain fixed annuities and interest-sensitive life contracts are adjusted periodically by the Company to reflect current market conditions subject to contractually guaranteed minimum rates. Crediting rates for indexed life contracts are generally based on an equity index, such as the Standard & Poor’s 500 Index (“S&P 500”). Interest credited also includes amortization of DSI expenses. DSI is amortized into interest credited using the same method used to amortize DAC. Contract charges for variable life and variable annuity products consist of fees assessed against the contractholder account balances for contract maintenance, administration, mortality, expense and surrender of the contract prior to contractually specified dates. Contract benefits incurred for variable annuity products include guaranteed minimum death, income, withdrawal and accumulation benefits. All of the Company’s variable annuity business is ceded through reinsurance agreements and the contract charges and contract benefits related thereto are reported net of reinsurance ceded. Other revenue presentation Other revenue represents gross dealer concessions received in connection with sales of non-proprietary Deferred policy acquisition and sales inducement costs Costs that are related directly to the successful acquisition of new or renewal life insurance policies are deferred and recorded as DAC. These costs are principally agency’s and brokers’ remuneration and certain underwriting expenses. DSI costs, which are deferred and recorded as other assets, relate to sales inducements offered on sales to new customers, principally on interest-sensitive life contracts. These sales inducements are primarily in the form of additional credits to the customer’s account balance or enhancements to interest credited for a specified period which are in excess of the rates currently being credited to similar contracts without sales inducements. All other acquisition costs are expensed as incurred and included in operating costs and expenses. Amortization of DAC is included in amortization of deferred policy acquisition costs and is described in more detail below. DSI is amortized into income using the same methodology and assumptions as DAC and is included in interest credited to contractholder funds. For traditional life and voluntary accident and health insurance, DAC is amortized over the premium paying period of the related policies in proportion to the estimated revenues on such business. Assumptions used in the amortization of DAC and reserve calculations are established at the time the policy is issued and are generally not revised during the life of the policy. Any deviations from projected business in force resulting from actual policy terminations differing from expected levels and any estimated premium deficiencies may result in a change to the rate of amortization in the period such events occur. Generally, the amortization periods for these policies approximates the estimated lives of the policies. The Company periodically reviews the recoverability of DAC using actual experience and current assumptions. Prior to fourth quarter 2017, the Company evaluated traditional life insurance products and immediate annuities with life contingencies on an aggregate basis. Beginning in fourth quarter 2017, traditional life insurance products, immediate annuities with life contingencies, and voluntary accident and health insurance products are reviewed individually. If actual experience and current assumptions are adverse compared to the original assumptions and a premium deficiency is determined to exist, any remaining unamortized DAC balance would be expensed to the extent not recoverable and the establishment of a premium deficiency reserve may be required for any remaining deficiency. For interest-sensitive life insurance, DAC and DSI are amortized in proportion to the incidence of the total present value of gross profits, which includes both actual historical gross profits (“AGP”) and estimated future gross profits (“EGP”) expected to be earned over the estimated lives of the contracts. The amortization is net of interest on the prior period DAC balance using rates established at the inception of the contracts. Actual amortization periods generally range from 15-30 10-20 AGP and EGP primarily consist of the following components: contract charges for the cost of insurance less mortality costs and other benefits; investment income and realized capital gains and losses less interest credited; and surrender and other contract charges less maintenance expenses. The principal assumptions for determining the amount of EGP are mortality, persistency, expenses, investment returns, including capital gains and losses on assets supporting contract liabilities, interest crediting rates to contractholders, and the effects of any hedges. For products whose supporting investments are exposed to capital losses in excess of the Company’s expectations which may cause periodic AGP to become temporarily negative, EGP and AGP utilized in DAC and DSI amortization may be modified to exclude the excess capital losses. The Company performs quarterly reviews of DAC and DSI recoverability for interest-sensitive life contracts using current assumptions. If a change in the amount of EGP is significant, it could result in the unamortized DAC or DSI not being recoverable, resulting in a charge which is included as a component of amortization of deferred policy acquisition costs or interest credited to contractholder funds, respectively. The DAC and DSI balances presented include adjustments to reflect the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized capital gains or losses in the respective product investment portfolios were actually realized. The adjustments are recorded net of tax in AOCI. DAC, DSI and deferred income taxes determined on unrealized capital gains and losses and reported in AOCI recognize the impact on shareholder’s equity consistently with the amounts that would be recognized in the income statement on realized capital gains and losses. Customers of the Company may exchange one insurance policy or investment contract for another offered by the Company, or make modifications to an existing investment or life contract issued by the Company. These transactions are identified as internal replacements for accounting purposes. Internal replacement transactions determined to result in replacement contracts that are substantially unchanged from the replaced contracts are accounted for as continuations of the replaced contracts. Unamortized DAC and DSI related to the replaced contracts continue to be deferred and amortized in connection with the replacement contracts. For interest-sensitive life contracts, the EGP of the replacement contracts are treated as a revision to the EGP of the replaced contracts in the determination of amortization of DAC and DSI. For traditional life insurance policies, any changes to unamortized DAC that result from replacement contracts are treated as prospective revisions. Any costs associated with the issuance of replacement contracts are characterized as maintenance costs and expensed as incurred. Internal replacement transactions determined to result in a substantial change to the replaced contracts are accounted for as an extinguishment of the replaced contracts, and any unamortized DAC and DSI related to the replaced contracts are eliminated with a corresponding charge to amortization of deferred policy acquisition costs or interest credited to contractholder funds, respectively. Reinsurance In the normal course of business, the Company seeks to limit aggregate and single exposure to losses on large risks by purchasing reinsurance. The Company has also used reinsurance to effect the disposition of certain blocks of business. The amounts reported as reinsurance recoverables include amounts billed to reinsurers on losses paid as well as estimates of amounts expected to be recovered from reinsurers on insurance liabilities and contractholder funds that have not yet been paid. Reinsurance recoverables on unpaid losses are estimated based upon assumptions consistent with those used in establishing the liabilities related to the underlying reinsured contracts. Insurance liabilities are reported gross of reinsurance recoverables. Reinsurance premiums are generally reflected in income in a manner consistent with the recognition of premiums on the reinsured contracts. Reinsurance does not extinguish the Company’s primary liability under the policies written. Therefore, the Company regularly evaluates the financial condition of its reinsurers and establishes allowances for uncollectible reinsurance as appropriate. The Company has a reinsurance treaty with ALIC through which it cedes reinvestment related risk on its structured settlement annuities. The terms of the treaty meet the accounting definition of a derivative. Accordingly, the treaty is recorded in the Statement of Financial Position at fair value. Changes in the fair value of the treaty, premiums paid to ALIC and settlements received from ALIC are recognized in realized capital gains and losses. Income taxes Income taxes are accounted for using the asset and liability method under which deferred tax assets and liabilities are recognized for temporary differences between the financial reporting and tax bases of assets and liabilities at the enacted tax rates. The principal assets and liabilities giving rise to such differences are investments (including unrealized capital gains and losses), insurance reserves and DAC. A deferred tax asset valuation allowance is established when it is more likely than not such assets will not be realized. The Company recognizes interest expense related to income tax matters in income tax expense and penalties in operating costs and expenses. Reserve for life-contingent contract benefits The reserve for life-contingent contract benefits payable under insurance policies, including traditional life insurance, life-contingent immediate annuities and voluntary accident and health insurance products, is computed on the basis of long-term actuarial assumptions of future investment yields, mortality, morbidity, policy terminations and expenses. These assumptions, which for traditional life insurance are applied using the net level premium method, include provisions for adverse deviation and generally vary by characteristics such as type of coverage, year of issue and policy duration. The assumptions are established at the time the policy is issued and are generally not changed during the life of the policy. The Company periodically reviews the adequacy of reserves using actual experience and current assumptions. If actual experience and current assumptions are adverse compared to the original assumptions and a premium deficiency is determined to exist, any remaining unamortized DAC balance would be expensed to the extent not recoverable and the establishment of a premium deficiency reserve may be required for any remaining deficiency. In 2019 and 2018, the Company’s reviews concluded that no premium deficiency adjustments were necessary. Prior to fourth quarter 2017, the Company evaluated traditional life insurance products and immediate annuities with life contingencies on an aggregate basis. Beginning in fourth quarter 2017, traditional life insurance products, immediate annuities with life contingencies, and voluntary accident and health insurance are reviewed individually. The Company also reviews these policies for circumstances where projected profits would be recognized in early years followed by projected losses in later years. If this circumstance exists, the Company will accrue a liability, during the period of profits, to offset the losses at such time as the future losses are expected to commence using a method updated prospectively over time. To the extent that unrealized gains on fixed income securities would result in a premium deficiency if those gains were realized, the related increase in reserves for certain immediate annuities with life contingencies is recorded net of tax as a reduction of unrealized net capital gains included in AOCI. Contractholder funds Contractholder funds represent interest-bearing liabilities arising from the sale of products such as interest-sensitive life insurance and fixed annuities. Contractholder funds primarily comprise cumulative deposits received and interest credited to the contractholder less cumulative contract benefits, surrenders, withdrawals and contract charges for mortality or administrative expenses. Contractholder funds also include reserves for secondary guarantees on interest-sensitive life insurance and certain fixed annuity contracts and reserves for certain guarantees on reinsured variable annuity contracts. Separate accounts Separate accounts assets are carried at fair value. The assets of the separate accounts are legally segregated and available only to settle separate accounts contract obligations. Separate accounts liabilities represent the contractholders’ claims to the related assets and are carried at an amount equal to the separate accounts assets. Investment income and realized capital gains and losses of the separate accounts accrue directly to the contractholders and therefore are not included in the Company’s Statements of Operations and Comprehensive Income. Deposits to and surrenders and withdrawals from the separate accounts are reflected in separate accounts liabilities and are not included in cash flows. Absent any contract provision wherein the Company provides a guarantee, variable annuity and variable life insurance contractholders bear the investment risk that the separate accounts’ funds may not meet their stated investment objectives. All of the Company’s variable annuity business was reinsured beginning in 2006. Off-balance Commitments to invest, commitments to purchase private placement securities, commitments to extend mortgage loans and financial guarantees have off-balance Adopted accounting standard Accounting for Hedging Activities Effective January 1, 2019, the Company adopted new Financial Accounting Standards Board (“FASB”) guidance intended to better align hedge accounting with an organization’s risk management activities. The new guidance expands hedge accounting to nonfinancial and financial risk components and revises the measurement methodologies. Separate presentation of hedge ineffectiveness is eliminated with the intention to provide greater transparency to the full impact of hedging by requiring presentation of the results of the hedged item and hedging instrument in a single financial statement line item. In addition, the amendments were designed to reduce complexity by simplifying hedge effectiveness testing. The adoption had no impact on the Company’s results of operations or financial position. Pending accounting standards Measurement of Credit Losses on Financial Instruments In June 2016, the FASB issued guidance which revises the credit loss recognition criteria for certain financial assets measured at amortized cost, including reinsurance recoverables. The new guidance replaces the existing incurred loss recognition model with an expected loss recognition model. The objective of the expected credit loss model is for a reporting entity to recognize its estimate of expected credit losses for affected financial assets in a valuation allowance that when deducted from the amortized cost basis of the related financial assets results in a net carrying value at the amount expected to be collected. The reporting entity must consider all relevant information available when estimating expected credit losses, including details about past events, current conditions, and reasonable and supportable forecasts over the life of an asset. Financial assets may be evaluated individually or on a pooled basis when they share similar risk characteristics. The measurement of credit losses for available-for-sale The Company’s implementation activities, which are being finalized, include review and validation of models, methodologies, data inputs and assumptions to be used to estimate expected credit losses. The implementation impacts relate primarily to the Company’s commercial mortgage loans and reinsurance recoverables and are dependent on economic conditions and judgments at the date of adoption. Based on the economic conditions at the date of adoption and the balances at the reporting date, the Company estimates the application of the current expected credit loss requirements will result in total valuation allowances for credit losses of approximately $12 million as of the date of adoption. After consideration of existing valuation allowances maintained prior to adoption of the new guidance, the Company expects to recognize a cumulative-effect decrease in retained income of approximately $6 million, after-tax, Accounting for Long-Duration Insurance Contracts In August 2018, the FASB issued guidance revising the accounting for certain long-duration insurance contracts. The new guidance introduces material changes to the measurement of the Company’s reserves for traditional life, life-contingent immediate annuities and certain voluntary accident and health insurance products. Under the new guidance, measurement assumptions, including those for mortality, morbidity and policy terminations, will be required to be reviewed and updated at least annually. The effect of updating measurement assumptions other than the discount rate are required to be measured on a retrospective basis and reported in net income. In addition, reserves under the new guidance are required to be discounted using an upper medium grade fixed income instrument yield required to be updated through OCI at each reporting date. Current GAAP requires reserves to utilize assumptions set at policy issuance unless updated current assumptions indicate that recorded reserves are deficient. The new guidance also requires DAC and other capitalized balances currently amortized in proportion to premiums or gross profits to be amortized on a constant level basis over the expected term for all long-duration insurance contracts. DAC will not be subject to loss recognition testing but will be reduced when actual lapse experience exceeds expected experience. The new guidance will no longer require adjustments to DAC and DSI related to unrealized gains and losses on investment securities supporting the related business. All market risk benefit product features will be measured at fair value with changes in fair value recorded in net income with the exception of changes in the fair value attributable to changes in the reporting entity’s own credit risk, which are required to be recognized in OCI. Substantially all of the Company’s market risk benefits are reinsured and therefore these impacts are not expected to be material to the Company. The new guidance will be included in the comparable financial statements issued in reporting periods beginning after December 15, 2021, thereby requiring restatement of prior periods presented. Early adoption is permitted. The new guidance will be applied to affected contracts and DAC on the basis of existing carrying amounts at the earliest period presented or retrospectively using actual historical experience as of contract inception. The new guidance for market risk benefits is required to be adopted retrospectively. The Company is evaluating the anticipated impacts of applying the new guidance to both retained income and AOCI. The requirements of the new guidance represent a material change from existing GAAP, however, the underlying economics of the business and related cash flows are unchanged. The Company is evaluating the specific impacts of adopting the new guidance and anticipates the financial statement impact of adopting the new guidance to be material, largely attributed to the impact of transitioning to a discount rate based on an upper-medium grade fixed income investment yield and updates to mortality assumptions. The Company expects the most significant impacts will occur in the run-off Simplifications to the Accounting for Income Taxes In December 2019, the FASB issued amendments to simplify the accounting for income taxes. The amendments eliminate certain exceptions in the existing guidance including those related to intraperiod tax allocation and deferred tax liability recognition when changes in control of equity method and foreign subsidiary investments occur. The amendments require recognition of the effect of an enacted change in tax laws or rates in the interim period that includes the enactment date, provide an option to not allocate taxes to a legal entity that is not subject to tax as well as other minor changes. The amendments are effective for interim and annual reporting periods beginning after December 15, 2020. The new guidance specifies which amendments should be applied prospectively, retrospective to all periods presented or on a modified retrospective basis through a cumulative-effect adjustment to retained income as of the beginning of the year of adoption. The impact of adoption is not expected to be material to the Company’s results of operations or financial position.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2019
Supplemental Cash Flow Information	3. Supplemental Cash Flow Information Non-cash Liabilities for collateral received in conjunction with the Company’s securities lending program were $158.1 million, $69.8 million and $59.1 million as of December 31, 2019, 2018 and 2017, respectively, and are reported in other liabilities and accrued expenses. The accompanying cash flows are included in cash flows from operating activities in the Statements of Cash Flows along with the activities resulting from management of the proceeds, which for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Net change in proceeds managed Net change in short-term investments $ (88,323 ) $ (10,721 ) $ 1,864 Operating cash flow (used) provided $ (88,323 ) $ (10,721 ) $ 1,864 Net change in liabilities Liabilities for collateral, beginning of year $ (69,788 ) $ (59,067 ) $ (60,931 ) Liabilities for collateral, end of year (158,111 ) (69,788 ) (59,067 ) Operating cash flow provided (used) $ 88,323 $ 10,721 $ (1,864 )

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2019
Related Party Transactions	4. Related Party Transactions Business operations The Company uses services performed by AIC, ALIC and other affiliates, and business facilities owned or leased and operated by AIC in conducting its business activities. In addition, the Company shares the services of employees with AIC. The Company reimburses its affiliates for the operating expenses incurred on behalf of the Company. The Company is charged for the cost of these operating expenses based on the level of services provided. Operating expenses, including compensation, retirement and other benefit programs (see Note 14), allocated to the Company were $45.0 million, $46.2 million and $46.3 million in 2019, 2018 and 2017, respectively. A portion of these expenses relate to the acquisition of business, which are deferred and amortized into income as described in Note 2. Structured settlement annuities The Company previously issued structured settlement annuities, a type of immediate annuity, to fund structured settlements in matters involving AIC. In most cases, these annuities were issued under a “qualified assignment” whereby Allstate Assignment Company and prior to July 1, 2001 Allstate Settlement Corporation (“ASC”), both wholly owned subsidiaries of ALIC, purchased annuities from the Company and assumed AIC’s obligation to make future payments. AIC issued surety bonds to guarantee the payment of structured settlement benefits assumed by ASC (from both AIC and non-related Broker-Dealer agreements The Company receives distribution services from Allstate Financial Services, LLC, an affiliated broker-dealer company, for certain annuity and variable life insurance contracts sold by Allstate exclusive agencies and exclusive financial specialists. For these services, the Company incurred commission and other distribution expenses of $317 thousand, $215 thousand and $259 thousand in 2019, 2018 and 2017, respectively. The Company has a service agreement with Allstate Distributors, LLC (“ADLLC”), a broker-dealer company owned by ALIC, whereby ADLLC promotes and markets products sold by the Company. In return for these services, the Company recorded expense of $3 thousand, $5 thousand and $6 thousand in 2019, 2018 and 2017, respectively. Reinsurance The Company has reinsurance agreements with ALIC whereby a portion of the Company’s premiums and policy benefits are ceded to ALIC (see Note 9). The Company has a reinsurance treaty (the “structured settlement annuity reinsurance agreement”) through which it cedes reinvestment related risk on its structured settlement annuities to ALIC. Under the terms of the treaty, the Company pays a premium to ALIC that varies with the aggregate structured settlement annuity statutory reserve balance. In return, ALIC guarantees that the yield on the portion of the Company’s investment portfolio that supports structured settlement annuity liabilities will not fall below contractually determined rates. The Company ceded premium related to structured settlement annuities to ALIC of $4.2 million, $3.4 million and $3.5 million in 2019, 2018 and 2017, respectively. The Company received settlements from ALIC of $1.0 million, zero and zero in 2019, 2018 and 2017, respectively. As of December 31, 2019 and 2018, the carrying value of the structured settlement reinsurance treaty was $231.5 million and $169.4 million, respectively, which is recorded in other assets. The premiums ceded and changes in the fair value of the reinsurance treaty are reflected as a component of realized capital gains and losses as the treaty is recorded as a derivative instrument. In 2019, ALIC established a trust for the benefit of the Company and will maintain it with assets equal to or greater than the Company’s statutory-basis cession. As of December 31, 2019, the trust held $1.45 billion of investments. Income taxes The Company is a party to a federal income tax allocation agreement with the Corporation (see Note 12). Intercompany loan agreement The Company has an intercompany loan agreement with the Corporation. The amount of intercompany loans available to the Company is at the discretion of the Corporation. The maximum amount of loans the Corporation will have outstanding to all its eligible subsidiaries at any given point in time is limited to $1.00 billion. The Corporation may use commercial paper borrowings, bank lines of credit and securities lending to fund intercompany borrowings. The Company had no amounts outstanding under the intercompany loan agreement as of December 31, 2019 or 2018.

Investments

Investments	12 Months Ended
	Dec. 31, 2019
Investments	5. Investments Fair values The amortized cost, gross unrealized gains and losses and fair value for fixed income securities are as follows: Amortized cost Gross unrealized Fair value ($ in thousands) Gains Losses December 31, 2019 U.S. government and agencies $ 43,280 $ 9,534 $ — $ 52,814 Municipal 433,038 119,242 — 552,280 Corporate 3,400,471 277,338 (2,564 ) 3,675,245 Foreign government 133,635 6,531 — 140,166 MBS 12,683 1,174 — 13,857 Total fixed income securities $ 4,023,107 $ 413,819 $ (2,564 ) $ 4,434,362 December 31, 2018 U.S. government and agencies $ 76,070 $ 9,394 $ — $ 85,464 Municipal 615,511 88,530 (118 ) 703,923 Corporate 3,514,421 118,369 (69,959 ) 3,562,831 Foreign government 128,926 7,896 — 136,822 ABS 19,906 — (18 ) 19,888 MBS 20,276 1,166 (26 ) 21,416 Total fixed income securities $ 4,375,110 $ 225,355 $ (70,121 ) $ 4,530,344 Scheduled maturities The scheduled maturities for fixed income securities are as follows: As of December 31, 2019 ($ in thousands) Amortized Fair value Due in one year or less $ 319,944 $ 322,640 Due after one year through five years 1,257,931 1,320,313 Due after five years through ten years 1,613,303 1,733,809 Due after ten years 819,246 1,043,743 4,010,424 4,420,505 MBS 12,683 13,857 Total $ 4,023,107 $ 4,434,362 Actual maturities may differ from those scheduled as a result of calls and make-whole payments by the issuers. MBS is shown separately because of the potential for prepayment of principal prior to contractual maturity dates. Net investment income Net investment income for the years ended December 31 is as follows: ($ in thousands) 2019 2018 2017 Fixed income securities $ 208,816 $ 214,039 $ 228,507 Mortgage loans 32,566 30,920 28,263 Equity securities 4,283 5,565 5,465 Limited partnership interests 15,348 43,365 53,917 Short-term investments 4,393 2,966 1,200 Policy loans 2,343 2,339 2,443 Investment income, before expense 267,749 299,194 319,795 Investment expense (11,743 ) (11,311 ) (9,100 ) Net investment income $ 256,006 $ 287,883 $ 310,695 Realized capital gains and losses Realized capital gains (losses) by asset type for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Fixed income securities $ 1,389 $ (1,306 ) $ 5,436 Mortgage loans — 466 1,128 Equity securities 40,780 (16,364 ) 799 Limited partnership interests 5,383 (3,895 ) 6,451 Derivatives 59,087 638 52,506 Short-term investments (12 ) (93 ) 12 Realized capital gains (losses) $ 106,627 $ (20,554 ) $ 66,332 Realized capital gains (losses) by transaction type for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Impairment write-downs $ (169 ) $ (285 ) $ (5,370 ) Sales 4,698 (1,548 ) 19,196 Valuation of equity investments (1) 43,011 (19,359 ) — Valuation and settlements of derivative instruments 59,087 638 52,506 Realized capital gains (losses) $ 106,627 $ (20,554 ) $ 66,332 (1) Includes valuation of equity securities and certain limited partnership interests where the underlying assets are predominately public equity securities. Sales of fixed income securities resulted in gross gains of $4.9 million, $4.4 million, and $19.8 million and gross losses of $3.3 million, $5.4 million and $8.2 million during 2019, 2018 and 2017, respectively. The following table presents the net pre-tax For the years ended ($ in thousands) 2019 2018 Equity securities $ 29,558 $ (12,897 ) Limited partnership interests carried at fair value 9,165 16,968 Total $ 38,723 $ 4,071 OTTI losses by asset type for the years ended December 31 are as follows: 2019 2018 2017 ($ in thousands) Gross Included Net Gross Included Net Gross Included Net Fixed income securities: Corporate $ — $ — $ — $ — $ — $ — $ (1,481 ) $ — $ (1,481 ) MBS (1,202 ) 1,033 (169 ) (68 ) (217 ) (285 ) (2,338 ) 893 (1,445 ) Total fixed income securities (1,202 ) 1,033 (169 ) (68 ) (217 ) (285 ) (3,819 ) 893 (2,926 ) Equity securities — — — — — — (2,422 ) — (2,422 ) Limited partnership interests — — — — — — (22 ) — (22 ) OTTI losses $ (1,202 ) $ 1,033 $ (169 ) $ (68 ) $ (217 ) $ (285 ) $ (6,263 ) $ 893 $ (5,370 ) The total amount of OTTI losses included in AOCI at the time of impairment for fixed income securities, which were not included in earnings, are presented in the following table. ($ in thousands) December 31, December 31, MBS (1) $ (1,188 ) $ (358 ) (1) The amounts exclude $2.0 million and $1.9 million as of December 31, 2019 and 2018, respectively, of net unrealized gains related to changes in valuation of the fixed income securities subsequent to the impairment measurement date. Rollforwards of the cumulative credit losses recognized in earnings for fixed income securities held as of December 31 are as follows: ($ in thousands) 2019 2018 2017 Beginning balance $ (2,684 ) $ (3,192 ) $ (4,594 ) Additional credit loss for securities previously other-than-temporarily impaired (169 ) (285 ) (128 ) Additional credit loss for securities not previously other-than-temporarily impaired — — (2,798 ) Reduction in credit loss for securities disposed or collected 1,740 793 4,328 Ending balance $ (1,113 ) $ (2,684 ) $ (3,192 ) The Company uses its best estimate of future cash flows expected to be collected from the fixed income security, discounted at the security’s original or current effective rate, as appropriate, to calculate a recovery value and determine whether a credit loss exists. The determination of cash flow estimates is inherently subjective, and methodologies may vary depending on facts and circumstances specific to the security. All reasonably available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable assumptions and forecasts, are considered when developing the estimate of cash flows expected to be collected. That information generally includes, but is not limited to, the remaining payment terms of the security, prepayment speeds, foreign exchange rates, the financial condition and future earnings potential of the issue or issuer, expected defaults, expected recoveries, the value of underlying collateral, vintage, geographic concentration of underlying collateral, available reserves or escrows, current subordination levels, third party guarantees and other credit enhancements. Other information, such as industry analyst reports and forecasts, sector credit ratings, financial condition of the bond insurer for insured fixed income securities, and other market data relevant to the realizability of contractual cash flows, may also be considered. The estimated fair value of collateral will be used to estimate recovery value if the Company determines that the security is dependent on the liquidation of collateral for ultimate settlement. If the estimated recovery value is less than the amortized cost of the security, a credit loss exists and an OTTI for the difference between the estimated recovery value and amortized cost is recorded in earnings. The portion of the unrealized loss related to factors other than credit remains classified in AOCI. If the Company determines that the fixed income security does not have sufficient cash flow or other information to estimate a recovery value for the security, the Company may conclude that the entire decline in fair value is deemed to be credit related and the loss is recorded in earnings. Unrealized net capital gains and losses Unrealized net capital gains and losses included in AOCI are as follows: ($ in thousands) Fair value Gross unrealized Unrealized net December 31, 2019 Gains Losses Fixed income securities $ 4,434,362 $ 413,819 $ (2,564 ) $ 411,255 Short-term investments 224,098 4 (17 ) (13 ) EMA limited partnerships (1) (205 ) Unrealized net capital gains and losses, pre-tax 411,037 Amounts recognized for: Insurance reserves (2) (231,357 ) DAC and DSI (3) (21,820 ) Amounts recognized (253,177 ) Deferred income taxes (33,151 ) Unrealized net capital gains and losses, after-tax $ 124,709 December 31, 2018 Fixed income securities $ 4,530,344 $ 225,355 $ (70,121 ) $ 155,234 Short-term investments 88,548 — (4 ) (4 ) EMA limited partnerships (50 ) Unrealized net capital gains and losses, pre-tax 155,180 Amounts recognized for: Insurance reserves (80,628 ) DAC and DSI (2,277 ) Amounts recognized (82,905 ) Deferred income taxes (15,178 ) Unrealized net capital gains and losses, after-tax $ 57,097 (1) Unrealized net capital gains and losses for limited partnership interests represent the Company’s share of EMA limited partnerships’ OCI. Fair value and gross unrealized gains and losses are not applicable. (2) The insurance reserves adjustment represents the amount by which the reserve balance would increase if the net unrealized gains in the applicable product portfolios were realized and reinvested at lower interest rates, resulting in a premium deficiency. This adjustment primarily relates to structured settlement annuities with life contingencies (a type of immediate annuities with life contingencies). (3) The DAC and DSI adjustment balance represents the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized gains or losses in the respective product portfolios were realized. Change in unrealized net capital gains and losses The change in unrealized net capital gains and losses for the years ended December 31 is as follows: ($ in thousands) 2019 2018 2017 Fixed income securities $ 256,021 $ (212,483 ) $ 29,700 Equity securities (1) — — 32,927 Short-term investments (9 ) 9 (12 ) EMA limited partnerships (155 ) (40 ) 51 Total 255,857 (212,514 ) 62,666 Amounts recognized for: Insurance reserves (150,729 ) 141,714 (165,992 ) DAC and DSI (19,543 ) 6,780 1,465 Amounts recognized (170,272 ) 148,494 (164,527 ) Deferred income taxes (17,973 ) 13,445 60,664 Increase (decrease) in unrealized net capital gains and losses, after-tax $ 67,612 $ (50,575 ) $ (41,197 ) (1) Upon adoption of the recognition and measurement accounting standard on January 1, 2018, $42.4 million of pre-tax Portfolio monitoring The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income security whose carrying value may be other-than-temporarily impaired. For each fixed income security in an unrealized loss position, the Company assesses whether management with the appropriate authorityhas made the decision to sell or whether it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes. If a security meets either of these criteria, the security’s decline in fair value is considered other than temporary and is recorded in earnings. If the Company has not made the decision to sell the fixed income security and it is not more likely than not the Company will be required to sell the fixed income security before recovery of its amortized cost basis, the Company evaluates whether it expects to receive cash flows sufficient to recover the entire amortized cost basis of the security. The Company calculates the estimated recovery value by discounting the best estimate of future cash flows at the security’s original or current effective rate, as appropriate, and compares this to the amortized cost of the security. If the Company does not expect to receive cash flows sufficient to recover the entire amortized cost basis of the fixed income security, the credit loss component of the impairment is recorded in earnings, with the remaining amount of the unrealized loss related to other factors recognized in OCI. The Company’s portfolio monitoring process includes a quarterly review of all securities to identify instances where the fair value of a security compared to its amortized cost is below established thresholds. The process also includes the monitoring of other impairment indicators such as ratings, ratings downgrades and payment defaults. The securities identified, in addition to other securities for which the Company may have a concern, are evaluated for potential OTTI using all reasonably available information relevant to the collectability or recovery of the security. Inherent in the Company’s evaluation of OTTI for these securities are assumptions and estimates about the financial condition and future earnings potential of the issue or issuer. Some of the factors that may be considered in evaluating whether a decline in fair value is other than temporary are: 1) the financial condition, near-term and long-term prospects of the issue or issuer, including relevant industry specific market conditions and trends, geographic location and implications of rating agency actions and offering prices; 2) the specific reasons that a security is in an unrealized loss position, including overall market conditions which could affect liquidity; and 3) the length of time and extent to which the fair value has been less than amortized cost. The following table summarizes the gross unrealized losses and fair value of securities by the length of time that individual securities have been in a continuous unrealized loss position. ($ in thousands) Less than 12 months 12 months or more Total Number Fair Unrealized Number Fair Unrealized December 31, 2019 Fixed income securities Corporate 44 $ 104,484 $ (815 ) 17 $ 31,900 $ (1,749 ) $ (2,564 ) MBS 2 38 — 2 1 — — Total fixed income securities 46 $ 104,522 $ (815 ) 19 $ 31,901 $ (1,749 ) $ (2,564 ) Investment grade fixed income securities 22 $ 82,142 $ (347 ) 3 $ 9,845 $ (130 ) $ (477 ) Below investment grade fixed income securities 24 22,380 (468 ) 16 22,056 (1,619 ) (2,087 ) Total fixed income securities 46 $ 104,522 $ (815 ) 19 $ 31,901 $ (1,749 ) $ (2,564 ) December 31, 2018 Fixed income securities Municipal 1 $ 9,371 $ (11 ) 1 $ 4,893 $ (107 ) $ (118 ) Corporate 451 1,308,566 (40,510 ) 123 480,729 (29,449 ) (69,959 ) ABS 1 10,010 (9 ) 1 9,878 (9 ) (18 ) MBS 90 1,086 (5 ) 20 939 (21 ) (26 ) Total fixed income securities 543 $ 1,329,033 $ (40,535 ) 145 $ 496,439 $ (29,586 ) $ (70,121 ) Investment grade fixed income securities 309 $ 1,111,745 $ (27,375 ) 122 $ 470,388 $ (26,471 ) $ (53,846 ) Below investment grade fixed income securities 234 217,288 (13,160 ) 23 26,051 (3,115 ) (16,275 ) Total fixed income securities 543 $ 1,329,033 $ (40,535 ) 145 $ 496,439 $ (29,586 ) $ (70,121 ) The following table summarizes gross unrealized losses by unrealized loss position and credit quality as of December 31, 2019. ($ in thousands) Investment Below investment Total Fixed income securities with unrealized loss position less than 20% of amortized cost (1) (2) $ (477 ) $ (1,722 ) $ (2,199 ) Fixed income securities with unrealized loss position greater than or equal to 20% of amortized cost (3) (4) — (365 ) (365 ) Total unrealized losses $ (477 ) $ (2,087 ) $ (2,564 ) (1) Below investment grade fixed income securities include $468 thousand that have been in an unrealized loss position for less than twelve months. (2) Related to securities with an unrealized loss position less than 20% of amortized cost, the degree of which suggests that these securities do not pose a high risk of being other-than-temporarily impaired. (3) No below investment grade fixed income securities have been in an unrealized loss position for a period of twelve or more consecutive months. (4) Evaluated based on factors such as discounted cash flows and the financial condition and near-term and long-term prospects of the issue or issuer and were determined to have adequate resources to fulfill contractual obligations. Investment grade is defined as a security having a rating of Aaa, Aa, A or Baa from Moody’s, a rating of AAA, AA, A or BBB from S&P Global Ratings (“S&P”), a comparable rating from another nationally recognized rating agency, or a comparable internal rating if an externally provided rating is not available. Market prices for certain securities may have credit spreads which imply higher or lower credit quality than the current third-party rating. Unrealized losses on investment grade securities are principally related to an increase in market yields which may include increased risk-free interest rates and/or wider credit spreads since the time of initial purchase. The unrealized losses are expected to reverse as the securities approach maturity. ABS and MBS in an unrealized loss position were evaluated based on actual and projected collateral losses relative to the securities’ positions in the respective securitization trusts, security specific expectations of cash flows, and credit ratings. This evaluation also takes into consideration credit enhancement, measured in terms of (i) subordination from other classes of securities in the trust that are contractually obligated to absorb losses before the class of security the Company owns, and (ii) the expected impact of other structural features embedded in the securitization trust beneficial to the class of securities the Company owns, such as overcollateralization and excess spread. Municipal bonds in an unrealized loss position were evaluated based on the underlying credit quality of the primary obligor, obligation type and quality of the underlying assets. As of December 31, 2019, the Company has not made the decision to sell and it is not more likely than not the Company will be required to sell fixed income securities with unrealized losses before recovery of the amortized cost basis. Limited partnerships Investments in limited partnership interests include interests in private equity funds, real estate funds and other funds. As of December 31, 2019 and 2018, the carrying value of EMA limited partnerships totaled $277.2 million and $278.1 million, respectively, and limited partnerships carried at fair value totaled $109.1 million and $104.8 million, respectively. Principal factors influencing carrying value appreciation or decline include operating performance, comparable public company earnings multiples, capitalization rates and the economic environment. For equity method limited partnerships, the Company recognizes an impairment loss when evidence demonstrates that the loss is other than temporary. Evidence of a loss in value that is other than temporary may include the absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain a level of earnings that would justify the carrying amount of the investment. Changes in fair value limited partnerships are recorded through net investment income and therefore are not tested for impairment. Mortgage loans The Company’s mortgage loans are commercial mortgage loans collateralized by a variety of commercial real estate property types located across the United States and totaled, net of valuation allowance, $733.3 million and $696.1 million as of December 31, 2019 and 2018, respectively. Substantially all of the commercial mortgage loans are non-recourse The following table shows the principal geographic distribution of commercial real estate represented in the Company’s mortgage loan portfolio. No other state represented more than 5% of the portfolio as of December 31. (% of mortgage loan portfolio carrying value) 2019 2018 Texas 19.9 % 16.1 % California 16.7 18.4 North Carolina 8.2 8.8 Utah 5.9 2.1 Nevada 5.8 6.3 New Jersey 5.6 6.6 Illinois 5.5 6.1 The types of properties collateralizing the mortgage loans as of December 31 are as follows: (% of mortgage loan portfolio carrying value) 2019 2018 Apartment complex 32.6 % 31.3 % Office buildings 27.4 27.2 Warehouse 16.5 15.7 Retail 15.6 17.3 Other 7.9 8.5 Total 100.0 % 100.0 % The contractual maturities of the mortgage loan portfolio as of December 31, 2019 are as follows: ($ in thousands) Number Carrying Percent 2020 2 $ 7,235 1.0 % 2021 9 57,821 7.9 2022 10 61,004 8.3 2023 14 111,481 15.2 Thereafter 62 495,717 67.6 Total 97 $ 733,258 100.0 % Mortgage loans are evaluated for impairment on a specific loan basis through a quarterly credit monitoring process and review of key credit quality indicators. Mortgage loans are considered impaired when it is probable that the Company will not collect the contractual principal and interest. Valuation allowances are established for impaired loans to reduce the carrying value to the fair value of the collateral less costs to sell or the present value of the loan’s expected future repayment cash flows discounted at the loan’s original effective interest rate. Impaired mortgage loans may not have a valuation allowance when the fair value of the collateral less costs to sell is higher than the carrying value. Valuation allowances are adjusted for subsequent changes in the fair value of the collateral less costs to sell or present value of the loan’s expected future repayment cash flows. Mortgage loans are charged off against their corresponding valuation allowances when there is no reasonable expectation of recovery. The impairment evaluation is non-statistical Accrual of income is suspended for mortgage loans that are in default or when full and timely collection of principal and interest payments is not probable. Cash receipts on mortgage loans on nonaccrual status are generally recorded as a reduction of carrying value. Debt service coverage ratio is considered a key credit quality indicator when mortgage loans are evaluated for impairment. Debt service coverage ratio represents the amount of estimated cash flows from the property available to the borrower to meet principal and interest payment obligations. Debt service coverage ratio estimates are updated annually or more frequently if conditions are warranted based on the Company’s credit monitoring process. The following table reflects the carrying value of non-impaired 2019 2018 ($ in thousands) Debt service coverage ratio distribution Fixed rate Variable Total Fixed rate Variable Total Below 1.0 $ — $ — $ — $ — $ — $ — 1.0 - 1.25 48,780 — 48,780 25,447 — 25,447 1.26 - 1.50 221,384 — 221,384 189,063 — 189,063 Above 1.50 434,675 28,419 463,094 453,153 28,399 481,552 Total non-impaired $ 704,839 $ 28,419 $ 733,258 $ 667,663 $ 28,399 $ 696,062 Mortgage loans with a debt service coverage ratio below 1.0 that are not considered impaired primarily relate to instances where the borrower has the financial capacity to fund the revenue shortfalls from the properties for the foreseeable term, the decrease in cash flows from the properties is considered temporary, or there are other risk mitigating circumstances such as additional collateral, escrow balances or borrower guarantees. There were no impaired mortgage loans and no valuation allowances as of December 31, 2019 or 2018. Payments on all mortgage loans were current as of December 31, 2019, 2018 and 2017. Municipal bonds The Company maintains a diversified portfolio of municipal bonds which totaled $552.3 million and $703.9 million as of December 31, 2019 and 2018, respectively. The municipal bond portfolio includes general obligations of state and local issuers and revenue bonds (including pre-refunded (% of municipal bond portfolio carrying value) 2019 2018 California 33.3 % 28.1 % Texas 10.8 12.2 Oregon 10.6 7.6 Illinois 8.0 5.9 Short-term investments Short-term investments, including money market funds, commercial paper, U.S. Treasury bills and other short-term investments, are carried at fair value. As of December 31, 2019 and 2018, the fair value of short-term investments totaled $224.1 million and $88.5 million, respectively. Policy loans Policy loans are carried at unpaid principal balances. As of December 31, 2019 and 2018, the carrying value of policy loans totaled $38.6 million and $39.4 million, respectively. Other investments Other investments consist of derivatives. Derivatives are carried at fair value. As of December 31, 2019 and 2018, the fair value of derivatives totaled $5.2 million and $653 thousand, respectively. Concentration of credit risk As of December 31, 2019, the Company is not exposed to any credit concentration risk of a single issuer and its affiliates greater than 10% of the Company’s shareholder’s equity, other than the U.S. government and its agencies. Securities loaned The Company’s business activities include securities lending programs with third parties, mostly large banks. As of December 31, 2019 and 2018, fixed income and equity securities with a carrying value of $152.3 million and $66.6 million, respectively, were on loan under these agreements. Interest income on collateral, net of fees, was $342 thousand, $286 thousand and $235 thousand in 2019, 2018 and 2017, respectively. Other investment information Included in fixed income securities are below investment grade assets totaling $406.0 million and $279.2 million as of December 31, 2019 and 2018, respectively. As of December 31, 2019, fixed income securities with a carrying value of $2.2 million were on deposit with regulatory authorities as required by law. As of December 31, 2019, there were no fixed income securities or other investments that were non-income

Fair Value of Assets and Liabil

Fair Value of Assets and Liabilities	12 Months Ended
	Dec. 31, 2019
Fair Value of Assets and Liabilities	6. Fair Value of Assets and Liabilities Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The hierarchy for inputs used in determining fair value maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Assets and liabilities recorded on the Statements of Financial Position at fair value are categorized in the fair value hierarchy based on the observability of inputs to the valuation techniques as follows: Level 1: Assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company can access. Level 2: Assets and liabilities whose values are based on the following: (a) Quoted prices for similar assets or liabilities in active markets; (b) Quoted prices for identical or similar assets or liabilities in markets that are not active; or (c) Valuation models whose inputs are observable, directly or indirectly, for substantially the full term of the asset or liability. Level 3: Assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. Unobservable inputs reflect the Company’s estimates of the assumptions that market participants would use in valuing the assets and liabilities. The availability of observable inputs varies by instrument. In situations where fair value is based on internally developed pricing models or inputs that are unobservable in the market, the determination of fair value requires more judgment. The degree of judgment exercised by the Company in determining fair value is typically greatest for instruments categorized in Level 3. In many instances, valuation inputs used to measure fair value fall into different levels of the fair value hierarchy. The category level in the fair value hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company uses prices and inputs that are current as of the measurement date, including during periods of market disruption. In periods of market disruption, the ability to observe prices and inputs may be reduced for many instruments. The Company is responsible for the determination of fair value and the supporting assumptions and methodologies. The Company gains assurance that assets and liabilities are appropriately valued through the execution of various processes and controls designed to ensure the overall reasonableness and consistent application of valuation methodologies, including inputs and assumptions, and compliance with accounting standards. For fair values received from third parties or internally estimated, the Company’s processes and controls are designed to ensure that the valuation methodologies are appropriate and consistently applied, the inputs and assumptions are reasonable and consistent with the objective of determining fair value, and the fair values are accurately recorded. For example, on a continuing basis, the Company assesses the reasonableness of individual fair values that have stale security prices or that exceed certain thresholds as compared to previous fair values received from valuation service providers or brokers or derived from internal models. The Company performs procedures to understand and assess the methodologies, processes and controls of valuation service providers. In addition, the Company may validate the reasonableness of fair values by comparing information obtained from valuation service providers or brokers to other third party valuation sources for selected securities. The Company performs ongoing price validation procedures such as back-testing of actual sales, which corroborate the various inputs used in internal models to market observable data. When fair value determinations are expected to be more variable, the Company validates them through reviews by members of management who have relevant expertise and who are independent of those charged with executing investment transactions. The Company has two types of situations where investments are classified as Level 3 in the fair value hierarchy. (1) Specific inputs significant to the fair value estimation models are not market observable. This primarily occurs in the Company’s use of broker quotes to value certain securities where the inputs have not been corroborated to be market observable, and the use of valuation models that use significant non-market (2) Quotes continue to be received from independent third-party valuation service providers and all significant inputs are market observable; however, there has been a significant decrease in the volume and level of activity for the asset when compared to normal market activity such that the degree of market observability has declined to a point where categorization as a Level 3 measurement is considered appropriate. The indicators considered in determining whether a significant decrease in the volume and level of activity for a specific asset has occurred include the level of new issuances in the primary market, trading volume in the secondary market, the level of credit spreads over historical levels, applicable bid-ask Certain assets are not carried at fair value on a recurring basis, including investments such as mortgage loans and policy loans. Accordingly, such investments are only included in the fair value hierarchy disclosure when the investment is subject to remeasurement at fair value after initial recognition and the resulting remeasurement is reflected in the financial statements. In determining fair value, the Company principally uses the market approach which generally utilizes market transaction data for the same or similar instruments. To a lesser extent, the Company uses the income approach which involves determining fair values from discounted cash flow methodologies. For the majority of Level 2 and Level 3 valuations, a combination of the market and income approaches is used. Summary of significant inputs and valuation techniques for Level 2 and Level 3 assets and liabilities measured at fair value on a recurring basis Level 2 measurements • Fixed income securities: U.S. government and agencies, municipal, corporate - public and foreign government: Corporate - privately placed: Corporate - privately placed also includes redeemable preferred stock that are valued using quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields, underlying stock prices and credit spreads. ABS and MBS: non-binding • Equity securities • Short-term: • Other investments Over-the-counter Level 3 measurements • Fixed income securities: Municipal: non-binding Corporate - public and privately placed: non-binding • Equity securities: • Other investments: non-market • Other assets: non-market • Contractholder funds: non-market Investments excluded from the fair value hierarchy Limited partnerships carried at fair value, which do not have readily determinable fair values, use NAV provided by the investees and are excluded from the fair value hierarchy. These investments are generally not redeemable by the investees and generally cannot be sold without approval of the general partner. The Company receives distributions of income and proceeds from the liquidation of the underlying assets of the investees, which usually takes place in years 4-9 10-12 The following table summarizes the Company’s assets and liabilities measured at fair value as of December 31, 2019. ($ in thousands) Quoted prices Significant Significant Counterparty Balance Assets Fixed income securities: U.S. government and agencies $ 2,250 $ 50,564 $ — $ 52,814 Municipal — 530,584 21,696 552,280 Corporate - public — 2,688,680 5,221 2,693,901 Corporate - privately placed — 962,072 19,272 981,344 Foreign government — 140,166 — 140,166 MBS — 13,857 — 13,857 Total fixed income securities 2,250 4,385,923 46,189 4,434,362 Equity securities 265,195 858 8,080 274,133 Short-term investments 124,763 99,335 — 224,098 Other investments: Free-standing derivatives — 6,008 75 $ (846 ) 5,237 Separate account assets 265,546 — — 265,546 Other assets — — 231,491 231,491 Total recurring basis assets $ 657,754 $ 4,492,124 $ 285,835 $ (846 ) $ 5,434,867 % of total assets at fair value 12.1 % 82.6 % 5.3 % — % 100.0 % Investments reported at NAV 109,066 Total $ 5,543,933 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ — $ — $ (16,653 ) $ (16,653 ) Other liabilities: Free-standing derivatives — (2,920 ) — $ 15 (2,905 ) Total recurring basis liabilities $ — $ (2,920 ) $ (16,653 ) $ 15 $ (19,558 ) % of total liabilities at fair value — % 15.0 % 85.1 % (0.1 )% 100.0 % The following table summarizes the Company’s assets and liabilities measured at fair value as of December 31, 2018. ($ in thousands) Quoted prices Significant Significant Counterparty Balance Assets Fixed income securities: U.S. government and agencies $ 36,299 $ 49,165 $ — $ 85,464 Municipal — 683,102 20,821 703,923 Corporate - public — 2,437,942 6,761 2,444,703 Corporate - privately placed — 1,106,938 11,190 1,118,128 Foreign government — 136,822 — 136,822 ABS — 19,888 — 19,888 MBS — 21,416 — 21,416 Total fixed income securities 36,299 4,455,273 38,772 4,530,344 Equity securities 172,077 731 12,162 184,970 Short-term investments 50,353 38,195 — 88,548 Other investments: Free-standing derivatives — 1,240 394 $ (981 ) 653 Separate account assets 241,710 — 241,710 Other assets 1 — 169,386 169,387 Total recurring basis assets $ 500,440 $ 4,495,439 $ 220,714 $ (981 ) $ 5,215,612 % of total assets at fair value 9.6 % 86.2 % 4.2 % — % 100.0 % Investments reported at NAV 104,778 Total $ 5,320,390 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ — $ — $ (3,801) $ (3,801 ) Other liabilities: Free-standing derivatives — (192 ) — $ 11 (181 ) Total recurring basis liabilities $ — $ (192 ) $ (3,801) $ 11 $ (3,982 ) % of total liabilities at fair value — % 4.8 % 95.5 % (0.3 )% 100.0 % The following table summarizes quantitative information about the significant unobservable inputs used in Level 3 fair value measurements. ($ in thousands) Fair value Valuation Unobservable Range Weighted December 31, 2019 Other assets – Structured settlement annuity reinsurance agreement $ 231,491 Stochastic cash Ultimate 129.8 - 203.6 165.7 basis Derivatives embedded in life contracts – equity-indexed and forward starting options $ (14,239 ) Stochastic cash Projected 3.9 - 4.2% 4.00% December 31, 2018 Other assets – Structured settlement annuity reinsurance agreement $ 169,386 Stochastic cash Ultimate 129.8 - 218.6 169.3 basis If the ultimate reinvestment spreads increased (decreased), it would result in a lower (higher) fair value for the structured settlement annuity reinsurance agreement. The embedded derivatives are equity-indexed and forward starting options in certain life products that provide customers with interest crediting rates based on the performance of the S&P 500. If the projected option cost increased (decreased), it would result in a higher (lower) liability fair value. As of December 31, 2019 and 2018, Level 3 fair value measurements of fixed income securities total $46.2 million and $38.8 million, respectively, and include $8.4 million and $33.4 million, respectively, of securities valued based on non-binding non-binding The following table presents the rollforward of Level 3 assets and liabilities held at fair value during the year ended December 31, 2019. ($ in thousands) Total gains (losses) Balance as of Net OCI Transfers Transfers out of Level 3 Assets Fixed income securities: Municipal $ 20,821 $ — $ 1,695 $ — $ — Corporate - public 6,761 1 542 — (2,083 ) Corporate - privately placed 11,190 6 422 13,987 — Total fixed income securities 38,772 7 2,659 13,987 (2,083 ) Equity securities 12,162 2,653 — — (16 ) Free-standing derivatives, net 394 (200 ) — — — Other assets 169,386 62,105 — — — Total recurring Level 3 assets $ 220,714 $ 64,565 $ 2,659 $ 13,987 $ (2,099 ) Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ (3,801 ) $ (1,664 ) $ — $ (10,128 ) $ — Total recurring Level 3 liabilities $ (3,801 ) $ (1,664 ) $ — $ (10,128 ) $ — Purchases Sales Issues Settlements Balance as of Assets Fixed income securities: Municipal $ — $ (820 ) $ — $ — $ 21,696 Corporate - public — — — — 5,221 Corporate - privately placed — — — (6,333 ) 19,272 Total fixed income securities — (820 ) — (6,333 ) 46,189 Equity securities 210 (6,768 ) — (161 ) 8,080 Free-standing derivatives, net 18 — — (137 ) 75 (1) Other assets — — — — 231,491 Total recurring Level 3 assets $ 228 $ (7,588 ) $ — $ (6,631 ) $ 285,835 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ — $ — $ (1,283 ) $ 223 $ (16,653 ) Total recurring Level 3 liabilities $ — $ — $ (1,283 ) $ 223 $ (16,653 ) (1) Comprises $75 thousand of assets The following table presents the total Level 3 gains (losses) included in net income for the year ended December 31, 2019. ($ in thousands) Net investment Realized capital Contract Interest credited to Total Components of net income $ (535 ) $ 65,100 $ 987 $ (2,651 ) $ 62,901 The following table presents the rollforward of Level 3 assets and liabilities held at fair value during the year ended December 31, 2018. ($ in thousands) Total gains (losses) Balance as of Net OCI Transfers into Level 3 Transfers out of Level 3 Assets Fixed income securities: Municipal $ 21,178 $ — $ (357 ) $ — $ — Corporate - public 7,312 1 (383 ) — — Corporate - privately placed 55,979 4 (639 ) — (22,957 ) ABS 15,205 — (205 ) — — Total fixed income securities 99,674 5 (1,584 ) — (22,957 ) Equity securities 7,159 2,600 (5 ) — — Free-standing derivatives, net 336 65 — — — Other assets 166,290 3,096 — — — Total recurring Level 3 assets $ 273,459 $ 5,766 $ (1,589 ) $ — $ (22,957 ) Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ (4,796 ) $ 995 $ — $ — $ — Total recurring Level 3 liabilities $ (4,796 ) $ 995 $ — $ — $ — Purchases Sales Issues Settlements Balance as of Assets Fixed income securities: Municipal $ — $ — $ — $ — $ 20,821 Corporate - public — — — (169 ) 6,761 Corporate - privately placed — — — (21,197 ) 11,190 ABS — — — (15,000 ) — Total fixed income securities — — — (36,366 ) 38,772 Equity securities 3,723 (1,315 ) — — 12,162 Free-standing derivatives, net 66 — — (73 ) 394 (1) Other assets — — — — 169,386 Total recurring Level 3 assets $ 3,789 $ (1,315 ) $ — $ (36,439 ) $ 220,714 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ — $ — $ — $ — $ (3,801 ) Total recurring Level 3 liabilities $ — $ — $ — $ — $ (3,801 ) (1) Comprises $394 thousand of assets The following table presents the total Level 3 gains (losses) included in net income for the year ended December 31, 2018. ($ in thousands) Net investment Realized capital Contract Interest credited to Total Components of net income $ 3 $ 5,763 $ (326 ) $ 1,321 $ 6.761 The following table presents the rollforward of Level 3 assets and liabilities held at fair value during the year ended December 31, 2017. Total gains (losses) ($ in thousands) Balance as of Net OCI Transfers Transfers Assets Fixed income securities: Municipal $ 22,723 $ 15 $ 347 $ — $ — Corporate - public 4,091 — (64 ) — (1,565 ) Corporate - privately placed 75,713 4,080 (4,520 ) — — ABS 14,803 — 402 — — Total fixed income securities 117,330 4,095 (3,835 ) — (1,565 ) Equity securities 5,920 585 492 — (275 ) Free-standing derivatives, net 311 (54 ) — — — Other assets 109,578 56,712 — — — Total recurring Level 3 assets $ 233,139 $ 61,338 $ (3,343 ) $ — $ (1,840 ) Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ (7,177 ) $ 2,381 $ — $ — $ — Total recurring Level 3 liabilities $ (7,177 ) $ 2,381 $ — $ — $ — Purchases Sales Issues Settlements Balance as of Assets Fixed income securities: Municipal $ — $ — $ — $ (1,907 ) $ 21,178 Corporate - public 4,989 — — (139 ) 7,312 Corporate - privately placed 1 (18,000 ) — (1,295 ) 55,979 ABS — — — — 15,205 Total fixed income securities 4,990 (18,000 ) — (3,341 ) 99,674 Equity securities 1,018 (581 ) — — 7,159 Free-standing derivatives, net 127 — — (48 ) 336 (1) Other assets — — — — 166,290 Total recurring Level 3 assets $ 6,135 $ (18,581 ) $ — $ (3,389 ) $ 273,459 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ — $ — $ — $ — $ (4,796 ) Total recurring Level 3 liabilities $ — $ — $ — $ — $ (4,796 ) (1) Comprises $336 thousand of assets The following table presents the total Level 3 gains (losses) included in net income for the year ended December 31, 2017. ($ in thousands) Net investment Realized capital Contract Interest credited to Total Components of net income $ 606 $ 60,732 $ 2,937 $ (556 ) $ 63,719 Transfers between level categorizations may occur due to changes in the availability of market observable inputs, which generally are caused by changes in market conditions such as liquidity, trading volume or bid-ask There were no transfers between Level 1 and Level 2 during 2019, 2018 or 2017. Transfers into Level 3 during 2019, 2018 and 2017 included situations where a quote was not provided by the Company’s independent third-party valuation service provider and as a result the price was stale or had been replaced with a broker quote where the inputs had not been corroborated to be market observable resulting in the security being classified as Level 3. Transfers into Level 3 during 2019 also included derivatives embedded in equity-indexed universal life contracts due to refinements in the valuation modeling resulting in an increase in significance of non-market The table below provides valuation changes included in net income for Level 3 assets and liabilities held as of December 31. ($ in thousands) 2019 2018 2017 Assets Fixed income securities: Municipal $ — $ — $ 15 Corporate 3 3 5 Total fixed income securities 3 3 20 Free-standing derivatives, net (200 ) 65 (55 ) Equity securities 82 2,594 586 Other assets 62,105 3,096 56,712 Total recurring Level 3 assets $ 61,990 $ 5,758 $ 57,263 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ (1,664 ) $ 995 $ 2,381 Total recurring Level 3 liabilities $ (1,664 ) $ 995 $ 2,381 Total included in net income $ 60,326 $ 6,753 $ 59,644 Components of net income Net investment income $ (535 ) $ 3 $ 606 Realized capital gains and losses 62,525 5,755 56,657 Contract benefits 987 (326 ) 2,937 Interest credited to contractholder funds (2,651 ) 1,321 (556 ) Total included in net income $ 60,326 $ 6,753 $ 59,644 Presented below are the carrying values and fair value estimates of financial instruments not carried at fair value. ($ in thousands) December 31, 2019 December 31, 2018 Financial Assets Fair value Carrying Fair value Carrying Fair value Mortgage loans Level 3 $ 733,258 $ 764,201 $ 696,062 $ 699,936 Financial Liabilities Contractholder funds on investment contracts Level 3 $ 1,605,574 $ 1,730,341 $ 1,755,866 $ 1,821,641 Liability for collateral Level 2 158,111 158,111 69,788 69,788

Derivative Financial Instrument

Derivative Financial Instruments and Off-balance sheet Financial Instruments	12 Months Ended
	Dec. 31, 2019
Derivative Financial Instruments and Off-balance sheet Financial Instruments	7. Derivative Financial Instruments and Off-balance The Company uses derivatives for risk reduction focused on managing the risks with certain assets and liabilities arising from the potential adverse impacts from changes in risk-free interest rates, changes in equity market valuations and foreign currency fluctuations. Asset-liability management is a risk management strategy that is principally employed to balance the respective interest-rate sensitivities of the Company’s assets and liabilities. Depending upon the attributes of the assets acquired and liabilities issued, derivative instruments such as interest rate caps are utilized to change the interest rate characteristics of existing assets and liabilities to ensure the relationship is maintained within specified ranges and to reduce exposure to rising or falling interest rates. Futures and options are used for hedging the equity exposure contained in the Company’s equity indexed life product contracts that offer equity returns to contractholders. Foreign currency forwards are primarily used by the Company to reduce the foreign currency risk associated with holding foreign currency denominated investments. The Company also has a reinsurance treaty that is recorded as a derivative instrument, under which it primarily cedes reinvestment related risk on its structured settlement annuities to ALIC. The Company also has derivatives embedded in non-derivative The notional amounts specified in the contracts are used to calculate the exchange of contractual payments under the agreements and are generally not representative of the potential for gain or loss on these agreements. Fair value, which is equal to the carrying value, is the estimated amount that the Company would receive or pay to terminate the derivative contracts at the reporting date. The carrying value amounts for OTC derivatives are further adjusted for the effects, if any, of enforceable master netting agreements and are presented on a net basis, by counterparty agreement, in the Statements of Financial Position. Non-hedge non-hedge non-hedge non-hedge The following table provides a summary of the volume and fair value positions of derivative instruments as well as their reporting location in the Statement of Financial Position as of December 31, 2019. None of these derivatives are designated as accounting hedging instruments. Volume (1) ($ in thousands, except number of contracts) Balance sheet location Notional Number Fair value, Gross Gross Asset derivatives Equity and index contracts Options Other investments $ — 140 $ 5,232 $ 5,232 $ — Other contracts Structured settlement annuity reinsurance agreement Other assets — n/a 231,491 231,491 — Total asset derivatives $ — 140 $ 236,723 $ 236,723 $ — Liability derivatives Interest rate contracts Interest rate cap agreements Other liabilities & $ 13,400 n/a $ 75 $ 75 $ — Equity and index contracts Options Other liabilities & — 139 (2,832 ) — (2,832 ) Futures Other liabilities & — 1 — — — Foreign currency contracts Foreign currency forwards Other liabilities & 17,984 n/a 683 771 (88 ) Embedded derivative financial instruments Guaranteed accumulation benefits Contractholder funds 23,629 n/a (1,987 ) — (1,987 ) Guaranteed withdrawal benefits Contractholder funds 15,369 n/a (427 ) — (427 ) Equity-indexed options in life product contracts Contractholder funds 43,855 n/a (14,239 ) — (14,239 ) Total liability derivatives 114,237 140 (18,727 ) $ 846 $ (19,573 ) Total derivatives $ 114,237 280 $ 217,996 (1) Volume for OTC derivative contracts is represented by their notional amounts. Volume for exchange traded derivatives is represented by the number of contracts, which is the basis on which they are traded. (n/a = not applicable) The following table provides a summary of the volume and fair value positions of derivative instruments as well as their reporting location in the Statement of Financial Position as of December 31, 2018. None of these derivatives are designated as accounting hedging instruments. Volume ($ in thousands, except number of contracts) Balance sheet location Notional Number Fair Gross Gross Asset derivatives Interest rate contracts Interest rate cap agreements Other investments $ 1,500 n/a $ 17 $ 17 $ — Equity and index contracts Options Other investments — 122 556 556 — Futures Other assets — 1 1 1 — Foreign currency contracts Foreign currency forwards Other investments 16,091 n/a 670 684 (14 ) Other contracts Structured settlement annuity reinsurance agreement Other assets — n/a 169,386 169,386 — Total asset derivatives $ 17,591 123 $ 170,630 $ 170,644 $ (14 ) Liability derivatives Interest rate contracts Interest rate cap agreements Other liabilities & $ 12,600 n/a $ 377 $ 377 $ — Equity and index contracts Options Other liabilities & — 121 (178 ) — (178 ) Embedded derivative financial instruments Guaranteed accumulation benefits Contractholder funds 25,381 n/a (3,003 ) — (3,003 ) Guaranteed withdrawal benefits Contractholder funds 14,507 n/a (398 ) — (398 ) Equity-indexed options in life product contracts Contractholder funds 36,265 n/a (400 ) — (400 ) Total liability derivatives 88,753 121 (3,602 ) $ 377 $ (3,979 ) Total derivatives $ 106,344 244 $ 167,028 The following table provides gross and net amounts for the Company’s OTC derivatives, all of which are subject to enforceable master netting agreements. Offsets ($ in thousands) Gross Counter- Cash Net Securities Net December 31, 2019 Asset derivatives $ 846 $ (846 ) $ — $ — $ — $ — Liability derivatives (88 ) 846 (831 ) (73 ) — (73 ) December 31, 2018 Asset derivatives $ 1,078 $ (391 ) $ (590 ) $ 97 $ — $ 97 Liability derivatives (14 ) 391 (380 ) (3 ) — (3 ) The following tables present gains and losses from valuation and settlements reported on derivatives in the Statements of Operations and Comprehensive Income. ($ in thousands) Realized Contract Interest Total gain (loss) 2019 Interest rate contracts $ (200 ) $ — $ — $ (200 ) Equity and index contracts 1 — 1,987 1,988 Embedded derivative financial instruments — 987 (3,711 ) (2,724 ) Foreign currency contracts 364 — — 364 Other contracts - structured settlement annuity reinsurance agreement 58,922 — — 58,922 Total $ 59,087 $ 987 $ (1,724 ) $ 58,350 2018 Interest rate contracts $ 65 $ — $ — $ 65 Equity and index contracts — — (768 ) (768 ) Embedded derivative financial instruments — (326 ) 1,321 995 Foreign currency contracts 887 — — 887 Other contracts - structured settlement annuity reinsurance agreement (314 ) — — (314 ) Total $ 638 $ (326 ) $ 553 $ 865 2017 Interest rate contracts $ (54 ) $ — $ — $ (54 ) Equity and index contracts — — 1,289 1,289 Embedded derivative financial instruments — 2,937 (556 ) 2,381 Foreign currency contracts (697 ) — — (697 ) Other contracts - structured settlement annuity reinsurance agreement 53,257 — — 53,257 Total $ 52,506 $ 2,937 $ 733 $ 56,176 The Company manages its exposure to credit risk by utilizing highly rated counterparties, establishing risk control limits, executing legally enforceable master netting agreements (“MNAs”) and obtaining collateral where appropriate. The Company uses MNAs for OTC derivative transactions that permit either party to net payments due for transactions and collateral is either pledged or obtained when certain predetermined exposure limits are exceeded. As of December 31, 2019, counterparties pledged $831 thousand in collateral to the Company posted under MNA’s for contracts without credit-risk contingent features. The Company did not pledge any collateral under MNA’s. The Company has not incurred any losses on derivative financial instruments due to counterparty nonperformance. Other derivatives, including futures and option contracts, are traded on organized exchanges which require margin deposits and guarantee the execution of trades, thereby mitigating any potential credit risk. Counterparty credit exposure represents the Company’s potential loss if all of the counterparties concurrently fail to perform under the contractual terms of the contracts and all collateral, if any, becomes worthless. This exposure is measured by the fair value of OTC derivative contracts with a positive fair value at the reporting date reduced by the effect, if any, of legally enforceable master netting agreements. The following table summarizes the counterparty credit exposure as of December 31 by counterparty credit rating as it relates to the Company’s OTC derivatives. 2019 2018 ($ in thousands) Rating (1) Number Notional (2) Credit (2) Exposure, (2) Number Notional (2) Credit (2) Exposure, (2) A+ 2 $ 30,670 $ 770 $ — 2 $ 30,191 $ 1,064 $ 97 (1) Allstate uses the lower of S&P or Moody’s long-term debt issuer ratings. (2) Only OTC derivatives with a net positive fair value are included for each counterparty. For certain exchange traded derivatives, margin deposits are required as well as daily cash settlements of margin accounts. As of December 31, 2019, the Company pledged $291 thousand in the form of margin deposits. Market risk is the risk that the Company will incur losses due to adverse changes in market rates and prices. Market risk exists for all of the derivative financial instruments the Company currently holds, as these instruments may become less valuable due to adverse changes in market conditions. To limit this risk, the Company’s senior management has established risk control limits. In addition, changes in fair value of the derivative financial instruments that the Company uses for risk management purposes are generally offset by the change in the fair value or cash flows of the hedged risk component of the related assets, liabilities or forecasted transactions. Certain of the Company’s derivative instruments contain credit-risk-contingent termination events, cross-default provisions and credit support annex agreements. Credit-risk-contingent termination events allow the counterparties to terminate the derivative agreement or a specific trade on certain dates if the Company’s financial strength credit ratings by Moody’s or S&P fall below a certain level. Credit-risk-contingent cross-default provisions allow the counterparties to terminate the derivative agreement if the Company defaults by pre-determined The following summarizes the fair value of derivative instruments with termination, cross-default or collateral credit-risk-contingent features that are in a liability position as of December 31, as well as the fair value of assets that are netted against the liability in accordance with provisions within legally enforceable MNAs. ($ in thousands) 2019 2018 Gross liability fair value of contracts containing credit-risk-contingent features $ 83 $ — Gross asset fair value of contracts containing credit-risk-contingent features and subject to MNAs (70 ) — Maximum amount of additional exposure for contracts with credit-risk-contingent features if all features were triggered concurrently $ 13 $ — Off-balance The contractual amounts of off-balance ($ in thousands) 2019 2018 Commitments to invest in limited partnership interests $ 127,515 $ 153,719 Commitments to extend mortgage loans 13,000 10,000 Private placement commitments 15,000 — In the preceding table, the contractual amounts represent the amount at risk if the contract is fully drawn upon, the counterparty defaults and the value of any underlying security becomes worthless. Unless noted otherwise, the Company does not require collateral or other security to support off-balance Commitments to invest in limited partnership interests represent agreements to acquire new or additional participation in certain limited partnership investments. The Company enters into these agreements in the normal course of business. Because the investments in limited partnerships are not actively traded, it is not practical to estimate the fair value of these commitments. Commitments to extend mortgage loans are agreements to lend to a borrower provided there is no violation of any condition established in the contract. The Company enters into these agreements to commit to future loan fundings at predetermined interest rates. Commitments generally have fixed expiration dates or other termination clauses. The fair value of these commitments is insignificant. Private placement commitments represent commitments to purchase private placement private equity securities at a future date. The Company enters into these agreements in the normal course of business. The fair value of these commitments generally cannot be estimated on the date the commitment is made as the terms and conditions of the underlying private placement securities are not yet final. Because the private equity securities are not actively traded, it is not practical to estimate fair value of the commitments.

Reserve for Life-Contingent Con

Reserve for Life-Contingent Contract Benefits and Contractholder Funds	12 Months Ended
	Dec. 31, 2019
Reserve for Life-Contingent Contract Benefits and Contractholder Funds	8. Reserve for Life-Contingent Contract Benefits and Contractholder Funds As of December 31, the reserve for life-contingent contract benefits consists of the following: ($ in thousands) 2019 2018 Immediate fixed annuities: Structured settlement annuities $ 2,051,363 $ 1,882,914 Other immediate fixed annuities 61,039 63,774 Traditional life insurance 265,971 258,336 Accident and health insurance 32,261 25,360 Other 1,175 1,752 Total reserve for life-contingent contract benefits $ 2,411,809 $ 2,232,136 The following table highlights the key assumptions generally used in calculating the reserve for life-contingent contract benefits. Product Mortality Interest rate Estimation method Structured settlement annuities U.S. population with projected calendar year improvements; mortality rates adjusted for each impaired life based on reduction in life expectancy Interest rate assumptions range from 3.8% to 7.0% Present value of contractually specified future benefits Other immediate fixed annuities 1983 individual annuity mortality table; Annuity 2000 mortality table with internal modifications; Annuity 2000 mortality table Interest rate assumptions range from 0.6% to 5.4% Present value of expected future benefits based on historical experience Traditional life insurance Actual company experience plus loading Interest rate assumptions range from 3.0% to 8.0% Net level premium reserve method using the Company’s withdrawal experience rates; includes reserves for unpaid claims Accident and health insurance Actual company experience plus loading Interest rate assumptions range from 3.5% to 6.0% Unearned premium; additional contract reserves for mortality risk and unpaid claims Other: Variable annuity guaranteed minimum death benefits (1) Annuity 2012 mortality table with internal modifications Interest rate assumptions range from 2.0% to 5.8% Projected benefit ratio applied to cumulative assessments (1) In 2006, the Company disposed of its variable annuity business through a reinsurance agreement with The Prudential Insurance Company of America, a subsidiary of Prudential Financial, Inc. (collectively “Prudential”). To the extent that unrealized gains on fixed income securities would result in a premium deficiency had those gains actually been realized, an insurance reserves adjustment is recorded for certain immediate annuities with life contingencies. This liability is included in the reserve for life-contingent contract benefits with respect to this unrealized deficiency. The offset to this liability is recorded as a reduction of the unrealized net capital gains included in AOCI. This liability was $231.4 million and $80.6 million as of December 31, 2019 and 2018, respectively. As of December 31, contractholder funds consist of the following: ($ in thousands) 2019 2018 Interest-sensitive life insurance $ 756,995 $ 740,694 Investment contracts: Fixed annuities 1,741,488 1,896,222 Other investment contracts 49,485 44,384 Total contractholder funds $ 2,547,968 $ 2,681,300 The following table highlights the key contract provisions relating to contractholder funds. Product Interest rate Withdrawal/surrender charges Interest-sensitive life insurance Interest rates credited range from 0.0% to 10.0% for equity-indexed life (whose returns are indexed to the S&P 500) and 2.0% to 5.1% for all other products Either a percentage of account balance or dollar amount grading off generally over 20 years Fixed annuities Interest rates credited range from 0.6% to 7.0% for immediate annuities and 1.0% to 5.0% for other fixed annuities Either a declining or a level percentage charge generally over ten years or less. Additionally, approximately 12.2% of fixed annuities are subject to market value adjustment for discretionary withdrawals Other investment contracts: Guaranteed minimum income, accumulation and withdrawal benefits on variable annuities (1) Interest rates used in establishing reserves range from 1.7% to 10.3% Withdrawal and surrender charges are based on the terms of the related interest-sensitive life insurance or fixed annuity contract (1) In 2006, the Company disposed of its variable annuity business through a reinsurance agreement with Prudential. Contractholder funds activity for the years ended December 31 is as follows: ($ in thousands) 2019 2018 2017 Balance, beginning of year $ 2,681,300 $ 2,874,884 $ 3,018,733 Deposits 104,850 107,606 103,107 Interest credited 86,338 91,430 97,355 Benefits (104,681 ) (114,006 ) (108,819 ) Surrenders and partial withdrawals (152,898 ) (190,873 ) (166,388 ) Contract charges (75,879 ) (75,483 ) (74,733 ) Net transfers from separate accounts 88 256 54 Other adjustments 8,850 (12,514 ) 5,575 Balance, end of year $ 2,547,968 $ 2,681,300 $ 2,874,884 The Company offered various guarantees to variable annuity contractholders. In 2006, the Company disposed of its variable annuity business through a reinsurance agreement with Prudential. Liabilities for variable contract guarantees related to death benefits are included in the reserve for life-contingent contract benefits and the liabilities related to the income, withdrawal and accumulation benefits are included in contractholder funds. All liabilities for variable contract guarantees are reported on a gross basis on the balance sheet with a corresponding reinsurance recoverable asset. Absent any contract provision wherein the Company guarantees either a minimum return or account value upon death, a specified contract anniversary date, partial withdrawal or annuitization, variable annuity and variable life insurance contractholders bear the investment risk that the separate accounts’ funds may not meet their stated investment objectives. The account balances of variable annuity contracts’ separate accounts with guarantees included $222.2 million and $202.2 million of equity, fixed income and balanced mutual funds and $21.7 million and $21.5 million of money market mutual funds as of December 31, 2019 and 2018, respectively. The table below presents information regarding the Company’s variable annuity contracts with guarantees. The Company’s variable annuity contracts may offer more than one type of guarantee in each contract; therefore, the sum of amounts listed exceeds the total account balances of variable annuity contracts’ separate accounts with guarantees. As of December 31, ($ in thousands) 2019 2018 In the event of death Separate account value $ 243,833 $ 223,651 Net amount at risk (1) $ 4,392 $ 16,137 Average attained age of contractholders 68 years 67 years At annuitization (includes income benefit guarantees) Separate account value $ 18,849 $ 16,873 Net amount at risk (2) $ 1,750 $ 2,898 Weighted average waiting period until annuitization options available None None For cumulative periodic withdrawals Separate account value $ 15,173 $ 13,989 Net amount at risk (3) $ 421 $ 485 Accumulation at specified dates Separate account value $ 24,033 $ 25,272 Net amount at risk (4) $ 224 $ 849 Weighted average waiting period until guarantee date 3 years 3 years (1) Defined as the estimated current guaranteed minimum death benefit in excess of the current account balance as of the balance sheet date. (2) Defined as the estimated present value of the guaranteed minimum annuity payments in excess of the current account balance. (3) Defined as the estimated current guaranteed minimum withdrawal balance (initial deposit) in excess of the current account balance as of the balance sheet date. (4) Defined as the estimated present value of the guaranteed minimum accumulation balance in excess of the current account balance. The liability for death and income benefit guarantees is equal to a benefit ratio multiplied by the cumulative contract charges earned, plus accrued interest less contract excess guarantee benefit payments. The benefit ratio is calculated as the estimated present value of all expected contract excess guarantee benefits divided by the present value of all expected contract charges. The establishment of reserves for these guarantees requires the projection of future fund values, mortality, persistency and customer benefit utilization rates. These assumptions are periodically reviewed and updated. For guarantees related to death benefits, benefits represent the projected excess guaranteed minimum death benefit payments. For guarantees related to income benefits, benefits represent the present value of the minimum guaranteed annuitization benefits in excess of the projected account balance at the time of annuitization. Projected benefits and contract charges used in determining the liability for certain guarantees are developed using models and stochastic scenarios that are also used in the development of estimated expected gross profits. Underlying assumptions for the liability related to income benefits include assumed future annuitization elections based on factors such as the extent of benefit to the potential annuitant, eligibility conditions and the annuitant’s attained age. The liability for guarantees is re-evaluated Guarantees related to withdrawal and accumulation benefits are considered to be derivative financial instruments; therefore, the liability for these benefits is established based on its fair value. The following table summarizes the liabilities for guarantees. ($ in thousands) Liability for interest-sensitive Liability for Liability for Total Balance, December 31, 2018 (1) $ 30,674 $ 572 $ 3,401 $ 34,647 Less reinsurance recoverables 1,752 568 3,401 5,721 Net balance as of December 31, 2018 28,922 4 — 28,926 Incurred guarantee benefits 4,412 (1 ) — 4,411 Paid guarantee benefits (388 ) — — (388 ) Net change 4,024 (1 ) — 4,023 Net balance as of December 31, 2019 32,946 3 — 32,949 Plus reinsurance recoverables 1,189 333 2,414 3,936 Balance, December 31, 2019 (2) $ 34,135 $ 336 $ 2,414 $ 36,885 Balance, December 31, 2017 (3) $ 27,927 $ 462 $ 3,075 $ 31,464 Less reinsurance recoverables 1,340 457 3,075 4,872 Net balance as of December 31, 2017 26,587 5 — 26,592 Incurred guarantee benefits 2,585 (1 ) — 2,584 Paid guarantee benefits (250 ) — — (250 ) Net change 2,335 (1 ) — 2,334 Net balance as of December 31, 2018 28,922 4 — 28,926 Plus reinsurance recoverables 1,752 568 3,401 5,721 Balance, December 31, 2018 (4) $ 30,674 $ 572 $ 3,401 $ 34,647 (1) Included in the total liability balance as of December 31, 2018 are reserves for variable annuity death benefits of $1.8 million, variable annuity income benefits of $0.6 million, variable annuity accumulation benefits of $3.0 million, variable annuity withdrawal benefits of $0.4 million and other guarantees of $28.8 million. (2) Included in the total liability balance as of December 31, 2019 are reserves for variable annuity death benefits of $1.2 million, variable annuity income benefits of $0.3 million, variable annuity accumulation benefits of $2.0 million, variable annuity withdrawal benefits of $0.4 million and other guarantees of $33.0 million. (3) Included in the total liability balance as of December 31, 2017 are reserves for variable annuity death benefits of $1.3 million, variable annuity income benefits of $0.5 million, variable annuity accumulation benefits of $2.8 million, variable annuity withdrawal benefits of $0.3 million and other guarantees of $26.6 million.

Reinsurance

Reinsurance	12 Months Ended
	Dec. 31, 2019
Reinsurance	9. Reinsurance The Company reinsures certain of its risks to unaffiliated reinsurers and ALIC under yearly renewable term, coinsurance and modified coinsurance agreements. These agreements result in a passing of the agreed-upon percentage of risk to the reinsurer in exchange for negotiated reinsurance premium payments. Modified coinsurance is similar to coinsurance, except that the cash and investments that support the liability for contract benefits are not transferred to the assuming company and settlements are made on a net basis between the companies. As of December 31, 2019 and 2018, for certain term life insurance policies, the Company ceded up to 90% of the mortality risk depending on the year of policy issuance. Further, the Company cedes the mortality risk associated with coverage in excess of $2.0 million per life to ALIC. Prior to July 1, 2013, the Company ceded mortality risk in excess of $250 thousand per life to ALIC. In addition, the Company has used reinsurance to effect the disposition of certain blocks of business. The Company had reinsurance recoverables of $166.9 million and $170.6 million as of December 31, 2019 and 2018, respectively, due from Prudential related to the disposal of its variable annuity business that was effected through reinsurance agreements. The amounts ceded to Prudential for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Premiums and contract charges $ 4,797 $ 5,189 $ 5,401 Contract benefits (890 ) 1,459 (3,251 ) Interest credited to contractholder funds 4,307 4,533 4,805 Operating costs and expenses 867 868 943 As of December 31, 2019 and 2018, the Company had reinsurance recoverables of $579 thousand and $722 thousand, respectively, due from a subsidiary of Citigroup (Triton Insurance Company) in connection with the disposition of the direct response distribution business in 2003. As of December 31, 2019, the gross life insurance in force was $43.09 billion of which $482.9 million and $8.10 billion were ceded to affiliated and unaffiliated reinsurers, respectively. The effects of reinsurance on premiums and contract charges for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Direct $ 203,614 $ 199,289 $ 185,875 Assumed - non-affiliate 697 685 672 Ceded Affiliate (2,186 ) (1,972 ) (1,730 ) Non-affiliate (16,359 ) (17,361 ) (17,705 ) Premiums and contract charges, net of reinsurance $ 185,766 $ 180,641 $ 167,112 The effects of reinsurance on contract benefits for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Direct $ 272,200 $ 248,008 $ 237,998 Assumed - non-affiliate 500 586 550 Ceded Affiliate (2,354 ) (55 ) (882 ) Non-affiliate (11,333 ) (10,961 ) (7,173 ) Contract benefits, net of reinsurance $ 259,013 $ 237,578 $ 230,493 The effects of reinsurance on interest credited to contractholder funds for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Direct $ 90,758 $ 96,002 $ 102,164 Assumed - non-affiliate 13 13 18 Ceded - non-affiliate (4,307 ) (4,533 ) (4,805 ) Interest credited to contractholder funds, net of reinsurance $ 86,464 $ 91,482 $ 97,377 In addition to amounts included in the table above are reinsurance premiums ceded to ALIC of $4.2 million, $3.4 million and $3.5 million and settlements received from ALIC of $1.0 million, zero and zero in 2019, 2018 and 2017, respectively, under the terms of the structured settlement annuity reinsurance agreement (see Note 4).

Deferred Policy Acquisition and

Deferred Policy Acquisition and Sales Inducement Costs	12 Months Ended
	Dec. 31, 2019
Deferred Policy Acquisition and Sales Inducement Costs	10. Deferred Policy Acquisition and Sales Inducement Costs Deferred policy acquisition costs for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Balance, beginning of year $ 155,887 $ 146,333 $ 137,358 Acquisition costs deferred 16,771 19,577 24,522 Amortization charged to income (30,396 ) (16,299 ) (16,992 ) Effect of unrealized gains and losses (18,144 ) 6,276 1,445 Balance, end of year $ 124,118 $ 155,887 $ 146,333 DSI activity, which primarily relates to interest-sensitive life contracts, for the years ended December 31 was as follows: ($ in thousands) 2019 2018 2017 Balance, beginning of year $ 2,391 $ 2,278 $ 2,265 Sales inducements deferred 125 128 167 Amortization charged to income (251 ) (181 ) (188 ) Effect of unrealized gains and losses (489 ) 166 34 Balance, end of year $ 1,776 $ 2,391 $ 2,278

Guarantees and Contingent Liabi

Guarantees and Contingent Liabilities Guaranty funds	12 Months Ended
	Dec. 31, 2019
Guarantees and Contingent Liabilities Guaranty funds	11. Guarantees and Contingent Liabilities Guaranty funds Under state insurance guaranty fund laws, insurers doing business in a state can be assessed, up to prescribed limits, for certain obligations of insolvent insurance companies to policyholders and claimants. Amounts assessed to each company are typically related to its proportion of business written in each state. The Company’s policy is to accrue assessments when the entity for which the insolvency relates has met its state of domicile’s statutory definition of insolvency and the amount of the loss is reasonably estimable. In most states, the definition is met with a declaration of financial insolvency by a court of competent jurisdiction. In certain states there must also be a final order of liquidation. Since most states allow a credit against premium or other state related taxes for assessments, an asset is recorded based on paid and accrued assessments for the amount the Company expects to recover on the respective state’s tax return and is realized over the period allocated by each state. As of both December 31, 2019 and 2018, the liability balance included in other liabilities and accrued expenses was $759 thousand. The related premium tax offsets included in other assets were $916 thousand and $1.1 million as of December 31, 2019 and 2018, respectively. Guarantees In the normal course of business, the Company provides standard indemnifications to contractual counterparties in connection with numerous transactions, including acquisitions and divestitures. The types of indemnifications typically provided include indemnifications for breaches of representations and warranties, taxes and certain other liabilities, such as third party lawsuits. The indemnification clauses are often standard contractual terms and are entered into in the normal course of business based on an assessment that the risk of loss would be remote. The terms of the indemnifications vary in duration and nature. In many cases, the maximum obligation is not explicitly stated and the contingencies triggering the obligation to indemnify have not occurred and are not expected to occur. Consequently, the maximum amount of the obligation under such indemnifications is not determinable. Historically, the Company has not made any material payments pursuant to these obligations. The aggregate liability balance related to all guarantees was not material as of December 31, 2019. Regulation and compliance The Company is subject to extensive laws, regulations and regulatory actions. From time to time, regulatory authorities or legislative bodies seek to impose additional regulations regarding agency and broker compensation, regulate the nature of and amount of investments, impose fines and penalties for unintended errors or mistakes, impose additional regulations regarding cybersecurity and privacy, and otherwise expand overall regulation of insurance products and the insurance industry. In addition, the Company is subject to laws and regulations administered and enforced by federal agencies, international agencies, and other organizations, including but not limited to the Securities and Exchange Commission, the Financial Industry Regulatory Authority, and the U.S. Department of Justice. The Company has established procedures and policies to facilitate compliance with laws and regulations, to foster prudent business operations, and to support financial reporting. The Company routinely reviews its practices to validate compliance with laws and regulations and with internal procedures and policies. As a result of these reviews, from time to time the Company may decide to modify some of its procedures and policies. Such modifications, and the reviews that led to them, may be accompanied by payments being made and costs being incurred. The ultimate changes and eventual effects of these actions on the Company’s business, if any, are uncertain.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2019
Income Taxes	12. Income Taxes The Company joins with the Corporation and its other subsidiaries (the “Allstate Group”) in the filing of a consolidated federal income tax return and is party to a federal income tax allocation agreement (the “Allstate Tax Sharing Agreement”). Under the Allstate Tax Sharing Agreement, the Company pays to or receives from the Corporation the amount, if any, by which the Allstate Group’s federal income tax liability is affected by virtue of inclusion of the Company in the consolidated federal income tax return. Effectively, this results in the Company’s annual income tax provision being computed, with adjustments, as if the Company filed a separate return. Deferred income taxes result from temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements that will result in taxable or deductible amounts in future years. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in years in which those temporary differences are expected to be recovered or settled. Deferred tax assets and liabilities are adjusted through income tax expense as changes in tax laws or rates are enacted. In 2020, the Internal Revenue Service (“IRS”) is expected to complete their audit of the Allstate Group’s 2015 and 2016 federal income tax returns and begin the 2017 and 2018 tax year examinations. The 2013 and 2014 federal income tax return audit is complete through the exam phase and is expected to be finalized in 2020. Any adjustments that may result from IRS examinations of the Allstate Group’s tax return are not expected to have a material effect on the financial statements. The Company recognizes tax positions in the financial statements only when it is more likely than not that the position will be sustained on examination by the relevant taxing authority based on the technical merits of the position. A position that meets this standard is measured at the largest amount of benefit that will more likely than not be realized on settlement. A liability is established for differences between positions taken in a tax return and amounts recognized in the financial statements. The Company had no liability for unrecognized tax benefits as of December 31, 2019, 2018 or 2017, and believes it is reasonably possible that the liability balance will not significantly increase within the next twelve months. No amounts have been accrued for interest or penalties. The components of the deferred income tax assets and liabilities as of December 31 are as follows: ($ in thousands) 2019 2018 Deferred tax assets Unrealized foreign currency translation adjustments on limited partnerships $ 317 $ — Accrued liabilities 25 25 Other assets 20 5 Total deferred tax assets 362 30 Deferred tax liabilities Investments (78,081 ) (75,864 ) Unrealized net capital gains (33,151 ) (15,178 ) Life and annuity reserves (29,048 ) (32,450 ) DAC (14,447 ) (18,713 ) Other liabilities (484 ) (858 ) Unrealized foreign currency translation adjustments on limited partnerships — (573 ) Total deferred tax liabilities (155,211 ) (143,636 ) Net deferred tax liability $ (154,849 ) $ (143,606 ) Although realization is not assured, management believes it is more likely than not that the deferred tax assets will be realized based on the Company’s assessment that the deductions ultimately recognized for tax purposes will be fully utilized. The components of income tax expense (benefit) for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Current $ 36,766 $ 11,257 $ 12,837 Deferred (5,840 ) 1,570 (59,572 ) Total income tax expense (benefit) $ 30,926 $ 12,827 $ (46,735 ) The Company paid income taxes of $1.0 million, $16.0 million and $6.8 million in 2019, 2018 and 2017, respectively. A reconciliation of the statutory federal income tax rate to the effective income tax rate on income from operations for the years ended December 31 is as follows: 2019 2018 2017 Statutory federal income tax rate - expense 21.0 % 21.0 % 35.0 % State income taxes 1.8 5.4 0.7 Tax Legislation benefit — (3.9 ) (65.1 ) Adjustments to prior year tax liabilities 1.4 (0.1 ) — Other (0.1 ) (0.3 ) (0.3 ) Effective income tax rate - expense (benefit) 24.1 % 22.1 % (29.7 )%

Statutory Financial Information

Statutory Financial Information and Dividend Limitations	12 Months Ended
	Dec. 31, 2019
Statutory Financial Information and Dividend Limitations	13. Statutory Financial Information and Dividend Limitations The Company prepares its statutory-basis financial statements in conformity with accounting practices prescribed or permitted by the New York Department of Financial Services (“NYDFS”). Prescribed statutory accounting practices include a variety of publications of the National Association of Insurance Commissioners (“NAIC”), as well as state laws, regulations and general administrative rules. Permitted statutory accounting practices encompass all accounting practices not so prescribed. The State of New York requires insurance companies domiciled in its state to prepare statutory-basis financial statements in conformity with the NAIC Accounting Practices and Procedures Manual, subject to any deviations prescribed or permitted by the NYDFS. Statutory accounting practices differ from GAAP primarily since they require charging policy acquisition and certain sales inducement costs to expense as incurred, establishing life insurance reserves based on different actuarial assumptions, and valuing certain investments and establishing deferred taxes on a different basis. Statutory net (loss) income was $(34.0) million, $68.0 million and $50.8 million in 2019, 2018 and 2017, respectively. Statutory capital and surplus was $614.2 million and $644.5 million as of December 31, 2019 and 2018, respectively. Dividend Limitations The ability of the Company to pay dividends is dependent on business conditions, income, cash requirements and other relevant factors. The payment of shareholder dividends by the Company without the prior approval of the NYDFS is limited to formula amounts based on capital and surplus and net gain from operations excluding realized capital gains and losses, determined in conformity with statutory accounting practices, as well as the timing and amount of dividends paid in the preceding twelve months. The Company did not pay any dividends in 2019. The maximum amount of dividends the Company will be able to pay without prior NYDFS approval at a given point in time during 2020 is $61.4 million. Any dividend must be paid out of unassigned surplus excluding unrealized appreciation from investments, which totaled $373.7 million as of December 31, 2019, and cannot result in capital and surplus being less than the minimum amount required by law. Under state insurance laws, insurance companies are required to maintain paid up capital of not less than the minimum capital requirement applicable to the types of insurance they are authorized to write. Insurance companies are also subject to risk-based capital (“RBC”) requirements adopted by state insurance regulators. A company’s “authorized control level RBC” is calculated using various factors applied to certain financial balances and activity. Companies that do not maintain adjusted statutory capital and surplus at a level in excess of the company action level RBC, which is two times authorized control level RBC, are required to take specified actions. Company action level RBC is significantly in excess of the minimum capital requirements. Total adjusted statutory capital and surplus and authorized control level RBC of the Company were $639.3 million and $88.9 million, respectively, as of December 31, 2019.

Benefit Plans

Benefit Plans	12 Months Ended
	Dec. 31, 2019
Benefit Plans	14. Benefit Plans Pension and other postretirement plans Defined benefit pension plans and other postretirement plans, sponsored by the Corporation, cover most full-time employees, certain part-time employees and employee-agents. Benefits under the pension plans are based upon the employee’s length of service and eligible annual compensation. The Corporation also provides a medical coverage subsidy for eligible employees hired before January 1, 2003, including their eligible dependents, when they retire. The cost allocated to the Company for these plans was $609 thousand, $439 thousand and $1.2 million in 2019, 2018 and 2017, respectively. The Corporation has reserved the right to modify or terminate its benefit plans at any time and for any reason. Allstate 401(k) Savings Plan Employees of AIC are eligible to become members of the Allstate 401(k) Savings Plan (“Allstate Plan”). The Corporation’s contributions are based on the Corporation’s matching obligation. The cost allocated to the Company for the Allstate Plan was $953 thousand, $1.0 million and $895 thousand in 2019, 2018 and 2017, respectively.

Other Comprehensive Income

Other Comprehensive Income	12 Months Ended
	Dec. 31, 2019
Other Comprehensive Income	15. Other Comprehensive Income The components of other comprehensive income (loss) on a pre-tax after-tax 2019 2018 2017 ($ in thousands) Pre-tax Tax After-tax Pre-tax Tax After-tax Pre-tax Tax After-tax Unrealized net holding gains and losses arising during the period, net of related offsets $ 86,980 $ (18,266 ) $ 68,714 $ (65,379 ) $ 13,730 $ (51,649 ) $ (89,152 ) $ 31,203 $ (57,949 ) Less: reclassification adjustment of realized capital gains and losses 1,395 (293 ) 1,102 (1,359 ) 285 (1,074 ) 12,710 (4,449 ) 8,261 Unrealized net capital gains and losses 85,585 (17,973 ) 67,612 (64,020 ) 13,445 (50,575 ) (101,862 ) 35,652 (66,210 ) Unrealized foreign currency translation adjustments (3,963 ) 832 (3,131 ) 124 (26 ) 98 3,706 (1,297 ) 2,409 Other comprehensive income (loss) $ 81,622 $ (17,141 ) $ 64,481 $ (63,896 ) $ 13,419 $ (50,477 ) $ (98,156 ) $ 34,355 $ (63,801 )

Summary of Investments Other Th

Summary of Investments Other Than Investments in Related Parties	12 Months Ended
	Dec. 31, 2019
Summary of Investments Other Than Investments in Related Parties	ALLSTATE LIFE INSURANCE COMPANY OF NEW YORK SCHEDULE I - SUMMARY OF INVESTMENTS OTHER THAN INVESTMENTS IN RELATED PARTIES DECEMBER 31, 2019 ($ in thousands) Cost/ Fair Amount Type of investment Fixed maturities: Bonds: United States government, government agencies and authorities $ 43,280 $ 52,814 $ 52,814 States, municipalities and political subdivisions 433,038 552,280 552,280 Foreign governments 133,635 140,166 140,166 Public utilities 601,930 673,843 673,843 All other corporate bonds 2,798,541 3,001,402 3,001,402 Mortgage-backed securities 12,683 13,857 13,857 Total fixed maturities 4,023,107 $ 4,434,362 4,434,362 Equity securities: Common stocks: Public utilities 3,117 $ 4,172 4,172 Banks, trusts and insurance companies 16,061 21,053 21,053 Industrial, miscellaneous and all other 211,902 246,529 246,529 Nonredeemable preferred stocks 2,038 2,379 2,379 Total equity securities 233,118 $ 274,133 274,133 Mortgage loans on real estate (none acquired in satisfaction of debt) 733,258 $ 764,201 733,258 Policy loans 38,583 38,583 Derivative instruments 5,237 $ 5,237 5,237 Limited partnership interests 386,310 386,310 Short-term investments 224,111 $ 224,098 224,098 Total investments $ 5,643,724 $ 6,095,981

Reinsurance_2

Reinsurance	12 Months Ended
	Dec. 31, 2019
Reinsurance	ALLSTATE LIFE INSURANCE COMPANY OF NEW YORK SCHEDULE IV - REINSURANCE ($ in thousands) Gross amount Ceded to other companies (1) Assumed from other companies Net amount Percentage of amount assumed to net Year ended December 31, 2019 Life insurance in force $ 42,654,371 $ 8,581,710 $ 436,841 $ 34,509,502 1.3 % Premiums and contract charges: Life insurance $ 156,192 $ 17,595 $ 697 $ 139,294 0.5 % Accident and health insurance 47,422 950 — 46,472 — % Total premiums and contract charges $ 203,614 $ 18,545 $ 697 $ 185,766 0.4 % Year ended December 31, 2018 Life insurance in force $ 42,502,450 $ 8,914,558 $ 455,594 $ 34,043,486 1.3 % Premiums and contract charges: Life insurance $ 154,016 $ 18,322 $ 685 $ 136,379 0.5 % Accident and health insurance 45,273 1,011 — 44,262 — % Total premiums and contract charges $ 199,289 $ 19,333 $ 685 $ 180,641 0.4 % Year ended December 31, 2017 Life insurance in force $ 41,866,862 $ 9,142,525 $ 467,937 $ 33,192,274 1.4 % Premiums and contract charges: Life insurance $ 149,811 $ 18,316 $ 672 $ 132,167 0.5 % Accident and health insurance 36,064 1,119 — 34,945 — % Total premiums and contract charges $ 185,875 $ 19,435 $ 672 $ 167,112 0.4 % (1) No reinsurance or coinsurance income was netted against premiums ceded in 2019, 2018 or 2017.

Valuation Allowances and Qualif

Valuation Allowances and Qualifying Accounts	12 Months Ended
	Dec. 31, 2019
Valuation Allowances and Qualifying Accounts	ALLSTATE LIFE INSURANCE COMPANY OF NEW YORK SCHEDULE V - VALUATION ALLOWANCES AND QUALIFYING ACCOUNTS Additions ($ in thousands) Description Balance Charged expenses Other Deductions Balance Year ended December 31, 2019 Allowance for reinsurance recoverables $ — $ 34 $ — $ — $ 34 Allowance for estimated losses on mortgage loans — — — — — Year ended December 31, 2018 Allowance for estimated losses on mortgage loans $ — $ — $ — $ — $ — Year ended December 31, 2017 Allowance for estimated losses on mortgage loans $ — $ — $ — $ — $ —

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2019
Investments	Investments Fixed income securities include bonds, asset-backed securities (“ABS”) and mortgage-backed securities (“MBS”). MBS includes residential and commercial mortgage-backed securities that were previously disclosed separately. Fixed income securities, which may be sold prior to their contractual maturity, are designated as available-for-sale pay-downs Mortgage loans are carried at unpaid principal balances, net of unamortized premium or discount and valuation allowances. Valuation allowances are established for impaired loans when it is probable that contractual principal and interest will not be collected. Equity securities primarily include common stocks, exchange traded funds, non-redeemable Investments in limited partnership interests are primarily accounted for in accordance with the equity method of accounting (“EMA”) and include interests in private equity funds, real estate funds and other funds. Investments in limited partnership interests purchased prior to January 1, 2018 where the Company’s interest is so minor that it exercises virtually no influence over operating and financial policies are accounted for at fair value primarily utilizing the net asset value (“NAV”) as a practical expedient to determine fair value. Short-term investments, including money market funds, commercial paper, U.S. Treasury bills and other short-term investments, are carried at fair value. Policy loans are carried at unpaid principal balances. Other investments consist of derivatives. Derivatives are carried at fair value. Investment income primarily consists of interest, dividends, income from limited partnership interests, and income from certain derivative transactions. Interest is recognized on an accrual basis using the effective yield method and dividends are recorded at the ex-dividend pay-downs, Realized capital gains and losses include gains and losses on investment sales, write-downs in value due to other-than-temporary declines in fair value, adjustments to valuation allowances on mortgage loans, valuation changes of equity investments, including equity securities and certain limited partnerships where the underlying assets are predominately public equity securities, and periodic changes in fair value and settlements of certain derivatives including hedge ineffectiveness. Realized capital gains and losses on investment sales are determined on a specific identification basis.
Derivative and embedded derivative financial instruments	Derivative and embedded derivative financial instruments Derivative financial instruments include equity futures, options, interest rate caps, foreign currency forwards and a reinvestment related risk transfer reinsurance agreement with ALIC that meets the accounting definition of a derivative (see Note 4). Derivatives required to be separated from the host instrument and accounted for as derivative financial instruments (“subject to bifurcation”) are embedded in equity-indexed life contracts and reinsured variable annuity contracts. All derivatives are accounted for on a fair value basis and reported as other investments, other assets, other liabilities and accrued expenses or contractholder funds. The income statement effects of derivatives, including fair value gains and losses and accrued periodic settlements, are reported either in realized capital gains and losses or in a single line item together with the results of the associated asset or liability for which risks are being managed. Embedded derivative instruments subject to bifurcation are also accounted for on a fair value basis and are reported together with the host contract. The change in fair value of derivatives embedded in life and annuity product contracts and subject to bifurcation is reported in contract benefits or interest credited to contractholder funds. Cash flows from embedded derivatives subject to bifurcation are reported consistently with the host contracts within the Statements of Cash Flows. Cash flows from other derivatives are reported in cash flows from investing activities within the Statements of Cash Flows.
Securities loaned	Securities loaned The Company’s business activities include securities lending transactions, which are used primarily to generate net investment income. The proceeds received in conjunction with securities lending transactions can be reinvested in short-term investments or fixed income securities. These transactions are short-term in nature, usually 30 days or less. The Company receives cash collateral for securities loaned in an amount generally equal to 102% and 105% of the fair value of domestic and foreign securities, respectively, and records the related obligations to return the collateral in other liabilities and accrued expenses. The carrying value of these obligations approximates fair value because of their relatively short-term nature. The Company monitors the market value of securities loaned on a daily basis and obtains additional collateral as necessary under the terms of the agreements to mitigate counterparty credit risk. The Company maintains the right and ability to repossess the securities loaned on short notice.
Recognition of Premium Revenues and Contract Charges, and Related Benefits and Interest Credited	Recognition of premium revenues and contract charges, and related benefits and interest credited Traditional life insurance products consist principally of products with fixed and guaranteed premiums and benefits, primarily term and whole life insurance products. Voluntary accident and health insurance products are expected to remain in force for an extended period and therefore are primarily classified as long-duration contracts. Premiums from these products are recognized as revenue when due from policyholders. Benefits are reflected in contract benefits and recognized over the life of the policy in relation to premiums. Immediate annuities with life contingencies, including certain structured settlement annuities, provide benefits over a period that extends beyond the period during which premiums are collected. Premiums from these products are recognized as revenue when received at the inception of the contract. Benefits are recognized in relation to premiums with the establishment of a reserve. The change in reserve over time is recorded in contract benefits and primarily relates to accumulation at the discount rate and annuitant mortality. Profits from these policies come primarily from investment income, which is recognized over the life of the contract. Interest-sensitive life contracts, such as universal life and single premium life, are insurance contracts whose terms are not fixed and guaranteed. The terms that may be changed include premiums paid by the contractholder, interest credited to the contractholder account balance and contract charges assessed against the contractholder account balance. Premiums from these contracts are reported as contractholder fund deposits. Contract charges consist of fees assessed against the contractholder account balance for the cost of insurance (mortality risk), contract administration and surrender of the contract prior to contractually specified dates. These contract charges are recognized as revenue when assessed against the contractholder account balance. Contract benefits include life-contingent benefit payments in excess of the contractholder account balance. Contracts that do not subject the Company to significant risk arising from mortality or morbidity are referred to as investment contracts. Fixed annuities, including market value adjusted annuities and immediate annuities without life contingencies, are considered investment contracts. Consideration received for such contracts is reported as contractholder fund deposits. Contract charges for investment contracts consist of fees assessed against the contractholder account balance for maintenance, administration and surrender of the contract prior to contractually specified dates, and are recognized when assessed against the contractholder account balance. Interest credited to contractholder funds represents interest accrued or paid on interest-sensitive life and investment contracts. Crediting rates for certain fixed annuities and interest-sensitive life contracts are adjusted periodically by the Company to reflect current market conditions subject to contractually guaranteed minimum rates. Crediting rates for indexed life contracts are generally based on an equity index, such as the Standard & Poor’s 500 Index (“S&P 500”). Interest credited also includes amortization of DSI expenses. DSI is amortized into interest credited using the same method used to amortize DAC. Contract charges for variable life and variable annuity products consist of fees assessed against the contractholder account balances for contract maintenance, administration, mortality, expense and surrender of the contract prior to contractually specified dates. Contract benefits incurred for variable annuity products include guaranteed minimum death, income, withdrawal and accumulation benefits. All of the Company’s variable annuity business is ceded through reinsurance agreements and the contract charges and contract benefits related thereto are reported net of reinsurance ceded.
Other revenue presentation	Other revenue presentation Other revenue represents gross dealer concessions received in connection with sales of non-proprietary
Deferred Policy Acquisition and Sales Inducement Costs	Deferred policy acquisition and sales inducement costs Costs that are related directly to the successful acquisition of new or renewal life insurance policies are deferred and recorded as DAC. These costs are principally agency’s and brokers’ remuneration and certain underwriting expenses. DSI costs, which are deferred and recorded as other assets, relate to sales inducements offered on sales to new customers, principally on interest-sensitive life contracts. These sales inducements are primarily in the form of additional credits to the customer’s account balance or enhancements to interest credited for a specified period which are in excess of the rates currently being credited to similar contracts without sales inducements. All other acquisition costs are expensed as incurred and included in operating costs and expenses. Amortization of DAC is included in amortization of deferred policy acquisition costs and is described in more detail below. DSI is amortized into income using the same methodology and assumptions as DAC and is included in interest credited to contractholder funds. For traditional life and voluntary accident and health insurance, DAC is amortized over the premium paying period of the related policies in proportion to the estimated revenues on such business. Assumptions used in the amortization of DAC and reserve calculations are established at the time the policy is issued and are generally not revised during the life of the policy. Any deviations from projected business in force resulting from actual policy terminations differing from expected levels and any estimated premium deficiencies may result in a change to the rate of amortization in the period such events occur. Generally, the amortization periods for these policies approximates the estimated lives of the policies. The Company periodically reviews the recoverability of DAC using actual experience and current assumptions. Prior to fourth quarter 2017, the Company evaluated traditional life insurance products and immediate annuities with life contingencies on an aggregate basis. Beginning in fourth quarter 2017, traditional life insurance products, immediate annuities with life contingencies, and voluntary accident and health insurance products are reviewed individually. If actual experience and current assumptions are adverse compared to the original assumptions and a premium deficiency is determined to exist, any remaining unamortized DAC balance would be expensed to the extent not recoverable and the establishment of a premium deficiency reserve may be required for any remaining deficiency. For interest-sensitive life insurance, DAC and DSI are amortized in proportion to the incidence of the total present value of gross profits, which includes both actual historical gross profits (“AGP”) and estimated future gross profits (“EGP”) expected to be earned over the estimated lives of the contracts. The amortization is net of interest on the prior period DAC balance using rates established at the inception of the contracts. Actual amortization periods generally range from 15-30 10-20 AGP and EGP primarily consist of the following components: contract charges for the cost of insurance less mortality costs and other benefits; investment income and realized capital gains and losses less interest credited; and surrender and other contract charges less maintenance expenses. The principal assumptions for determining the amount of EGP are mortality, persistency, expenses, investment returns, including capital gains and losses on assets supporting contract liabilities, interest crediting rates to contractholders, and the effects of any hedges. For products whose supporting investments are exposed to capital losses in excess of the Company’s expectations which may cause periodic AGP to become temporarily negative, EGP and AGP utilized in DAC and DSI amortization may be modified to exclude the excess capital losses. The Company performs quarterly reviews of DAC and DSI recoverability for interest-sensitive life contracts using current assumptions. If a change in the amount of EGP is significant, it could result in the unamortized DAC or DSI not being recoverable, resulting in a charge which is included as a component of amortization of deferred policy acquisition costs or interest credited to contractholder funds, respectively. The DAC and DSI balances presented include adjustments to reflect the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized capital gains or losses in the respective product investment portfolios were actually realized. The adjustments are recorded net of tax in AOCI. DAC, DSI and deferred income taxes determined on unrealized capital gains and losses and reported in AOCI recognize the impact on shareholder’s equity consistently with the amounts that would be recognized in the income statement on realized capital gains and losses. Customers of the Company may exchange one insurance policy or investment contract for another offered by the Company, or make modifications to an existing investment or life contract issued by the Company. These transactions are identified as internal replacements for accounting purposes. Internal replacement transactions determined to result in replacement contracts that are substantially unchanged from the replaced contracts are accounted for as continuations of the replaced contracts. Unamortized DAC and DSI related to the replaced contracts continue to be deferred and amortized in connection with the replacement contracts. For interest-sensitive life contracts, the EGP of the replacement contracts are treated as a revision to the EGP of the replaced contracts in the determination of amortization of DAC and DSI. For traditional life insurance policies, any changes to unamortized DAC that result from replacement contracts are treated as prospective revisions. Any costs associated with the issuance of replacement contracts are characterized as maintenance costs and expensed as incurred. Internal replacement transactions determined to result in a substantial change to the replaced contracts are accounted for as an extinguishment of the replaced contracts, and any unamortized DAC and DSI related to the replaced contracts are eliminated with a corresponding charge to amortization of deferred policy acquisition costs or interest credited to contractholder funds, respectively.
Reinsurance	Reinsurance In the normal course of business, the Company seeks to limit aggregate and single exposure to losses on large risks by purchasing reinsurance. The Company has also used reinsurance to effect the disposition of certain blocks of business. The amounts reported as reinsurance recoverables include amounts billed to reinsurers on losses paid as well as estimates of amounts expected to be recovered from reinsurers on insurance liabilities and contractholder funds that have not yet been paid. Reinsurance recoverables on unpaid losses are estimated based upon assumptions consistent with those used in establishing the liabilities related to the underlying reinsured contracts. Insurance liabilities are reported gross of reinsurance recoverables. Reinsurance premiums are generally reflected in income in a manner consistent with the recognition of premiums on the reinsured contracts. Reinsurance does not extinguish the Company’s primary liability under the policies written. Therefore, the Company regularly evaluates the financial condition of its reinsurers and establishes allowances for uncollectible reinsurance as appropriate. The Company has a reinsurance treaty with ALIC through which it cedes reinvestment related risk on its structured settlement annuities. The terms of the treaty meet the accounting definition of a derivative. Accordingly, the treaty is recorded in the Statement of Financial Position at fair value. Changes in the fair value of the treaty, premiums paid to ALIC and settlements received from ALIC are recognized in realized capital gains and losses.
Income taxes	Income taxes Income taxes are accounted for using the asset and liability method under which deferred tax assets and liabilities are recognized for temporary differences between the financial reporting and tax bases of assets and liabilities at the enacted tax rates. The principal assets and liabilities giving rise to such differences are investments (including unrealized capital gains and losses), insurance reserves and DAC. A deferred tax asset valuation allowance is established when it is more likely than not such assets will not be realized. The Company recognizes interest expense related to income tax matters in income tax expense and penalties in operating costs and expenses.
Reserve for life-contingent contract benefits	Reserve for life-contingent contract benefits The reserve for life-contingent contract benefits payable under insurance policies, including traditional life insurance, life-contingent immediate annuities and voluntary accident and health insurance products, is computed on the basis of long-term actuarial assumptions of future investment yields, mortality, morbidity, policy terminations and expenses. These assumptions, which for traditional life insurance are applied using the net level premium method, include provisions for adverse deviation and generally vary by characteristics such as type of coverage, year of issue and policy duration. The assumptions are established at the time the policy is issued and are generally not changed during the life of the policy. The Company periodically reviews the adequacy of reserves using actual experience and current assumptions. If actual experience and current assumptions are adverse compared to the original assumptions and a premium deficiency is determined to exist, any remaining unamortized DAC balance would be expensed to the extent not recoverable and the establishment of a premium deficiency reserve may be required for any remaining deficiency. In 2019 and 2018, the Company’s reviews concluded that no premium deficiency adjustments were necessary. Prior to fourth quarter 2017, the Company evaluated traditional life insurance products and immediate annuities with life contingencies on an aggregate basis. Beginning in fourth quarter 2017, traditional life insurance products, immediate annuities with life contingencies, and voluntary accident and health insurance are reviewed individually. The Company also reviews these policies for circumstances where projected profits would be recognized in early years followed by projected losses in later years. If this circumstance exists, the Company will accrue a liability, during the period of profits, to offset the losses at such time as the future losses are expected to commence using a method updated prospectively over time. To the extent that unrealized gains on fixed income securities would result in a premium deficiency if those gains were realized, the related increase in reserves for certain immediate annuities with life contingencies is recorded net of tax as a reduction of unrealized net capital gains included in AOCI.
Contractholder funds	Contractholder funds Contractholder funds represent interest-bearing liabilities arising from the sale of products such as interest-sensitive life insurance and fixed annuities. Contractholder funds primarily comprise cumulative deposits received and interest credited to the contractholder less cumulative contract benefits, surrenders, withdrawals and contract charges for mortality or administrative expenses. Contractholder funds also include reserves for secondary guarantees on interest-sensitive life insurance and certain fixed annuity contracts and reserves for certain guarantees on reinsured variable annuity contracts.
Separate accounts	Separate accounts Separate accounts assets are carried at fair value. The assets of the separate accounts are legally segregated and available only to settle separate accounts contract obligations. Separate accounts liabilities represent the contractholders’ claims to the related assets and are carried at an amount equal to the separate accounts assets. Investment income and realized capital gains and losses of the separate accounts accrue directly to the contractholders and therefore are not included in the Company’s Statements of Operations and Comprehensive Income. Deposits to and surrenders and withdrawals from the separate accounts are reflected in separate accounts liabilities and are not included in cash flows. Absent any contract provision wherein the Company provides a guarantee, variable annuity and variable life insurance contractholders bear the investment risk that the separate accounts’ funds may not meet their stated investment objectives. All of the Company’s variable annuity business was reinsured beginning in 2006.
Off-balance sheet financial instruments	Off-balance Commitments to invest, commitments to purchase private placement securities, commitments to extend mortgage loans and financial guarantees have off-balance
Adopted and pending accounting standards	Adopted accounting standard Accounting for Hedging Activities Effective January 1, 2019, the Company adopted new Financial Accounting Standards Board (“FASB”) guidance intended to better align hedge accounting with an organization’s risk management activities. The new guidance expands hedge accounting to nonfinancial and financial risk components and revises the measurement methodologies. Separate presentation of hedge ineffectiveness is eliminated with the intention to provide greater transparency to the full impact of hedging by requiring presentation of the results of the hedged item and hedging instrument in a single financial statement line item. In addition, the amendments were designed to reduce complexity by simplifying hedge effectiveness testing. The adoption had no impact on the Company’s results of operations or financial position. Pending accounting standards Measurement of Credit Losses on Financial Instruments In June 2016, the FASB issued guidance which revises the credit loss recognition criteria for certain financial assets measured at amortized cost, including reinsurance recoverables. The new guidance replaces the existing incurred loss recognition model with an expected loss recognition model. The objective of the expected credit loss model is for a reporting entity to recognize its estimate of expected credit losses for affected financial assets in a valuation allowance that when deducted from the amortized cost basis of the related financial assets results in a net carrying value at the amount expected to be collected. The reporting entity must consider all relevant information available when estimating expected credit losses, including details about past events, current conditions, and reasonable and supportable forecasts over the life of an asset. Financial assets may be evaluated individually or on a pooled basis when they share similar risk characteristics. The measurement of credit losses for available-for-sale The Company’s implementation activities, which are being finalized, include review and validation of models, methodologies, data inputs and assumptions to be used to estimate expected credit losses. The implementation impacts relate primarily to the Company’s commercial mortgage loans and reinsurance recoverables and are dependent on economic conditions and judgments at the date of adoption. Based on the economic conditions at the date of adoption and the balances at the reporting date, the Company estimates the application of the current expected credit loss requirements will result in total valuation allowances for credit losses of approximately $12 million as of the date of adoption. After consideration of existing valuation allowances maintained prior to adoption of the new guidance, the Company expects to recognize a cumulative-effect decrease in retained income of approximately $6 million, after-tax, Accounting for Long-Duration Insurance Contracts In August 2018, the FASB issued guidance revising the accounting for certain long-duration insurance contracts. The new guidance introduces material changes to the measurement of the Company’s reserves for traditional life, life-contingent immediate annuities and certain voluntary accident and health insurance products. Under the new guidance, measurement assumptions, including those for mortality, morbidity and policy terminations, will be required to be reviewed and updated at least annually. The effect of updating measurement assumptions other than the discount rate are required to be measured on a retrospective basis and reported in net income. In addition, reserves under the new guidance are required to be discounted using an upper medium grade fixed income instrument yield required to be updated through OCI at each reporting date. Current GAAP requires reserves to utilize assumptions set at policy issuance unless updated current assumptions indicate that recorded reserves are deficient. The new guidance also requires DAC and other capitalized balances currently amortized in proportion to premiums or gross profits to be amortized on a constant level basis over the expected term for all long-duration insurance contracts. DAC will not be subject to loss recognition testing but will be reduced when actual lapse experience exceeds expected experience. The new guidance will no longer require adjustments to DAC and DSI related to unrealized gains and losses on investment securities supporting the related business. All market risk benefit product features will be measured at fair value with changes in fair value recorded in net income with the exception of changes in the fair value attributable to changes in the reporting entity’s own credit risk, which are required to be recognized in OCI. Substantially all of the Company’s market risk benefits are reinsured and therefore these impacts are not expected to be material to the Company. The new guidance will be included in the comparable financial statements issued in reporting periods beginning after December 15, 2021, thereby requiring restatement of prior periods presented. Early adoption is permitted. The new guidance will be applied to affected contracts and DAC on the basis of existing carrying amounts at the earliest period presented or retrospectively using actual historical experience as of contract inception. The new guidance for market risk benefits is required to be adopted retrospectively. The Company is evaluating the anticipated impacts of applying the new guidance to both retained income and AOCI. The requirements of the new guidance represent a material change from existing GAAP, however, the underlying economics of the business and related cash flows are unchanged. The Company is evaluating the specific impacts of adopting the new guidance and anticipates the financial statement impact of adopting the new guidance to be material, largely attributed to the impact of transitioning to a discount rate based on an upper-medium grade fixed income investment yield and updates to mortality assumptions. The Company expects the most significant impacts will occur in the run-off Simplifications to the Accounting for Income Taxes In December 2019, the FASB issued amendments to simplify the accounting for income taxes. The amendments eliminate certain exceptions in the existing guidance including those related to intraperiod tax allocation and deferred tax liability recognition when changes in control of equity method and foreign subsidiary investments occur. The amendments require recognition of the effect of an enacted change in tax laws or rates in the interim period that includes the enactment date, provide an option to not allocate taxes to a legal entity that is not subject to tax as well as other minor changes. The amendments are effective for interim and annual reporting periods beginning after December 15, 2020. The new guidance specifies which amendments should be applied prospectively, retrospective to all periods presented or on a modified retrospective basis through a cumulative-effect adjustment to retained income as of the beginning of the year of adoption. The impact of adoption is not expected to be material to the Company’s results of operations or financial position.

General (Tables)

General (Tables)	12 Months Ended
	Dec. 31, 2019
Summary of Premiums and Contract Charges by Product	The following table summarizes premiums and contract charges by product. ($ in thousands) 2019 2018 2017 Premiums Traditional life insurance $ 61,980 $ 59,185 $ 55,996 Accident and health insurance 46,472 44,262 34,945 Total premiums 108,452 103,447 90,941 Contract charges Interest-sensitive life insurance 77,324 76,931 76,103 Fixed annuities (10 ) 263 68 Total contract charges 77,314 77,194 76,171 Total premiums and contract charges $ 185,766 $ 180,641 $ 167,112

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2019
Supplemental Cash Flow Information	The accompanying cash flows are included in cash flows from operating activities in the Statements of Cash Flows along with the activities resulting from management of the proceeds, which for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Net change in proceeds managed Net change in short-term investments $ (88,323 ) $ (10,721 ) $ 1,864 Operating cash flow (used) provided $ (88,323 ) $ (10,721 ) $ 1,864 Net change in liabilities Liabilities for collateral, beginning of year $ (69,788 ) $ (59,067 ) $ (60,931 ) Liabilities for collateral, end of year (158,111 ) (69,788 ) (59,067 ) Operating cash flow provided (used) $ 88,323 $ 10,721 $ (1,864 )

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2019
Schedule for Fixed Income Securities at Amortized Cost, Gross Unrealized Gains and Losses and Fair Value	The amortized cost, gross unrealized gains and losses and fair value for fixed income securities are as follows: Amortized cost Gross unrealized Fair value ($ in thousands) Gains Losses December 31, 2019 U.S. government and agencies $ 43,280 $ 9,534 $ — $ 52,814 Municipal 433,038 119,242 — 552,280 Corporate 3,400,471 277,338 (2,564 ) 3,675,245 Foreign government 133,635 6,531 — 140,166 MBS 12,683 1,174 — 13,857 Total fixed income securities $ 4,023,107 $ 413,819 $ (2,564 ) $ 4,434,362 December 31, 2018 U.S. government and agencies $ 76,070 $ 9,394 $ — $ 85,464 Municipal 615,511 88,530 (118 ) 703,923 Corporate 3,514,421 118,369 (69,959 ) 3,562,831 Foreign government 128,926 7,896 — 136,822 ABS 19,906 — (18 ) 19,888 MBS 20,276 1,166 (26 ) 21,416 Total fixed income securities $ 4,375,110 $ 225,355 $ (70,121 ) $ 4,530,344
Schedule of Net Investment Income	Net investment income Net investment income for the years ended December 31 is as follows: ($ in thousands) 2019 2018 2017 Fixed income securities $ 208,816 $ 214,039 $ 228,507 Mortgage loans 32,566 30,920 28,263 Equity securities 4,283 5,565 5,465 Limited partnership interests 15,348 43,365 53,917 Short-term investments 4,393 2,966 1,200 Policy loans 2,343 2,339 2,443 Investment income, before expense 267,749 299,194 319,795 Investment expense (11,743 ) (11,311 ) (9,100 ) Net investment income $ 256,006 $ 287,883 $ 310,695
Schedule of Realized Capital Gains (Losses) by Asset Type	Realized capital gains (losses) by asset type for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Fixed income securities $ 1,389 $ (1,306 ) $ 5,436 Mortgage loans — 466 1,128 Equity securities 40,780 (16,364 ) 799 Limited partnership interests 5,383 (3,895 ) 6,451 Derivatives 59,087 638 52,506 Short-term investments (12 ) (93 ) 12 Realized capital gains (losses) $ 106,627 $ (20,554 ) $ 66,332
Schedule of Realized Capital Gains (Losses) by Transaction Type	Realized capital gains (losses) by transaction type for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Impairment write-downs $ (169 ) $ (285 ) $ (5,370 ) Sales 4,698 (1,548 ) 19,196 Valuation of equity investments (1) 43,011 (19,359 ) — Valuation and settlements of derivative instruments 59,087 638 52,506 Realized capital gains (losses) $ 106,627 $ (20,554 ) $ 66,332 (1) Includes valuation of equity securities and certain limited partnership interests where the underlying assets are predominately public equity securities.
Schedule of Net Pre-Tax Appreciation (Decline) of Equity Securities and Limited Partnership Interests Carried at Fair Value Recognized in Net Income	The following table presents the net pre-tax For the years ended ($ in thousands) 2019 2018 Equity securities $ 29,558 $ (12,897 ) Limited partnership interests carried at fair value 9,165 16,968 Total $ 38,723 $ 4,071
Schedule of Other-Than-Temporary Impairment Losses by Asset Type	OTTI losses by asset type for the years ended December 31 are as follows: 2019 2018 2017 ($ in thousands) Gross Included Net Gross Included Net Gross Included Net Fixed income securities: Corporate $ — $ — $ — $ — $ — $ — $ (1,481 ) $ — $ (1,481 ) MBS (1,202 ) 1,033 (169 ) (68 ) (217 ) (285 ) (2,338 ) 893 (1,445 ) Total fixed income securities (1,202 ) 1,033 (169 ) (68 ) (217 ) (285 ) (3,819 ) 893 (2,926 ) Equity securities — — — — — — (2,422 ) — (2,422 ) Limited partnership interests — — — — — — (22 ) — (22 ) OTTI losses $ (1,202 ) $ 1,033 $ (169 ) $ (68 ) $ (217 ) $ (285 ) $ (6,263 ) $ 893 $ (5,370 )
Schedule of other-than-temporary impairment losses on fixed income securities included in Accumulated Other Comprehensive Income	The total amount of OTTI losses included in AOCI at the time of impairment for fixed income securities, which were not included in earnings, are presented in the following table. ($ in thousands) December 31, December 31, MBS (1) $ (1,188 ) $ (358 ) (1) The amounts exclude $2.0 million and $1.9 million as of December 31, 2019 and 2018, respectively, of net unrealized gains related to changes in valuation of the fixed income securities subsequent to the impairment measurement date.
Schedule of Rollforwards of Cumulative Credit Losses Recognized in Earnings for Fixed Income Securities Held	Rollforwards of the cumulative credit losses recognized in earnings for fixed income securities held as of December 31 are as follows: ($ in thousands) 2019 2018 2017 Beginning balance $ (2,684 ) $ (3,192 ) $ (4,594 ) Additional credit loss for securities previously other-than-temporarily impaired (169 ) (285 ) (128 ) Additional credit loss for securities not previously other-than-temporarily impaired — — (2,798 ) Reduction in credit loss for securities disposed or collected 1,740 793 4,328 Ending balance $ (1,113 ) $ (2,684 ) $ (3,192 )
Schedule of Unrealized Net Capital Gains and Losses Included in Accumulated Other Comprehensive Income	Unrealized net capital gains and losses included in AOCI are as follows: ($ in thousands) Fair value Gross unrealized Unrealized net December 31, 2019 Gains Losses Fixed income securities $ 4,434,362 $ 413,819 $ (2,564 ) $ 411,255 Short-term investments 224,098 4 (17 ) (13 ) EMA limited partnerships (1) (205 ) Unrealized net capital gains and losses, pre-tax 411,037 Amounts recognized for: Insurance reserves (2) (231,357 ) DAC and DSI (3) (21,820 ) Amounts recognized (253,177 ) Deferred income taxes (33,151 ) Unrealized net capital gains and losses, after-tax $ 124,709 December 31, 2018 Fixed income securities $ 4,530,344 $ 225,355 $ (70,121 ) $ 155,234 Short-term investments 88,548 — (4 ) (4 ) EMA limited partnerships (50 ) Unrealized net capital gains and losses, pre-tax 155,180 Amounts recognized for: Insurance reserves (80,628 ) DAC and DSI (2,277 ) Amounts recognized (82,905 ) Deferred income taxes (15,178 ) Unrealized net capital gains and losses, after-tax $ 57,097 (1) Unrealized net capital gains and losses for limited partnership interests represent the Company’s share of EMA limited partnerships’ OCI. Fair value and gross unrealized gains and losses are not applicable. (2) The insurance reserves adjustment represents the amount by which the reserve balance would increase if the net unrealized gains in the applicable product portfolios were realized and reinvested at lower interest rates, resulting in a premium deficiency. This adjustment primarily relates to structured settlement annuities with life contingencies (a type of immediate annuities with life contingencies). (3) The DAC and DSI adjustment balance represents the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized gains or losses in the respective product portfolios were realized.
Schedule of Change in Unrealized net Capital Gains and Losses	The change in unrealized net capital gains and losses for the years ended December 31 is as follows: ($ in thousands) 2019 2018 2017 Fixed income securities $ 256,021 $ (212,483 ) $ 29,700 Equity securities (1) — — 32,927 Short-term investments (9 ) 9 (12 ) EMA limited partnerships (155 ) (40 ) 51 Total 255,857 (212,514 ) 62,666 Amounts recognized for: Insurance reserves (150,729 ) 141,714 (165,992 ) DAC and DSI (19,543 ) 6,780 1,465 Amounts recognized (170,272 ) 148,494 (164,527 ) Deferred income taxes (17,973 ) 13,445 60,664 Increase (decrease) in unrealized net capital gains and losses, after-tax $ 67,612 $ (50,575 ) $ (41,197 ) (1) Upon adoption of the recognition and measurement accounting standard on January 1, 2018, $42.4 million of pre-tax
Summary of Gross Unrealized Losses and Fair Value of Fixed Income and Equity Securities by Length of Time	The following table summarizes the gross unrealized losses and fair value of securities by the length of time that individual securities have been in a continuous unrealized loss position. ($ in thousands) Less than 12 months 12 months or more Total Number Fair Unrealized Number Fair Unrealized December 31, 2019 Fixed income securities Corporate 44 $ 104,484 $ (815 ) 17 $ 31,900 $ (1,749 ) $ (2,564 ) MBS 2 38 — 2 1 — — Total fixed income securities 46 $ 104,522 $ (815 ) 19 $ 31,901 $ (1,749 ) $ (2,564 ) Investment grade fixed income securities 22 $ 82,142 $ (347 ) 3 $ 9,845 $ (130 ) $ (477 ) Below investment grade fixed income securities 24 22,380 (468 ) 16 22,056 (1,619 ) (2,087 ) Total fixed income securities 46 $ 104,522 $ (815 ) 19 $ 31,901 $ (1,749 ) $ (2,564 ) December 31, 2018 Fixed income securities Municipal 1 $ 9,371 $ (11 ) 1 $ 4,893 $ (107 ) $ (118 ) Corporate 451 1,308,566 (40,510 ) 123 480,729 (29,449 ) (69,959 ) ABS 1 10,010 (9 ) 1 9,878 (9 ) (18 ) MBS 90 1,086 (5 ) 20 939 (21 ) (26 ) Total fixed income securities 543 $ 1,329,033 $ (40,535 ) 145 $ 496,439 $ (29,586 ) $ (70,121 )
Schedule of Gross Unrealized Losses by Unrealized Loss Position and Credit quality	The following table summarizes gross unrealized losses by unrealized loss position and credit quality as of December 31, 2019. ($ in thousands) Investment Below investment Total Fixed income securities with unrealized loss position less than 20% of amortized cost (1) (2) $ (477 ) $ (1,722 ) $ (2,199 ) Fixed income securities with unrealized loss position greater than or equal to 20% of amortized cost (3) (4) — (365 ) (365 ) Total unrealized losses $ (477 ) $ (2,087 ) $ (2,564 ) (1) Below investment grade fixed income securities include $468 thousand that have been in an unrealized loss position for less than twelve months. (2) Related to securities with an unrealized loss position less than 20% of amortized cost, the degree of which suggests that these securities do not pose a high risk of being other-than-temporarily impaired. (3) No below investment grade fixed income securities have been in an unrealized loss position for a period of twelve or more consecutive months. (4) Evaluated based on factors such as discounted cash flows and the financial condition and near-term and long-term prospects of the issue or issuer and were determined to have adequate resources to fulfill contractual obligations.
Schedule of Commercial Mortgage Loans by Geographic Distribution	The following table shows the principal geographic distribution of commercial real estate represented in the Company’s mortgage loan portfolio. No other state represented more than 5% of the portfolio as of December 31. (% of mortgage loan portfolio carrying value) 2019 2018 Texas 19.9 % 16.1 % California 16.7 18.4 North Carolina 8.2 8.8 Utah 5.9 2.1 Nevada 5.8 6.3 New Jersey 5.6 6.6 Illinois 5.5 6.1
Schedule of Types of Properties Collateralizing Commercial Mortgage Loans	The types of properties collateralizing the mortgage loans as of December 31 are as follows: (% of mortgage loan portfolio carrying value) 2019 2018 Apartment complex 32.6 % 31.3 % Office buildings 27.4 27.2 Warehouse 16.5 15.7 Retail 15.6 17.3 Other 7.9 8.5 Total 100.0 % 100.0 %
Summary of Carrying Value of Non-Impaired Mortgage Loans by Debt Service Coverage Ration Distribution	The following table reflects the carrying value of non-impaired 2019 2018 ($ in thousands) Debt service coverage ratio distribution Fixed rate Variable Total Fixed rate Variable Total Below 1.0 $ — $ — $ — $ — $ — $ — 1.0 - 1.25 48,780 — 48,780 25,447 — 25,447 1.26 - 1.50 221,384 — 221,384 189,063 — 189,063 Above 1.50 434,675 28,419 463,094 453,153 28,399 481,552 Total non-impaired $ 704,839 $ 28,419 $ 733,258 $ 667,663 $ 28,399 $ 696,062
Schedule of Municipal Bonds Held For Investment by Geographic Distribution	The Company maintains a diversified portfolio of municipal bonds which totaled $552.3 million and $703.9 million as of December 31, 2019 and 2018, respectively. The municipal bond portfolio includes general obligations of state and local issuers and revenue bonds (including pre-refunded (% of municipal bond portfolio carrying value) 2019 2018 California 33.3 % 28.1 % Texas 10.8 12.2 Oregon 10.6 7.6 Illinois 8.0 5.9
Mortgage loans
Schedule of Securities Based on Contractual Maturities	The contractual maturities of the mortgage loan portfolio as of December 31, 2019 are as follows: ($ in thousands) Number Carrying Percent 2020 2 $ 7,235 1.0 % 2021 9 57,821 7.9 2022 10 61,004 8.3 2023 14 111,481 15.2 Thereafter 62 495,717 67.6 Total 97 $ 733,258 100.0 %
Fixed income securities
Schedule of Securities Based on Contractual Maturities	Scheduled maturities The scheduled maturities for fixed income securities are as follows: As of December 31, 2019 ($ in thousands) Amortized Fair value Due in one year or less $ 319,944 $ 322,640 Due after one year through five years 1,257,931 1,320,313 Due after five years through ten years 1,613,303 1,733,809 Due after ten years 819,246 1,043,743 4,010,424 4,420,505 MBS 12,683 13,857 Total $ 4,023,107 $ 4,434,362

Fair Value of Assets and Liab_2

Fair Value of Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2019
Summary of Assets and Liabilities Measured at Fair Value on Recurring and Non-Recurring Basis	The following table summarizes the Company’s assets and liabilities measured at fair value as of December 31, 2019. ($ in thousands) Quoted prices Significant Significant Counterparty Balance Assets Fixed income securities: U.S. government and agencies $ 2,250 $ 50,564 $ — $ 52,814 Municipal — 530,584 21,696 552,280 Corporate - public — 2,688,680 5,221 2,693,901 Corporate - privately placed — 962,072 19,272 981,344 Foreign government — 140,166 — 140,166 MBS — 13,857 — 13,857 Total fixed income securities 2,250 4,385,923 46,189 4,434,362 Equity securities 265,195 858 8,080 274,133 Short-term investments 124,763 99,335 — 224,098 Other investments: Free-standing derivatives — 6,008 75 $ (846 ) 5,237 Separate account assets 265,546 — — 265,546 Other assets — — 231,491 231,491 Total recurring basis assets $ 657,754 $ 4,492,124 $ 285,835 $ (846 ) $ 5,434,867 % of total assets at fair value 12.1 % 82.6 % 5.3 % — % 100.0 % Investments reported at NAV 109,066 Total $ 5,543,933 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ — $ — $ (16,653 ) $ (16,653 ) Other liabilities: Free-standing derivatives — (2,920 ) — $ 15 (2,905 ) Total recurring basis liabilities $ — $ (2,920 ) $ (16,653 ) $ 15 $ (19,558 ) % of total liabilities at fair value — % 15.0 % 85.1 % (0.1 )% 100.0 % The following table summarizes the Company’s assets and liabilities measured at fair value as of December 31, 2018. ($ in thousands) Quoted prices Significant Significant Counterparty Balance Assets Fixed income securities: U.S. government and agencies $ 36,299 $ 49,165 $ — $ 85,464 Municipal — 683,102 20,821 703,923 Corporate - public — 2,437,942 6,761 2,444,703 Corporate - privately placed — 1,106,938 11,190 1,118,128 Foreign government — 136,822 — 136,822 ABS — 19,888 — 19,888 MBS — 21,416 — 21,416 Total fixed income securities 36,299 4,455,273 38,772 4,530,344 Equity securities 172,077 731 12,162 184,970 Short-term investments 50,353 38,195 — 88,548 Other investments: Free-standing derivatives — 1,240 394 $ (981 ) 653 Separate account assets 241,710 — 241,710 Other assets 1 — 169,386 169,387 Total recurring basis assets $ 500,440 $ 4,495,439 $ 220,714 $ (981 ) $ 5,215,612 % of total assets at fair value 9.6 % 86.2 % 4.2 % — % 100.0 % Investments reported at NAV 104,778 Total $ 5,320,390 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ — $ — $ (3,801) $ (3,801 ) Other liabilities: Free-standing derivatives — (192 ) — $ 11 (181 ) Total recurring basis liabilities $ — $ (192 ) $ (3,801) $ 11 $ (3,982 ) % of total liabilities at fair value — % 4.8 % 95.5 % (0.3 )% 100.0 %
Summary of Quantitative Information About Significant Unobservable Inputs Used in Level Three Fair Value Measurements	The following table summarizes quantitative information about the significant unobservable inputs used in Level 3 fair value measurements. ($ in thousands) Fair value Valuation Unobservable Range Weighted December 31, 2019 Other assets – Structured settlement annuity reinsurance agreement $ 231,491 Stochastic cash Ultimate 129.8 - 203.6 165.7 basis Derivatives embedded in life contracts – equity-indexed and forward starting options $ (14,239 ) Stochastic cash Projected 3.9 - 4.2% 4.00% December 31, 2018 Other assets – Structured settlement annuity reinsurance agreement $ 169,386 Stochastic cash Ultimate 129.8 - 218.6 169.3 basis
Schedule of Rollforward of Level Three Assets and Liabilities Held at Fair Value on Recurring Basis	The following table presents the rollforward of Level 3 assets and liabilities held at fair value during the year ended December 31, 2019. ($ in thousands) Total gains (losses) Balance as of Net OCI Transfers Transfers out of Level 3 Assets Fixed income securities: Municipal $ 20,821 $ — $ 1,695 $ — $ — Corporate - public 6,761 1 542 — (2,083 ) Corporate - privately placed 11,190 6 422 13,987 — Total fixed income securities 38,772 7 2,659 13,987 (2,083 ) Equity securities 12,162 2,653 — — (16 ) Free-standing derivatives, net 394 (200 ) — — — Other assets 169,386 62,105 — — — Total recurring Level 3 assets $ 220,714 $ 64,565 $ 2,659 $ 13,987 $ (2,099 ) Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ (3,801 ) $ (1,664 ) $ — $ (10,128 ) $ — Total recurring Level 3 liabilities $ (3,801 ) $ (1,664 ) $ — $ (10,128 ) $ — Purchases Sales Issues Settlements Balance as of Assets Fixed income securities: Municipal $ — $ (820 ) $ — $ — $ 21,696 Corporate - public — — — — 5,221 Corporate - privately placed — — — (6,333 ) 19,272 Total fixed income securities — (820 ) — (6,333 ) 46,189 Equity securities 210 (6,768 ) — (161 ) 8,080 Free-standing derivatives, net 18 — — (137 ) 75 (1) Other assets — — — — 231,491 Total recurring Level 3 assets $ 228 $ (7,588 ) $ — $ (6,631 ) $ 285,835 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ — $ — $ (1,283 ) $ 223 $ (16,653 ) Total recurring Level 3 liabilities $ — $ — $ (1,283 ) $ 223 $ (16,653 ) (1) Comprises $75 thousand of assets The following table presents the total Level 3 gains (losses) included in net income for the year ended December 31, 2019. ($ in thousands) Net investment Realized capital Contract Interest credited to Total Components of net income $ (535 ) $ 65,100 $ 987 $ (2,651 ) $ 62,901 The following table presents the rollforward of Level 3 assets and liabilities held at fair value during the year ended December 31, 2018. ($ in thousands) Total gains (losses) Balance as of Net OCI Transfers into Level 3 Transfers out of Level 3 Assets Fixed income securities: Municipal $ 21,178 $ — $ (357 ) $ — $ — Corporate - public 7,312 1 (383 ) — — Corporate - privately placed 55,979 4 (639 ) — (22,957 ) ABS 15,205 — (205 ) — — Total fixed income securities 99,674 5 (1,584 ) — (22,957 ) Equity securities 7,159 2,600 (5 ) — — Free-standing derivatives, net 336 65 — — — Other assets 166,290 3,096 — — — Total recurring Level 3 assets $ 273,459 $ 5,766 $ (1,589 ) $ — $ (22,957 ) Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ (4,796 ) $ 995 $ — $ — $ — Total recurring Level 3 liabilities $ (4,796 ) $ 995 $ — $ — $ — Purchases Sales Issues Settlements Balance as of Assets Fixed income securities: Municipal $ — $ — $ — $ — $ 20,821 Corporate - public — — — (169 ) 6,761 Corporate - privately placed — — — (21,197 ) 11,190 ABS — — — (15,000 ) — Total fixed income securities — — — (36,366 ) 38,772 Equity securities 3,723 (1,315 ) — — 12,162 Free-standing derivatives, net 66 — — (73 ) 394 (1) Other assets — — — — 169,386 Total recurring Level 3 assets $ 3,789 $ (1,315 ) $ — $ (36,439 ) $ 220,714 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ — $ — $ — $ — $ (3,801 ) Total recurring Level 3 liabilities $ — $ — $ — $ — $ (3,801 ) (1) Comprises $394 thousand of assets The following table presents the total Level 3 gains (losses) included in net income for the year ended December 31, 2018. ($ in thousands) Net investment Realized capital Contract Interest credited to Total Components of net income $ 3 $ 5,763 $ (326 ) $ 1,321 $ 6.761 The following table presents the rollforward of Level 3 assets and liabilities held at fair value during the year ended December 31, 2017. Total gains (losses) ($ in thousands) Balance as of Net OCI Transfers Transfers Assets Fixed income securities: Municipal $ 22,723 $ 15 $ 347 $ — $ — Corporate - public 4,091 — (64 ) — (1,565 ) Corporate - privately placed 75,713 4,080 (4,520 ) — — ABS 14,803 — 402 — — Total fixed income securities 117,330 4,095 (3,835 ) — (1,565 ) Equity securities 5,920 585 492 — (275 ) Free-standing derivatives, net 311 (54 ) — — — Other assets 109,578 56,712 — — — Total recurring Level 3 assets $ 233,139 $ 61,338 $ (3,343 ) $ — $ (1,840 ) Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ (7,177 ) $ 2,381 $ — $ — $ — Total recurring Level 3 liabilities $ (7,177 ) $ 2,381 $ — $ — $ — Purchases Sales Issues Settlements Balance as of Assets Fixed income securities: Municipal $ — $ — $ — $ (1,907 ) $ 21,178 Corporate - public 4,989 — — (139 ) 7,312 Corporate - privately placed 1 (18,000 ) — (1,295 ) 55,979 ABS — — — — 15,205 Total fixed income securities 4,990 (18,000 ) — (3,341 ) 99,674 Equity securities 1,018 (581 ) — — 7,159 Free-standing derivatives, net 127 — — (48 ) 336 (1) Other assets — — — — 166,290 Total recurring Level 3 assets $ 6,135 $ (18,581 ) $ — $ (3,389 ) $ 273,459 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ — $ — $ — $ — $ (4,796 ) Total recurring Level 3 liabilities $ — $ — $ — $ — $ (4,796 ) (1) Comprises $336 thousand of assets
Fair Value Gain (losses) Net Income	The following table presents the total Level 3 gains (losses) included in net income for the year ended December 31, 2019. ($ in thousands) Net investment Realized capital Contract Interest credited to Total Components of net income $ (535 ) $ 65,100 $ 987 $ (2,651 ) $ 62,901 The following table presents the total Level 3 gains (losses) included in net income for the year ended December 31, 2018. ($ in thousands) Net investment Realized capital Contract Interest credited to Total Components of net income $ 3 $ 5,763 $ (326 ) $ 1,321 $ 6.761 The following table presents the total Level 3 gains (losses) included in net income for the year ended December 31, 2017. ($ in thousands) Net investment Realized capital Contract Interest credited to Total Components of net income $ 606 $ 60,732 $ 2,937 $ (556 ) $ 63,719
Schedule of Change in Unrealized Gains and Losses Included in Net Income for Level Three Assets and Liabilities Held	The table below provides valuation changes included in net income for Level 3 assets and liabilities held as of December 31. ($ in thousands) 2019 2018 2017 Assets Fixed income securities: Municipal $ — $ — $ 15 Corporate 3 3 5 Total fixed income securities 3 3 20 Free-standing derivatives, net (200 ) 65 (55 ) Equity securities 82 2,594 586 Other assets 62,105 3,096 56,712 Total recurring Level 3 assets $ 61,990 $ 5,758 $ 57,263 Liabilities Contractholder funds: Derivatives embedded in life and annuity contracts $ (1,664 ) $ 995 $ 2,381 Total recurring Level 3 liabilities $ (1,664 ) $ 995 $ 2,381 Total included in net income $ 60,326 $ 6,753 $ 59,644
Schedule of Carrying Values and Fair Value Estimates of Financial Instruments not Carried at Fair Value	Presented below are the carrying values and fair value estimates of financial instruments not carried at fair value. ($ in thousands) December 31, 2019 December 31, 2018 Financial Assets Fair value Carrying Fair value Carrying Fair value Mortgage loans Level 3 $ 733,258 $ 764,201 $ 696,062 $ 699,936 Financial Liabilities Contractholder funds on investment contracts Level 3 $ 1,605,574 $ 1,730,341 $ 1,755,866 $ 1,821,641 Liability for collateral Level 2 158,111 158,111 69,788 69,788

Derivative Financial Instrume_2

Derivative Financial Instruments and Off-balance sheet Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2019
Summary of Volume and Fair Value Positions of Derivative Instruments and Reporting Location in Statement of Financial Position	The following table provides a summary of the volume and fair value positions of derivative instruments as well as their reporting location in the Statement of Financial Position as of December 31, 2019. None of these derivatives are designated as accounting hedging instruments. Volume (1) ($ in thousands, except number of contracts) Balance sheet location Notional Number Fair value, Gross Gross Asset derivatives Equity and index contracts Options Other investments $ — 140 $ 5,232 $ 5,232 $ — Other contracts Structured settlement annuity reinsurance agreement Other assets — n/a 231,491 231,491 — Total asset derivatives $ — 140 $ 236,723 $ 236,723 $ — Liability derivatives Interest rate contracts Interest rate cap agreements Other liabilities & $ 13,400 n/a $ 75 $ 75 $ — Equity and index contracts Options Other liabilities & — 139 (2,832 ) — (2,832 ) Futures Other liabilities & — 1 — — — Foreign currency contracts Foreign currency forwards Other liabilities & 17,984 n/a 683 771 (88 ) Embedded derivative financial instruments Guaranteed accumulation benefits Contractholder funds 23,629 n/a (1,987 ) — (1,987 ) Guaranteed withdrawal benefits Contractholder funds 15,369 n/a (427 ) — (427 ) Equity-indexed options in life product contracts Contractholder funds 43,855 n/a (14,239 ) — (14,239 ) Total liability derivatives 114,237 140 (18,727 ) $ 846 $ (19,573 ) Total derivatives $ 114,237 280 $ 217,996 (1) Volume for OTC derivative contracts is represented by their notional amounts. Volume for exchange traded derivatives is represented by the number of contracts, which is the basis on which they are traded. (n/a = not applicable) The following table provides a summary of the volume and fair value positions of derivative instruments as well as their reporting location in the Statement of Financial Position as of December 31, 2018. None of these derivatives are designated as accounting hedging instruments. Volume ($ in thousands, except number of contracts) Balance sheet location Notional Number Fair Gross Gross Asset derivatives Interest rate contracts Interest rate cap agreements Other investments $ 1,500 n/a $ 17 $ 17 $ — Equity and index contracts Options Other investments — 122 556 556 — Futures Other assets — 1 1 1 — Foreign currency contracts Foreign currency forwards Other investments 16,091 n/a 670 684 (14 ) Other contracts Structured settlement annuity reinsurance agreement Other assets — n/a 169,386 169,386 — Total asset derivatives $ 17,591 123 $ 170,630 $ 170,644 $ (14 ) Liability derivatives Interest rate contracts Interest rate cap agreements Other liabilities & $ 12,600 n/a $ 377 $ 377 $ — Equity and index contracts Options Other liabilities & — 121 (178 ) — (178 ) Embedded derivative financial instruments Guaranteed accumulation benefits Contractholder funds 25,381 n/a (3,003 ) — (3,003 ) Guaranteed withdrawal benefits Contractholder funds 14,507 n/a (398 ) — (398 ) Equity-indexed options in life product contracts Contractholder funds 36,265 n/a (400 ) — (400 ) Total liability derivatives 88,753 121 (3,602 ) $ 377 $ (3,979 ) Total derivatives $ 106,344 244 $ 167,028
Schedule of gross and net amount for the Company's OTC derivatives subject to enforceable master netting arrangements	The following table provides gross and net amounts for the Company’s OTC derivatives, all of which are subject to enforceable master netting agreements. Offsets ($ in thousands) Gross Counter- Cash Net Securities Net December 31, 2019 Asset derivatives $ 846 $ (846 ) $ — $ — $ — $ — Liability derivatives (88 ) 846 (831 ) (73 ) — (73 ) December 31, 2018 Asset derivatives $ 1,078 $ (391 ) $ (590 ) $ 97 $ — $ 97 Liability derivatives (14 ) 391 (380 ) (3 ) — (3 )
Summary of Gains and Losses from Valuation and Settlements For Derivatives Not Designated As Hedges	The following tables present gains and losses from valuation and settlements reported on derivatives in the Statements of Operations and Comprehensive Income. ($ in thousands) Realized Contract Interest Total gain (loss) 2019 Interest rate contracts $ (200 ) $ — $ — $ (200 ) Equity and index contracts 1 — 1,987 1,988 Embedded derivative financial instruments — 987 (3,711 ) (2,724 ) Foreign currency contracts 364 — — 364 Other contracts - structured settlement annuity reinsurance agreement 58,922 — — 58,922 Total $ 59,087 $ 987 $ (1,724 ) $ 58,350 2018 Interest rate contracts $ 65 $ — $ — $ 65 Equity and index contracts — — (768 ) (768 ) Embedded derivative financial instruments — (326 ) 1,321 995 Foreign currency contracts 887 — — 887 Other contracts - structured settlement annuity reinsurance agreement (314 ) — — (314 ) Total $ 638 $ (326 ) $ 553 $ 865 2017 Interest rate contracts $ (54 ) $ — $ — $ (54 ) Equity and index contracts — — 1,289 1,289 Embedded derivative financial instruments — 2,937 (556 ) 2,381 Foreign currency contracts (697 ) — — (697 ) Other contracts - structured settlement annuity reinsurance agreement 53,257 — — 53,257 Total $ 52,506 $ 2,937 $ 733 $ 56,176
Summary of Counterparty Credit Exposure by Counterparty Credit Rating	The following table summarizes the counterparty credit exposure as of December 31 by counterparty credit rating as it relates to the Company’s OTC derivatives. 2019 2018 ($ in thousands) Rating (1) Number Notional (2) Credit (2) Exposure, (2) Number Notional (2) Credit (2) Exposure, (2) A+ 2 $ 30,670 $ 770 $ — 2 $ 30,191 $ 1,064 $ 97 (1) Allstate uses the lower of S&P or Moody’s long-term debt issuer ratings. (2) Only OTC derivatives with a net positive fair value are included for each counterparty.
Summary of Fair Value of Derivative Instruments with Termination, Cross-Default Or Collateral Credit-Risk-Contingent Features	The following summarizes the fair value of derivative instruments with termination, cross-default or collateral credit-risk-contingent features that are in a liability position as of December 31, as well as the fair value of assets that are netted against the liability in accordance with provisions within legally enforceable MNAs. ($ in thousands) 2019 2018 Gross liability fair value of contracts containing credit-risk-contingent features $ 83 $ — Gross asset fair value of contracts containing credit-risk-contingent features and subject to MNAs (70 ) — Maximum amount of additional exposure for contracts with credit-risk-contingent features if all features were triggered concurrently $ 13 $ —
Schedule of Contractual Amounts of Off Balance Sheet Financial instruments	The contractual amounts of off-balance ($ in thousands) 2019 2018 Commitments to invest in limited partnership interests $ 127,515 $ 153,719 Commitments to extend mortgage loans 13,000 10,000 Private placement commitments 15,000 —

Reserve for Life-Contingent C_2

Reserve for Life-Contingent Contract Benefits and Contractholder Funds (Tables)	12 Months Ended
	Dec. 31, 2019
Schedule of Reserve for Life-Contingent Contract Benefits	As of December 31, the reserve for life-contingent contract benefits consists of the following: ($ in thousands) 2019 2018 Immediate fixed annuities: Structured settlement annuities $ 2,051,363 $ 1,882,914 Other immediate fixed annuities 61,039 63,774 Traditional life insurance 265,971 258,336 Accident and health insurance 32,261 25,360 Other 1,175 1,752 Total reserve for life-contingent contract benefits $ 2,411,809 $ 2,232,136
Schedule of Key Assumptions Used In Calculation Reserve for Life-Contingent Contract Benefits	The following table highlights the key assumptions generally used in calculating the reserve for life-contingent contract benefits. Product Mortality Interest rate Estimation method Structured settlement annuities U.S. population with projected calendar year improvements; mortality rates adjusted for each impaired life based on reduction in life expectancy Interest rate assumptions range from 3.8% to 7.0% Present value of contractually specified future benefits Other immediate fixed annuities 1983 individual annuity mortality table; Annuity 2000 mortality table with internal modifications; Annuity 2000 mortality table Interest rate assumptions range from 0.6% to 5.4% Present value of expected future benefits based on historical experience Traditional life insurance Actual company experience plus loading Interest rate assumptions range from 3.0% to 8.0% Net level premium reserve method using the Company’s withdrawal experience rates; includes reserves for unpaid claims Accident and health insurance Actual company experience plus loading Interest rate assumptions range from 3.5% to 6.0% Unearned premium; additional contract reserves for mortality risk and unpaid claims Other: Variable annuity guaranteed minimum death benefits (1) Annuity 2012 mortality table with internal modifications Interest rate assumptions range from 2.0% to 5.8% Projected benefit ratio applied to cumulative assessments (1) In 2006, the Company disposed of its variable annuity business through a reinsurance agreement with The Prudential Insurance Company of America, a subsidiary of Prudential Financial, Inc. (collectively “Prudential”).
Schedule of Contractholder Funds	As of December 31, contractholder funds consist of the following: ($ in thousands) 2019 2018 Interest-sensitive life insurance $ 756,995 $ 740,694 Investment contracts: Fixed annuities 1,741,488 1,896,222 Other investment contracts 49,485 44,384 Total contractholder funds $ 2,547,968 $ 2,681,300
Schedule of Contract Provisions Related to Contractholder Funds	The following table highlights the key contract provisions relating to contractholder funds. Product Interest rate Withdrawal/surrender charges Interest-sensitive life insurance Interest rates credited range from 0.0% to 10.0% for equity-indexed life (whose returns are indexed to the S&P 500) and 2.0% to 5.1% for all other products Either a percentage of account balance or dollar amount grading off generally over 20 years Fixed annuities Interest rates credited range from 0.6% to 7.0% for immediate annuities and 1.0% to 5.0% for other fixed annuities Either a declining or a level percentage charge generally over ten years or less. Additionally, approximately 12.2% of fixed annuities are subject to market value adjustment for discretionary withdrawals Other investment contracts: Guaranteed minimum income, accumulation and withdrawal benefits on variable annuities (1) Interest rates used in establishing reserves range from 1.7% to 10.3% Withdrawal and surrender charges are based on the terms of the related interest-sensitive life insurance or fixed annuity contract (1) In 2006, the Company disposed of its variable annuity business through a reinsurance agreement with Prudential.
Schedule of Contractholder Funds Activity	Contractholder funds activity for the years ended December 31 is as follows: ($ in thousands) 2019 2018 2017 Balance, beginning of year $ 2,681,300 $ 2,874,884 $ 3,018,733 Deposits 104,850 107,606 103,107 Interest credited 86,338 91,430 97,355 Benefits (104,681 ) (114,006 ) (108,819 ) Surrenders and partial withdrawals (152,898 ) (190,873 ) (166,388 ) Contract charges (75,879 ) (75,483 ) (74,733 ) Net transfers from separate accounts 88 256 54 Other adjustments 8,850 (12,514 ) 5,575 Balance, end of year $ 2,547,968 $ 2,681,300 $ 2,874,884
Summary of Variable Annuity Contracts with Guarantees	The Company’s variable annuity contracts may offer more than one type of guarantee in each contract; therefore, the sum of amounts listed exceeds the total account balances of variable annuity contracts’ separate accounts with guarantees. As of December 31, ($ in thousands) 2019 2018 In the event of death Separate account value $ 243,833 $ 223,651 Net amount at risk (1) $ 4,392 $ 16,137 Average attained age of contractholders 68 years 67 years At annuitization (includes income benefit guarantees) Separate account value $ 18,849 $ 16,873 Net amount at risk (2) $ 1,750 $ 2,898 Weighted average waiting period until annuitization options available None None For cumulative periodic withdrawals Separate account value $ 15,173 $ 13,989 Net amount at risk (3) $ 421 $ 485 Accumulation at specified dates Separate account value $ 24,033 $ 25,272 Net amount at risk (4) $ 224 $ 849 Weighted average waiting period until guarantee date 3 years 3 years (1) Defined as the estimated current guaranteed minimum death benefit in excess of the current account balance as of the balance sheet date. (2) Defined as the estimated present value of the guaranteed minimum annuity payments in excess of the current account balance. (3) Defined as the estimated current guaranteed minimum withdrawal balance (initial deposit) in excess of the current account balance as of the balance sheet date. (4) Defined as the estimated present value of the guaranteed minimum accumulation balance in excess of the current account balance.
Schedule of Liabilities for Guarantees	The following table summarizes the liabilities for guarantees. ($ in thousands) Liability for interest-sensitive Liability for Liability for Total Balance, December 31, 2018 (1) $ 30,674 $ 572 $ 3,401 $ 34,647 Less reinsurance recoverables 1,752 568 3,401 5,721 Net balance as of December 31, 2018 28,922 4 — 28,926 Incurred guarantee benefits 4,412 (1 ) — 4,411 Paid guarantee benefits (388 ) — — (388 ) Net change 4,024 (1 ) — 4,023 Net balance as of December 31, 2019 32,946 3 — 32,949 Plus reinsurance recoverables 1,189 333 2,414 3,936 Balance, December 31, 2019 (2) $ 34,135 $ 336 $ 2,414 $ 36,885 Balance, December 31, 2017 (3) $ 27,927 $ 462 $ 3,075 $ 31,464 Less reinsurance recoverables 1,340 457 3,075 4,872 Net balance as of December 31, 2017 26,587 5 — 26,592 Incurred guarantee benefits 2,585 (1 ) — 2,584 Paid guarantee benefits (250 ) — — (250 ) Net change 2,335 (1 ) — 2,334 Net balance as of December 31, 2018 28,922 4 — 28,926 Plus reinsurance recoverables 1,752 568 3,401 5,721 Balance, December 31, 2018 (4) $ 30,674 $ 572 $ 3,401 $ 34,647 (1) Included in the total liability balance as of December 31, 2018 are reserves for variable annuity death benefits of $1.8 million, variable annuity income benefits of $0.6 million, variable annuity accumulation benefits of $3.0 million, variable annuity withdrawal benefits of $0.4 million and other guarantees of $28.8 million. (2) Included in the total liability balance as of December 31, 2019 are reserves for variable annuity death benefits of $1.2 million, variable annuity income benefits of $0.3 million, variable annuity accumulation benefits of $2.0 million, variable annuity withdrawal benefits of $0.4 million and other guarantees of $33.0 million. (3) Included in the total liability balance as of December 31, 2017 are reserves for variable annuity death benefits of $1.3 million, variable annuity income benefits of $0.5 million, variable annuity accumulation benefits of $2.8 million, variable annuity withdrawal benefits of $0.3 million and other guarantees of $26.6 million.

Reinsurance (Tables)

Reinsurance (Tables)	12 Months Ended
	Dec. 31, 2019
Schedule of Reinsurance Ceded Amount	The amounts ceded to Prudential for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Premiums and contract charges $ 4,797 $ 5,189 $ 5,401 Contract benefits (890 ) 1,459 (3,251 ) Interest credited to contractholder funds 4,307 4,533 4,805 Operating costs and expenses 867 868 943
Schedule of Effects of Reinsurance on Premiums and Contract Charges	The effects of reinsurance on premiums and contract charges for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Direct $ 203,614 $ 199,289 $ 185,875 Assumed - non-affiliate 697 685 672 Ceded Affiliate (2,186 ) (1,972 ) (1,730 ) Non-affiliate (16,359 ) (17,361 ) (17,705 ) Premiums and contract charges, net of reinsurance $ 185,766 $ 180,641 $ 167,112
Schedule of Effects of Reinsurance on Contract Benefits	The effects of reinsurance on contract benefits for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Direct $ 272,200 $ 248,008 $ 237,998 Assumed - non-affiliate 500 586 550 Ceded Affiliate (2,354 ) (55 ) (882 ) Non-affiliate (11,333 ) (10,961 ) (7,173 ) Contract benefits, net of reinsurance $ 259,013 $ 237,578 $ 230,493
Schedule of Effect of Reinsurance on Interest Credited to Contractholder Funds	The effects of reinsurance on interest credited to contractholder funds for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Direct $ 90,758 $ 96,002 $ 102,164 Assumed - non-affiliate 13 13 18 Ceded - non-affiliate (4,307 ) (4,533 ) (4,805 ) Interest credited to contractholder funds, net of reinsurance $ 86,464 $ 91,482 $ 97,377

Deferred Policy Acquisition a_2

Deferred Policy Acquisition and Sales Inducement Costs (Tables)	12 Months Ended
	Dec. 31, 2019
Schedule of Deferred Policy Acquisition Costs	Deferred policy acquisition costs for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Balance, beginning of year $ 155,887 $ 146,333 $ 137,358 Acquisition costs deferred 16,771 19,577 24,522 Amortization charged to income (30,396 ) (16,299 ) (16,992 ) Effect of unrealized gains and losses (18,144 ) 6,276 1,445 Balance, end of year $ 124,118 $ 155,887 $ 146,333
Schedule of Deferred Sales Inducement Activity	DSI activity, which primarily relates to interest-sensitive life contracts, for the years ended December 31 was as follows: ($ in thousands) 2019 2018 2017 Balance, beginning of year $ 2,391 $ 2,278 $ 2,265 Sales inducements deferred 125 128 167 Amortization charged to income (251 ) (181 ) (188 ) Effect of unrealized gains and losses (489 ) 166 34 Balance, end of year $ 1,776 $ 2,391 $ 2,278

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Components of Deferred Income Tax Assets and Liabilities	The components of the deferred income tax assets and liabilities as of December 31 are as follows: ($ in thousands) 2019 2018 Deferred tax assets Unrealized foreign currency translation adjustments on limited partnerships $ 317 $ — Accrued liabilities 25 25 Other assets 20 5 Total deferred tax assets 362 30 Deferred tax liabilities Investments (78,081 ) (75,864 ) Unrealized net capital gains (33,151 ) (15,178 ) Life and annuity reserves (29,048 ) (32,450 ) DAC (14,447 ) (18,713 ) Other liabilities (484 ) (858 ) Unrealized foreign currency translation adjustments on limited partnerships — (573 ) Total deferred tax liabilities (155,211 ) (143,636 ) Net deferred tax liability $ (154,849 ) $ (143,606 )
Components of Income Tax Expense	The components of income tax expense (benefit) for the years ended December 31 are as follows: ($ in thousands) 2019 2018 2017 Current $ 36,766 $ 11,257 $ 12,837 Deferred (5,840 ) 1,570 (59,572 ) Total income tax expense (benefit) $ 30,926 $ 12,827 $ (46,735 )
Reconciliation of Statutory Federal Income Tax Rate to Effective Income Tax Rate	A reconciliation of the statutory federal income tax rate to the effective income tax rate on income from operations for the years ended December 31 is as follows: 2019 2018 2017 Statutory federal income tax rate - expense 21.0 % 21.0 % 35.0 % State income taxes 1.8 5.4 0.7 Tax Legislation benefit — (3.9 ) (65.1 ) Adjustments to prior year tax liabilities 1.4 (0.1 ) — Other (0.1 ) (0.3 ) (0.3 ) Effective income tax rate - expense (benefit) 24.1 % 22.1 % (29.7 )%

Other Comprehensive Income (Tab

Other Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2019
Schedule of Components of Other Comprehensive Income on Pre-Tax and After-Tax Basis	The components of other comprehensive income (loss) on a pre-tax after-tax 2019 2018 2017 ($ in thousands) Pre-tax Tax After-tax Pre-tax Tax After-tax Pre-tax Tax After-tax Unrealized net holding gains and losses arising during the period, net of related offsets $ 86,980 $ (18,266 ) $ 68,714 $ (65,379 ) $ 13,730 $ (51,649 ) $ (89,152 ) $ 31,203 $ (57,949 ) Less: reclassification adjustment of realized capital gains and losses 1,395 (293 ) 1,102 (1,359 ) 285 (1,074 ) 12,710 (4,449 ) 8,261 Unrealized net capital gains and losses 85,585 (17,973 ) 67,612 (64,020 ) 13,445 (50,575 ) (101,862 ) 35,652 (66,210 ) Unrealized foreign currency translation adjustments (3,963 ) 832 (3,131 ) 124 (26 ) 98 3,706 (1,297 ) 2,409 Other comprehensive income (loss) $ 81,622 $ (17,141 ) $ 64,481 $ (63,896 ) $ 13,419 $ (50,477 ) $ (98,156 ) $ 34,355 $ (63,801 )

General - Additional Informatio

General - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statutory federal income tax rate	21.00%	21.00%	35.00%

Summary of Premiums and Contrac

Summary of Premiums and Contract Charges by Product (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Product Information [Line Items]
Premiums	$ 108,452	$ 103,447	$ 90,941
Contract charges	77,314	77,194	76,171
Total premiums and contract charges	185,766	180,641	167,112
Contract charges expense	(75,879)	(75,483)	(74,733)
Traditional life insurance
Product Information [Line Items]
Premiums	61,980	59,185	55,996
Accident and health insurance
Product Information [Line Items]
Premiums	46,472	44,262	34,945
Interest-sensitive life insurance
Product Information [Line Items]
Contract charges	77,324	76,931	76,103
Fixed annuities
Product Information [Line Items]
Contract charges		$ 263	$ 68
Contract charges expense	$ (10)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2019USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total valuation allowances for credit losses	$ 12
Cumulative-effect decrease in retained income, after tax	$ 6
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Amortization period of deferred acquisition costs	15 years
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Amortization period of deferred acquisition costs	30 years
Domestic Securities [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cash collateral for securities loaned as percentage of fair value	102.00%
Foreign Securities [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cash collateral for securities loaned as percentage of fair value	105.00%
Interest-sensitive life insurance | Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Amortization period of deferred acquisition costs	10 years
Interest-sensitive life insurance | Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Amortization period of deferred acquisition costs	20 years

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Supplemental Cash Flow Information [Line Items]
Non-cash modifications of certain mortgage loans and fixed income securities	$ 8,000	$ 8,200	$ 1,500
Liabilities for collateral received in conjunction with the securities lending program	$ 158,111	$ 69,788	$ 59,067	$ 60,931

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Net change in proceeds managed
Net change in short-term investments	$ (88,323)	$ (10,721)	$ 1,864
Operating cash flow (used) provided	(88,323)	(10,721)	1,864
Net change in liabilities
Liabilities for collateral, beginning of year	(69,788)	(59,067)	(60,931)
Liabilities for collateral, end of year	(158,111)	(69,788)	(59,067)
Operating cash flow provided (used)	$ 88,323	$ 10,721	$ (1,864)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Related Party Transaction [Line Items]
Operating expenses, including compensation, allocated by Allstate Insurance Company	$ 45,000	$ 46,200	$ 46,300
Reserve for annuities issued	2,411,809	2,232,136
Ceded premium related to structured settlement annuities	10,600	11,054	11,481
Investments	6,095,981	5,922,804
Maximum amount of loans Corporation will have outstanding to all eligible subsidiaries at any given point in time	1,000,000
Allstate Insurance Company ("AIC")
Related Party Transaction [Line Items]
Reserve for annuities issued	1,420,000	1,420,000
Allstate Life Insurance Company
Related Party Transaction [Line Items]
Reserve for annuities issued	559,500	574,900
Ceded premium related to structured settlement annuities	4,200	3,400	3,500
Carrying value of structured settlement reinsurance treaty	231,500	169,400
Investments	1,450
Allstate Distributors Services, LLC
Related Party Transaction [Line Items]
Broker-Dealer agreement, Promotion and marketing expense	3	5	6
Allstate Financial Services, LLC
Related Party Transaction [Line Items]
Broker-Dealer agreement, Commission and other distribution expenses	$ 317	$ 215	$ 259

Schedule for Fixed Income Secur

Schedule for Fixed Income Securities at Amortized Cost, Gross Unrealized Gains and Losses and Fair Value (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	$ 4,023,107	$ 4,375,110
Fair value	4,434,362	4,530,344
U.S. government and agencies
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	43,280	76,070
Gross unrealized gains	9,534	9,394
Fair value	52,814	85,464
Municipal
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	433,038	615,511
Gross unrealized gains	119,242	88,530
Gross unrealized losses		(118)
Fair value	552,280	703,923
Corporate
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	3,400,471	3,514,421
Gross unrealized gains	277,338	118,369
Gross unrealized losses	(2,564)	(69,959)
Fair value	3,675,245	3,562,831
Foreign government
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	133,635	128,926
Gross unrealized gains	6,531	7,896
Fair value	140,166	136,822
Mortgage-backed securities (MBS)
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	12,683	20,276
Gross unrealized gains	1,174	1,166
Gross unrealized losses		(26)
Fair value	13,857	21,416
Fixed income securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	4,023,107	4,375,110
Gross unrealized gains	413,819	225,355
Gross unrealized losses	(2,564)	(70,121)
Fair value	$ 4,434,362	4,530,344
Asset-backed securities (ABS)
Schedule of Available-for-sale Securities [Line Items]
Amortized cost		19,906
Gross unrealized losses		(18)
Fair value		$ 19,888

Schedule for Fixed Income Sec_2

Schedule for Fixed Income Securities Based on Contractual Maturities (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Amortized cost
Due in one year or less	$ 319,944
Due after one year through five years	1,257,931
Due after five years through ten years	1,613,303
Due after ten years	819,246
Available-for-sale Securities, Debt Maturities, Single Maturity Date, Amortized Cost Basis, Total	4,010,424
MBS	12,683
Total	4,023,107	$ 4,375,110
Fair value
Due in one year or less	322,640
Due after one year through five years	1,320,313
Due after five years through ten years	1,733,809
Due after ten years	1,043,743
Available-for-sale Securities, Debt Maturities, Single Maturity Date, Total	4,420,505
MBS	13,857
Total	$ 4,434,362	$ 4,530,344

Schedule of Net Investment Inco

Schedule of Net Investment Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Net Investment Income [Line Items]
Investment income, before expense	$ 267,749	$ 299,194	$ 319,795
Investment expense	(11,743)	(11,311)	(9,100)
Net investment income	256,006	287,883	310,695
Fixed income securities
Net Investment Income [Line Items]
Investment income, before expense	208,816	214,039	228,507
Equity securities
Net Investment Income [Line Items]
Investment income, before expense	4,283	5,565	5,465
Short-term
Net Investment Income [Line Items]
Investment income, before expense	4,393	2,966	1,200
Mortgage loans
Net Investment Income [Line Items]
Investment income, before expense	32,566	30,920	28,263
Limited partnership interests
Net Investment Income [Line Items]
Investment income, before expense	15,348	43,365	53,917
Policy loans
Net Investment Income [Line Items]
Investment income, before expense	$ 2,343	$ 2,339	$ 2,443

Schedule of Realized Capital Ga

Schedule of Realized Capital Gains (Losses) by Asset Type (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Gain (Loss) on Investments [Line Items]
Realized capital gains and losses	$ 106,627	$ (20,554)	$ 66,332
Fixed income securities
Gain (Loss) on Investments [Line Items]
Realized capital gains and losses	1,389	(1,306)	5,436
Equity securities
Gain (Loss) on Investments [Line Items]
Realized capital gains and losses	40,780	(16,364)	799
Mortgage loans
Gain (Loss) on Investments [Line Items]
Realized capital gains and losses		466	1,128
Limited partnership interests
Gain (Loss) on Investments [Line Items]
Realized capital gains and losses	5,383	(3,895)	6,451
Derivative instruments
Gain (Loss) on Investments [Line Items]
Realized capital gains and losses	59,087	638	52,506
Short-term investments
Gain (Loss) on Investments [Line Items]
Realized capital gains and losses	$ (12)	$ (93)	$ 12

Schedule of Realized Capital _2

Schedule of Realized Capital Gains (Losses) by Transaction Type (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Gain (Loss) on Investments [Line Items]
Impairment write-downs		$ (169)	$ (285)	$ (5,370)
Sales		4,698	(1,548)	19,196
Valuation of equity investments	[1]	43,011	(19,359)
Valuation and settlements of derivative instruments		59,087	638	52,506
Realized capital gains (losses)		$ 106,627	$ (20,554)	$ 66,332
[1]	Includes valuation of equity securities and certain limited partnership interests where the underlying assets are predominately public equity securities.

Investments - Additional Inform

Investments - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule of Investments [Line Items]
Limited partnership interests	$ 386,310	$ 382,853
Mortgage loans	733,258	696,062
Total impaired mortgage loans	0	0
Valuation allowances	0	0
Municipal debt carrying value	552,300	703,900
Short-term, at fair value	224,098	88,548
Policy loans	38,583	39,374
Other investments	5,237	653
Interest income on collateral, net of fees	342	286	$ 235
Debt securities	4,434,362	4,530,344
EMA limited partnerships
Schedule of Investments [Line Items]
Limited partnership interests	277,200	278,100
Fixed income securities
Schedule of Investments [Line Items]
Gross gains realized on sales of fixed income securities	4,900	4,400	19,800
Gross losses realized on sales of fixed income securities	3,300	5,400	$ 8,200
Fixed income securities on loan	152,300	66,600
Debt securities	4,434,362	4,530,344
Fixed income securities | Non Income Producing Investments
Schedule of Investments [Line Items]
Debt securities	0
Cost-method limited partnership interests
Schedule of Investments [Line Items]
Limited partnership interests	109,100	104,800
Below investment grade fixed income securities
Schedule of Investments [Line Items]
Debt securities	406,000	$ 279,200
Fixed income securities and short-term investments
Schedule of Investments [Line Items]
Assets on deposit with regulatory authorities	$ 2,200

Schedule of Net Pre-Tax Appreci

Schedule of Net Pre-Tax Appreciation (Decline) of Equity Securities and Limited Partnership Interests Carried at Fair Value Recognized in Net Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Gain (Loss) on Investments [Line Items]
Net pre tax appreciation decline at fair value	$ 38,723	$ 4,071
Equity securities
Gain (Loss) on Investments [Line Items]
Net pre tax appreciation decline at fair value	29,558	(12,897)
Limited partnership interests
Gain (Loss) on Investments [Line Items]
Net pre tax appreciation decline at fair value	$ 9,165	$ 16,968

Schedule of Other-Than-Temporar

Schedule of Other-Than-Temporary Impairment Losses by Asset Type (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Other Than Temporary Impairment Losses By Asset Type [Line Items]
Gross	$ (1,202)	$ (68)	$ (6,263)
Included in OCI	1,033	(217)	893
Net	(169)	(285)	(5,370)
Corporate
Other Than Temporary Impairment Losses By Asset Type [Line Items]
Gross			(1,481)
Net			(1,481)
Mortgage-backed securities (MBS)
Other Than Temporary Impairment Losses By Asset Type [Line Items]
Gross	(1,202)	(68)	(2,338)
Included in OCI	1,033	(217)	893
Net	(169)	(285)	(1,445)
Fixed income securities
Other Than Temporary Impairment Losses By Asset Type [Line Items]
Gross	(1,202)	(68)	(3,819)
Included in OCI	1,033	(217)	893
Net	$ (169)	$ (285)	(2,926)
Equity securities
Other Than Temporary Impairment Losses By Asset Type [Line Items]
Gross			(2,422)
Net			(2,422)
Limited Partner Interest
Other Than Temporary Impairment Losses By Asset Type [Line Items]
Gross			(22)
Net			$ (22)

Schedule of Other-Than-Tempor_2

Schedule of Other-Than-Temporary Impairment Losses on Fixed Income Securities included in Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Thousands		Dec. 31, 2019	Dec. 31, 2018
Mortgage-backed securities (MBS)
Other Than Temporary Impairment Losses Included In Accumulated Other Comprehensive Income [Line Items]
Amount of other-than-temporary impairment losses included in accumulated other comprehensive income for fixed income securities, not included in earnings	[1]	$ (1,188)	$ (358)
[1]	The amounts exclude $2.0 million and $1.9 million as of December 31, 2019 and 2018, respectively, of net unrealized gains related to changes in valuation of the fixed income securities subsequent to the impairment measurement date.

Schedule of Other-Than-Tempor_3

Schedule of Other-Than-Temporary Impairment Losses on Fixed Income Securities included in Accumulated Other Comprehensive Income (Parenthetical) (Detail) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Other Than Temporary Impairment Losses Included In Accumulated Other Comprehensive Income [Line Items]
Net unrealized gains related to changes in valuation of fixed income securities subsequent to impairment measurement date	$ 2	$ 1.9

Schedule of Rollforwards of Cum

Schedule of Rollforwards of Cumulative Credit Losses Recognized in Earnings for Fixed Income Securities Held (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule of Other than Temporary Impairments [Line Items]
Beginning balance	$ (2,684)	$ (3,192)	$ (4,594)
Additional credit loss for securities previously other-than-temporarily impaired	(169)	(285)	(128)
Additional credit loss for securities not previously other-than-temporarily impaired			(2,798)
Reduction in credit loss for securities disposed or collected	1,740	793	4,328
Ending balance	$ (1,113)	$ (2,684)	$ (3,192)

Schedule of Unrealized Net Capi

Schedule of Unrealized Net Capital Gains and Losses (Detail) - USD ($) $ in Thousands	Dec. 31, 2019		Dec. 31, 2018
Fair value
Fixed income securities	$ 4,434,362		$ 4,530,344
Short-term investments	224,098		88,548
Gross unrealized Gains
Fixed income securities	413,819		225,355
Short-term investments	4
Gross unrealized Losses
Fixed income securities	(2,564)		(70,121)
Short-term investments	(17)		(4)
Unrealized net gains (losses)
Fixed income securities	411,255		155,234
Short-term investments	(13)		(4)
EMA limited partnerships	(205)	[1]	(50)
Unrealized net capital gains and losses, pre-tax	411,037		155,180
Amounts recognized for:
Insurance reserves	(231,357)	[2]	(80,628)
DAC and DSI	(21,820)	[3]	(2,277)
Amounts recognized	(253,177)		(82,905)
Deferred income taxes	(33,151)		(15,178)
Total unrealized net capital gains and losses	$ 124,709		$ 57,097
[1]	Unrealized net capital gains and losses for limited partnership interests represent the Company's share of EMA limited partnerships' OCI. Fair value and gross unrealized gains and losses are not applicable.
[2]	The insurance reserves adjustment represents the amount by which the reserve balance would increase if the net unrealized gains in the applicable product portfolios were realized and reinvested at lower interest rates, resulting in a premium deficiency. This adjustment primarily relates to structured settlement annuities with life contingencies (a type of immediate annuities with life contingencies).
[3]	The DAC and DSI adjustment balance represents the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized gains or losses in the respective product portfolios were realized.

Schedule of Change in Unrealize

Schedule of Change in Unrealized net Capital Gains and Losses (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Change In Unrealized Gain Loss Recognized In Accumulated Other Comprehensive Income Loss [Line Items]
Change in unrealized net capital gains and losses		$ 255,857	$ (212,514)	$ 62,666
Amounts recognized for:
Insurance reserves		(150,729)	141,714	(165,992)
DAC and DSI		(19,543)	6,780	1,465
Amounts recognized		(170,272)	148,494	(164,527)
Deferred income taxes		(17,973)	13,445	60,664
Increase (decrease) in unrealized net capital gains and losses, after-tax		67,612	(50,575)	(41,197)
EMA limited partnerships
Change In Unrealized Gain Loss Recognized In Accumulated Other Comprehensive Income Loss [Line Items]
Change in unrealized net capital gains and losses		(155)	(40)	51
Short-term investments
Change In Unrealized Gain Loss Recognized In Accumulated Other Comprehensive Income Loss [Line Items]
Change in unrealized net capital gains and losses		(9)	9	(12)
Fixed income securities
Change In Unrealized Gain Loss Recognized In Accumulated Other Comprehensive Income Loss [Line Items]
Change in unrealized net capital gains and losses		$ 256,021	$ (212,483)	29,700
Equity securities
Change In Unrealized Gain Loss Recognized In Accumulated Other Comprehensive Income Loss [Line Items]
Change in unrealized net capital gains and losses	[1]			$ 32,927
[1]	Upon adoption of the recognition and measurement accounting standard on January 1, 2018, $42.4 million of pre-tax unrealized net capital gains for equity securities were reclassified from AOCI to retained income.

Schedule of Change in Unreali_2

Schedule of Change in Unrealized net Capital Gains and Losses (Parenthetical) (Detail) $ in Millions	Dec. 31, 2017USD ($)
Change In Unrealized Gain Loss Recognized In Accumulated Other Comprehensive Income Loss [Line Items]
Equity securities	$ 42.4

Summary of Gross Unrealized Los

Summary of Gross Unrealized Losses and Fair Value of Fixed Income and Equity Securities by Length of Time (Detail) $ in Thousands	Dec. 31, 2019USD ($)Securities	Dec. 31, 2018USD ($)Securities
Municipal
Schedule of Investments [Line Items]
Number of issues, continuous unrealized loss position for less than 12 months | Securities		1
Fair value, continuous unrealized loss position for less than 12 months		$ 9,371
Unrealized losses, continuous unrealized loss position for less than 12 months		$ (11)
Number of issues, continuous unrealized loss position for 12 months or more | Securities		1
Fair value, continuous unrealized loss position for 12 months or more		$ 4,893
Unrealized losses, continuous unrealized loss position for 12 months or more		(107)
Total unrealized losses		$ (118)
Corporate
Schedule of Investments [Line Items]
Number of issues, continuous unrealized loss position for less than 12 months | Securities	44	451
Fair value, continuous unrealized loss position for less than 12 months	$ 104,484	$ 1,308,566
Unrealized losses, continuous unrealized loss position for less than 12 months	$ (815)	$ (40,510)
Number of issues, continuous unrealized loss position for 12 months or more | Securities	17	123
Fair value, continuous unrealized loss position for 12 months or more	$ 31,900	$ 480,729
Unrealized losses, continuous unrealized loss position for 12 months or more	(1,749)	(29,449)
Total unrealized losses	$ (2,564)	$ (69,959)
Asset-backed securities (ABS)
Schedule of Investments [Line Items]
Number of issues, continuous unrealized loss position for less than 12 months | Securities		1
Fair value, continuous unrealized loss position for less than 12 months		$ 10,010
Unrealized losses, continuous unrealized loss position for less than 12 months		$ (9)
Number of issues, continuous unrealized loss position for 12 months or more | Securities		1
Fair value, continuous unrealized loss position for 12 months or more		$ 9,878
Unrealized losses, continuous unrealized loss position for 12 months or more		(9)
Total unrealized losses		$ (18)
Mortgage-backed securities (MBS)
Schedule of Investments [Line Items]
Number of issues, continuous unrealized loss position for less than 12 months | Securities	2	90
Fair value, continuous unrealized loss position for less than 12 months	$ 38	$ 1,086
Unrealized losses, continuous unrealized loss position for less than 12 months	$ 0	$ (5)
Number of issues, continuous unrealized loss position for 12 months or more | Securities	2	20
Fair value, continuous unrealized loss position for 12 months or more	$ 1	$ 939
Unrealized losses, continuous unrealized loss position for 12 months or more	0	(21)
Total unrealized losses	$ 0	$ (26)
Fixed income securities
Schedule of Investments [Line Items]
Number of issues, continuous unrealized loss position for less than 12 months | Securities	46	543
Fair value, continuous unrealized loss position for less than 12 months	$ 104,522	$ 1,329,033
Unrealized losses, continuous unrealized loss position for less than 12 months	$ (815)	$ (40,535)
Number of issues, continuous unrealized loss position for 12 months or more | Securities	19	145
Fair value, continuous unrealized loss position for 12 months or more	$ 31,901	$ 496,439
Unrealized losses, continuous unrealized loss position for 12 months or more	(1,749)	(29,586)
Total unrealized losses	$ (2,564)	$ (70,121)
Investment grade fixed income securities
Schedule of Investments [Line Items]
Number of issues, continuous unrealized loss position for less than 12 months | Securities	22	309
Fair value, continuous unrealized loss position for less than 12 months	$ 82,142	$ 1,111,745
Unrealized losses, continuous unrealized loss position for less than 12 months	$ (347)	$ (27,375)
Number of issues, continuous unrealized loss position for 12 months or more | Securities	3	122
Fair value, continuous unrealized loss position for 12 months or more	$ 9,845	$ 470,388
Unrealized losses, continuous unrealized loss position for 12 months or more	(130)	(26,471)
Total unrealized losses	$ (477)	$ (53,846)
Below investment grade fixed income securities
Schedule of Investments [Line Items]
Number of issues, continuous unrealized loss position for less than 12 months | Securities	24	234
Fair value, continuous unrealized loss position for less than 12 months	$ 22,380	$ 217,288
Unrealized losses, continuous unrealized loss position for less than 12 months	$ (468)	$ (13,160)
Number of issues, continuous unrealized loss position for 12 months or more | Securities	16	23
Fair value, continuous unrealized loss position for 12 months or more	$ 22,056	$ 26,051
Unrealized losses, continuous unrealized loss position for 12 months or more	(1,619)	(3,115)
Total unrealized losses	$ (2,087)	$ (16,275)

Investments - Schedule of Gross

Investments - Schedule of Gross Unrealized Losses by Unrealized Loss Position and Credit quality (Detail) - USD ($) $ in Thousands		Dec. 31, 2019	Dec. 31, 2018
Investment grade fixed income securities
Schedule of Investments [Line Items]
Total unrealized losses		$ (477)	$ (53,846)
Investment grade fixed income securities | Unrealized loss position less than 20% of amortized cost
Schedule of Investments [Line Items]
Total unrealized losses	[1],[2]	(477)
Below investment grade fixed income securities
Schedule of Investments [Line Items]
Total unrealized losses		(2,087)	(16,275)
Below investment grade fixed income securities | Unrealized loss position less than 20% of amortized cost
Schedule of Investments [Line Items]
Total unrealized losses	[1],[2]	(1,722)
Below investment grade fixed income securities | Unrealized loss position greater than or equal to 20% of amortized cost
Schedule of Investments [Line Items]
Total unrealized losses	[3],[4]	(365)
Fixed income securities
Schedule of Investments [Line Items]
Total unrealized losses		(2,564)	$ (70,121)
Fixed income securities | Unrealized loss position less than 20% of amortized cost
Schedule of Investments [Line Items]
Total unrealized losses	[1],[2]	(2,199)
Fixed income securities | Unrealized loss position greater than or equal to 20% of amortized cost
Schedule of Investments [Line Items]
Total unrealized losses	[3],[4]	$ (365)
[1]	Below investment grade fixed income securities include $468 thousand that have been in an unrealized loss position for less than twelve months.
[2]	Related to securities with an unrealized loss position less than 20% of amortized cost, the degree of which suggests that these securities do not pose a high risk of being other-than-temporarily impaired.
[3]	Evaluated based on factors such as discounted cash flows and the financial condition and near-term and long-term prospects of the issue or issuer and were determined to have adequate resources to fulfill contractual obligations.
[4]	No below investment grade fixed income securities have been in an unrealized loss position for a period of twelve or more consecutive months.

Investments - Schedule of Gro_2

Investments - Schedule of Gross Unrealized Losses by Unrealized Loss Position and Credit quality (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Below investment grade fixed income securities
Schedule of Investments [Line Items]
Unrealized losses, continuous unrealized loss position for less than 12 months	$ (468)	$ (13,160)

Schedule of Commercial Mortgage

Schedule of Commercial Mortgage Loans by Geographic Distribution (Detail)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	100.00%	100.00%
California
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	16.70%	18.40%
Illinois
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	5.50%	6.10%
New Jersey
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	5.60%	6.60%
Texas
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	19.90%	16.10%
North Carolina
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	8.20%	8.80%
Nevada
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	5.80%	6.30%
UTAH
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	5.90%	2.10%

Schedule of Types of Properties

Schedule of Types of Properties Collateralizing Commercial Mortgage Loans (Detail)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	100.00%	100.00%
Apartment complex
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	32.60%	31.30%
Office buildings
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	27.40%	27.20%
Retail
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	15.60%	17.30%
Warehouse
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	16.50%	15.70%
Other
Mortgage Loans on Real Estate [Line Items]
Percentage of mortgage loan portfolio carrying value	7.90%	8.50%

Schedule of Contractual Maturit

Schedule of Contractual Maturities of Mortgage Loans (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)Loan	Dec. 31, 2018USD ($)
Mortgage Loans on Real Estate [Line Items]
Number of loans | Loan	97
Carrying value, maturing in 2020 | $	$ 7,235
Carrying value, maturing in 2021 | $	57,821
Carrying value, maturing in 2022 | $	61,004
Carrying value, maturing in 2023 | $	111,481
Carrying value, maturing in Thereafter | $	495,717
Carrying value, Total | $	$ 733,258	$ 696,062
Percentage of mortgage loan portfolio carrying value	100.00%	100.00%
2020
Mortgage Loans on Real Estate [Line Items]
Number of loans | Loan	2
Percentage of mortgage loan portfolio carrying value	1.00%
2021
Mortgage Loans on Real Estate [Line Items]
Number of loans | Loan	9
Percentage of mortgage loan portfolio carrying value	7.90%
2022
Mortgage Loans on Real Estate [Line Items]
Number of loans | Loan	10
Percentage of mortgage loan portfolio carrying value	8.30%
2023
Mortgage Loans on Real Estate [Line Items]
Number of loans | Loan	14
Percentage of mortgage loan portfolio carrying value	15.20%
Thereafter
Mortgage Loans on Real Estate [Line Items]
Number of loans | Loan	62
Percentage of mortgage loan portfolio carrying value	67.60%

Summary of Carrying Value of No

Summary of Carrying Value of Non-Impaired Mortgage Loans by Debt Service Coverage Ration Distribution (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Mortgage Loans on Real Estate [Line Items]
Total	$ 733,258	$ 696,062
Non-impaired mortgage loans
Mortgage Loans on Real Estate [Line Items]
Total	733,258	696,062
Fixed rate mortgage loans | Non-impaired mortgage loans
Mortgage Loans on Real Estate [Line Items]
Total	704,839	667,663
Variable rate mortage loans | Non-impaired mortgage loans
Mortgage Loans on Real Estate [Line Items]
Total	28,419	28,399
1.0 - 1.25
Mortgage Loans on Real Estate [Line Items]
Total	48,780	25,447
1.0 - 1.25 | Fixed rate mortgage loans
Mortgage Loans on Real Estate [Line Items]
Total	48,780	25,447
1.26 - 1.50
Mortgage Loans on Real Estate [Line Items]
Total	221,384	189,063
1.26 - 1.50 | Fixed rate mortgage loans
Mortgage Loans on Real Estate [Line Items]
Total	221,384	189,063
Above 1.50
Mortgage Loans on Real Estate [Line Items]
Total	463,094	481,552
Above 1.50 | Fixed rate mortgage loans
Mortgage Loans on Real Estate [Line Items]
Total	434,675	453,153
Above 1.50 | Variable rate mortage loans
Mortgage Loans on Real Estate [Line Items]
Total	$ 28,419	$ 28,399

Schedule of Municipal Bonds Hel

Schedule of Municipal Bonds Held For Investment by Geographic Distribution (Detail)	Dec. 31, 2019	Dec. 31, 2018
California
Schedule of Investments [Line Items]
Percentage of municipal bond portfolio carrying value	33.30%	28.10%
Texas
Schedule of Investments [Line Items]
Percentage of municipal bond portfolio carrying value	10.80%	12.20%
Oregon
Schedule of Investments [Line Items]
Percentage of municipal bond portfolio carrying value	10.60%	7.60%
Illinois
Schedule of Investments [Line Items]
Percentage of municipal bond portfolio carrying value	8.00%	5.90%

Fair Value of Assets and Liab_3

Fair Value of Assets and Liabilities - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commitments to invest in limited partnership interests	$ 29,600
Fixed income securities	4,434,362	$ 4,530,344
Significant unobservable inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	46,189	38,772
Significant unobservable inputs (Level 3) | Fixed income securities - non-binding broker quotes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed income securities	$ 8,400	$ 33,400
Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liquidation period of underlying assets of the investees	4 years
Contractual obligations maturity term	10 years
Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liquidation period of underlying assets of the investees	9 years
Contractual obligations maturity term	12 years

Summary of Assets and Liabiliti

Summary of Assets and Liabilities Measured at Fair Value on Recurring and Non-Recurring Basis (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Assets
Fixed income securities	$ 4,434,362	$ 4,530,344
Equity securities	274,133	184,970
Short-term investments	224,098	88,548
Other investments:
Free-standing derivatives	5,237	653
Separate account assets	265,546	241,710
Other assets	231,491	169,387
Total assets at fair value	$ 5,434,867	$ 5,215,612
% of total assets at fair value	100.00%	100.00%
Investments reported at NAV	$ 109,066	$ 104,778
Total	5,543,933	5,320,390
Contractholder funds:
Derivatives embedded in life and annuity contracts	(16,653)	(3,801)
Other liabilities:
Other liabilities: Free-standing derivatives	(2,905)	(181)
Total liabilities at fair value	$ (19,558)	$ (3,982)
% of total liabilities at fair value	100.00%	100.00%
U.S. government and agencies
Assets
Fixed income securities	$ 52,814	$ 85,464
Municipal
Assets
Fixed income securities	552,280	703,923
Corporate - public
Assets
Fixed income securities	2,693,901	2,444,703
Corporate - privately placed
Assets
Fixed income securities	981,344	1,118,128
Foreign government
Assets
Fixed income securities	140,166	136,822
Mortgage-backed securities (MBS)
Assets
Fixed income securities	13,857	21,416
Asset Backed Securities - consumer and other
Assets
Fixed income securities		19,888
Counterparty and cash collateral netting
Other investments:
Free-standing derivatives	(846)	(981)
Total assets at fair value	(846)	(981)
Other liabilities:
Other liabilities: Free-standing derivatives	15	11
Total liabilities at fair value	$ 15	$ 11
% of total liabilities at fair value	(0.10%)	(0.30%)
Quoted prices in active markets for identical assets (Level 1)
Assets
Fixed income securities	$ 2,250	$ 36,299
Equity securities	265,195	172,077
Short-term investments	124,763	50,353
Other investments:
Separate account assets	265,546	241,710
Other assets		1
Total assets at fair value	$ 657,754	$ 500,440
% of total assets at fair value	12.10%	9.60%
Quoted prices in active markets for identical assets (Level 1) | U.S. government and agencies
Assets
Fixed income securities	$ 2,250	$ 36,299
Significant other observable inputs (Level 2)
Assets
Fixed income securities	4,385,923	4,455,273
Equity securities	858	731
Short-term investments	99,335	38,195
Other investments:
Free-standing derivatives	6,008	1,240
Total assets at fair value	$ 4,492,124	$ 4,495,439
% of total assets at fair value	82.60%	86.20%
Other liabilities:
Other liabilities: Free-standing derivatives	$ (2,920)	$ (192)
Total liabilities at fair value	$ (2,920)	$ (192)
% of total liabilities at fair value	15.00%	4.80%
Significant other observable inputs (Level 2) | U.S. government and agencies
Assets
Fixed income securities	$ 50,564	$ 49,165
Significant other observable inputs (Level 2) | Municipal
Assets
Fixed income securities	530,584	683,102
Significant other observable inputs (Level 2) | Corporate - public
Assets
Fixed income securities	2,688,680	2,437,942
Significant other observable inputs (Level 2) | Corporate - privately placed
Assets
Fixed income securities	962,072	1,106,938
Significant other observable inputs (Level 2) | Foreign government
Assets
Fixed income securities	140,166	136,822
Significant other observable inputs (Level 2) | Mortgage-backed securities (MBS)
Assets
Fixed income securities	13,857	21,416
Significant other observable inputs (Level 2) | Asset Backed Securities - consumer and other
Assets
Fixed income securities		19,888
Significant unobservable inputs (Level 3)
Assets
Fixed income securities	46,189	38,772
Equity securities	8,080	12,162
Other investments:
Free-standing derivatives	75	394
Other assets	231,491	169,386
Total assets at fair value	$ 285,835	$ 220,714
% of total assets at fair value	5.30%	4.20%
Contractholder funds:
Derivatives embedded in life and annuity contracts	$ (16,653)	$ (3,801)
Other liabilities:
Total liabilities at fair value	$ (16,653)	$ (3,801)
% of total liabilities at fair value	85.10%	95.50%
Significant unobservable inputs (Level 3) | Municipal
Assets
Fixed income securities	$ 21,696	$ 20,821
Significant unobservable inputs (Level 3) | Corporate - public
Assets
Fixed income securities	5,221	6,761
Significant unobservable inputs (Level 3) | Corporate - privately placed
Assets
Fixed income securities	$ 19,272	$ 11,190

Summary of Quantitative Informa

Summary of Quantitative Information About Significant Unobservable Inputs Used in Level Three Fair Value Measurements (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	$ 5,434,867	$ 5,215,612
Fair value	(19,558)	(3,982)
Structured settlement annuities | Stochastic cash flow model
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	$ 231,491	$ 169,386
Structured settlement annuities | Minimum | Stochastic cash flow model
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Ultimate reinvestment spreads	1.298%	1.298%
Structured settlement annuities | Maximum | Stochastic cash flow model
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Ultimate reinvestment spreads	2.036%	2.186%
Structured settlement annuities | Weighted average | Stochastic cash flow model
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Ultimate reinvestment spreads	1.657%	1.693%
Equity-indexed and forward starting options in life and annuity product contracts | Stochastic cash flow model
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	$ (14,239)
Equity-indexed and forward starting options in life and annuity product contracts | Minimum | Stochastic cash flow model
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Projected option cost	3.90%
Equity-indexed and forward starting options in life and annuity product contracts | Maximum | Stochastic cash flow model
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Projected option cost	4.20%
Equity-indexed and forward starting options in life and annuity product contracts | Weighted average | Stochastic cash flow model
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Projected option cost	4.00%

Schedule of Rollforward of Leve

Schedule of Rollforward of Level 3 Assets and Liabilities Held at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019		Dec. 31, 2018		Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Level 3 assets, Balance at beginning of period	$ 220,714		$ 273,459		$ 233,139
Level 3 assets, Total gains (losses) included in net income	64,565		5,766		61,338
Level 3 assets, Total gains (losses) included in OCI	2,659		(1,589)		(3,343)
Level 3 assets, Transfers into Level 3	13,987
Level 3 assets, Transfers out of Level 3	(2,099)		(22,957)		(1,840)
Level 3 liabilities, Balance at beginning of period	(3,801)		(4,796)		(7,177)
Level 3 liabilities, Total gains (losses) included in net income	(1,664)		995		2,381
Level 3 liabilities, Total gains (losses) included in OCI	0		0		0
Level 3 liabilities, Transfers into Level 3	(10,128)
Level 3 liabilities, Transfers out of Level 3	0		0		0
Level 3 assets, Purchases	228		3,789		6,135
Level 3 assets, Sales	(7,588)		(1,315)		(18,581)
Level 3 assets, Issues	0		0		0
Level 3 assets, Settlements	(6,631)		(36,439)		(3,389)
Level 3 assets, Balance at end of period	285,835		220,714		273,459
Level 3 liabilities, Purchases	0		0		0
Level 3 liabilities, Sales	0		0		0
Level 3 liabilities, Issues	(1,283)
Level 3 liabilities, Settlements	223
Level 3 liabilities, Balance at end of period	(16,653)		(3,801)		(4,796)
Municipal
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Level 3 assets, Balance at beginning of period	20,821		21,178		22,723
Level 3 assets, Total gains (losses) included in net income					15
Level 3 assets, Total gains (losses) included in OCI	1,695		(357)		347
Level 3 assets, Sales	(820)
Level 3 assets, Issues	0		0		0
Level 3 assets, Settlements					(1,907)
Level 3 assets, Balance at end of period	21,696		20,821		21,178
Corporate - public
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Level 3 assets, Balance at beginning of period	6,761		7,312		4,091
Level 3 assets, Total gains (losses) included in net income	1		1		0
Level 3 assets, Total gains (losses) included in OCI	542		(383)		(64)
Level 3 assets, Transfers out of Level 3	(2,083)				(1,565)
Level 3 assets, Purchases	0		0		4,989
Level 3 assets, Issues	0		0		0
Level 3 assets, Settlements			(169)		(139)
Level 3 assets, Balance at end of period	5,221		6,761		7,312
Corporate - privately placed
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Level 3 assets, Balance at beginning of period	11,190		55,979		75,713
Level 3 assets, Total gains (losses) included in net income	6		4		4,080
Level 3 assets, Total gains (losses) included in OCI	422		(639)		(4,520)
Level 3 assets, Transfers into Level 3	13,987
Level 3 assets, Transfers out of Level 3			(22,957)
Level 3 assets, Purchases					1
Level 3 assets, Sales					(18,000)
Level 3 assets, Issues	0		0		0
Level 3 assets, Settlements	(6,333)		(21,197)		(1,295)
Level 3 assets, Balance at end of period	19,272		11,190		55,979
Asset Backed Securities - CDO
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Level 3 assets, Balance at beginning of period			15,205		14,803
Level 3 assets, Total gains (losses) included in OCI			(205)		402
Level 3 assets, Issues			0		0
Level 3 assets, Settlements			(15,000)
Level 3 assets, Balance at end of period					15,205
Fixed income securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Level 3 assets, Balance at beginning of period	38,772		99,674		117,330
Level 3 assets, Total gains (losses) included in net income	7		5		4,095
Level 3 assets, Total gains (losses) included in OCI	2,659		(1,584)		(3,835)
Level 3 assets, Transfers into Level 3	13,987
Level 3 assets, Transfers out of Level 3	(2,083)		(22,957)		(1,565)
Level 3 assets, Purchases					4,990
Level 3 assets, Sales	(820)				(18,000)
Level 3 assets, Issues	0		0		0
Level 3 assets, Settlements	(6,333)		(36,366)		(3,341)
Level 3 assets, Balance at end of period	46,189		38,772		99,674
Equity securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Level 3 assets, Balance at beginning of period	12,162		7,159		5,920
Level 3 assets, Total gains (losses) included in net income	2,653		2,600		585
Level 3 assets, Total gains (losses) included in OCI			(5)		492
Level 3 assets, Transfers out of Level 3	(16)				(275)
Level 3 assets, Purchases	210		3,723		1,018
Level 3 assets, Sales	(6,768)		(1,315)		(581)
Level 3 assets, Issues	0		0		0
Level 3 assets, Settlements	(161)
Level 3 assets, Balance at end of period	8,080		12,162		7,159
Free-standing derivatives, net
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Level 3 assets, Balance at beginning of period	394	[1]	336	[2]	311
Level 3 assets, Total gains (losses) included in net income	(200)		65		(54)
Level 3 assets, Purchases	18		66		127
Level 3 assets, Issues	0		0		0
Level 3 assets, Settlements	(137)		(73)		(48)
Level 3 assets, Balance at end of period	75	[3]	394	[1]	336	[2]
Other assets
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Level 3 assets, Balance at beginning of period	169,386		166,290		109,578
Level 3 assets, Total gains (losses) included in net income	62,105		3,096		56,712
Level 3 assets, Issues	0		0		0
Level 3 assets, Balance at end of period	231,491		169,386		166,290
Derivatives embedded in life and annuity contracts
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Level 3 liabilities, Balance at beginning of period	(3,801)		(4,796)		(7,177)
Level 3 liabilities, Total gains (losses) included in net income	(1,664)		995		2,381
Level 3 liabilities, Total gains (losses) included in OCI	0		0		0
Level 3 liabilities, Transfers into Level 3	(10,128)
Level 3 liabilities, Transfers out of Level 3	0		0		0
Level 3 liabilities, Purchases	0		0		0
Level 3 liabilities, Sales	0		0		0
Level 3 liabilities, Issues	(1,283)
Level 3 liabilities, Settlements	223
Level 3 liabilities, Balance at end of period	$ (16,653)		$ (3,801)		$ (4,796)
[1]	Comprises $394 thousand of assets
[2]	Comprises $336 thousand of assets
[3]	Comprises $75 thousand of assets

Schedule of Level Three Gains (

Schedule of Level Three Gains (Losses) Included In Net Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Effect to net income included in investment income	$ 64,565	$ 5,766	$ 61,338
Contract benefits	987	(326)	2,937
Interest credited to contractholder funds	(2,651)	1,321	(556)
Total	62,901	6,761	63,719
Investment Income
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Effect to net income included in investment income	(535)	3	606
Capital Gain
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Effect to net income included in investment income	$ 65,100	$ 5,763	$ 60,732

Schedule of Change in Unreali_3

Schedule of Change in Unrealized Gains and Losses Included in Net Income for Level Three Assets and Liabilities Held (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	$ 61,990	$ 5,758	$ 57,263
Gains (losses) for Level 3 liabilities still held at the balance sheet date, included in earnings	(1,664)	995	2,381
Gains (losses) for Level 3 assets and liabilities still held at the balance sheet date, included in earnings	60,326	6,753	59,644
Gains (losses) for Level 3 liabilities still held at the balance sheet date, included in life and annuity contract benefits	987	(326)	2,937
Gains (losses) for Level 3 assets still held at the balance sheet date, included in interest credited to contract holder funds	(2,651)	1,321	(556)
Corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	3	3	5
Fixed income securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	3	3	20
Free-standing derivatives, net
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	(200)	65	(55)
Equity securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	82	2,594	586
Other assets
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	62,105	3,096	56,712
Derivatives embedded in life and annuity contracts
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Gains (losses) for Level 3 liabilities still held at the balance sheet date, included in earnings	(1,664)	995	2,381
Municipal
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings			15
Investment Income
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	(535)	3	606
Capital Gain
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	$ 62,525	$ 5,755	$ 56,657

Schedule of Carrying Values and

Schedule of Carrying Values and Fair Value Estimates of Financial Instruments not Carried at Fair Value (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Financial assets
Mortgage loans	$ 733,258	$ 696,062
Financial liabilities
Liability for collateral	158,111	69,788	$ 59,067	$ 60,931
Carrying value
Financial assets
Mortgage loans	733,258	696,062
Financial liabilities
Contractholder funds on investment contracts	1,605,574	1,755,866
Liability for collateral	158,111	69,788
Fair value
Financial assets
Mortgage loans	764,201	699,936
Financial liabilities
Contractholder funds on investment contracts	1,730,341	1,821,641
Liability for collateral	$ 158,111	$ 69,788

Summary of Volume and Fair Valu

Summary of Volume and Fair Value Positions of Derivative Instruments and Reporting Location in Statement of Financial Position (Detail) $ in Thousands	Dec. 31, 2019USD ($)Contract	Dec. 31, 2018USD ($)Contract
Derivatives, Fair Value [Line Items]
Total derivatives, Notional amount	$ 114,237	$ 106,344
Total derivatives, Number of contracts | Contract	280	244
Total derivatives	$ 217,996	$ 167,028
Derivatives not designated as accounting hedging instruments
Derivatives, Fair Value [Line Items]
Total asset derivatives, Notional amount	$ 0	$ 17,591
Total asset derivatives, Number of contracts | Contract	140	123
Total asset derivatives, Fair value, net	$ 236,723	$ 170,630
Asset derivatives, Gross asset	236,723	170,644
Asset derivatives, Gross liability	0	(14)
Total liability derivatives, Notional amount	$ 114,237	$ 88,753
Total liability derivatives, Number of contracts | Contract	140	121
Total liability derivatives, Fair value, net	$ (18,727)	$ (3,602)
Liability derivatives, Gross asset	846	377
Liability derivatives, Gross liability	(19,573)	(3,979)
Derivatives not designated as accounting hedging instruments | Contractholder funds | Guaranteed accumulation benefits
Derivatives, Fair Value [Line Items]
Total liability derivatives, Notional amount	23,629	25,381
Total liability derivatives, Fair value, net	(1,987)	(3,003)
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	(1,987)	(3,003)
Derivatives not designated as accounting hedging instruments | Contractholder funds | Withdrawal benefit
Derivatives, Fair Value [Line Items]
Total liability derivatives, Notional amount	15,369	14,507
Total liability derivatives, Fair value, net	(427)	(398)
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	(427)	(398)
Derivatives not designated as accounting hedging instruments | Interest rate cap agreement | Other investments
Derivatives, Fair Value [Line Items]
Total asset derivatives, Notional amount		1,500
Total asset derivatives, Fair value, net		17
Asset derivatives, Gross asset		17
Asset derivatives, Gross liability		0
Derivatives not designated as accounting hedging instruments | Interest rate cap agreement | Other liabilities and accrued expenses
Derivatives, Fair Value [Line Items]
Total liability derivatives, Notional amount	13,400	12,600
Total liability derivatives, Fair value, net	75	377
Liability derivatives, Gross asset	75	377
Liability derivatives, Gross liability	0	0
Derivatives not designated as accounting hedging instruments | Equity And Index Contracts Options | Other investments
Derivatives, Fair Value [Line Items]
Total asset derivatives, Notional amount	$ 0	$ 0
Total asset derivatives, Number of contracts | Contract	140	122
Total asset derivatives, Fair value, net	$ 5,232	$ 556
Asset derivatives, Gross asset	5,232	556
Asset derivatives, Gross liability	0	0
Derivatives not designated as accounting hedging instruments | Equity And Index Contracts Options | Other liabilities and accrued expenses
Derivatives, Fair Value [Line Items]
Total liability derivatives, Notional amount	$ 0	$ 0
Total liability derivatives, Number of contracts | Contract	139	121
Total liability derivatives, Fair value, net	$ (2,832)	$ (178)
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	(2,832)	(178)
Derivatives not designated as accounting hedging instruments | Equity And Index Contracts Futures [Member] | Other assets
Derivatives, Fair Value [Line Items]
Total asset derivatives, Notional amount		$ 0
Total asset derivatives, Number of contracts | Contract		1
Total asset derivatives, Fair value, net		$ 1
Asset derivatives, Gross asset		1
Asset derivatives, Gross liability		0
Derivatives not designated as accounting hedging instruments | Equity And Index Contracts Futures [Member] | Other liabilities and accrued expenses
Derivatives, Fair Value [Line Items]
Total liability derivatives, Notional amount	$ 0
Total liability derivatives, Number of contracts | Contract	1
Total liability derivatives, Fair value, net	$ 0
Liability derivatives, Gross asset	0
Liability derivatives, Gross liability	0
Derivatives not designated as accounting hedging instruments | Foreign currency forward | Other investments
Derivatives, Fair Value [Line Items]
Total asset derivatives, Notional amount		16,091
Total asset derivatives, Fair value, net		670
Asset derivatives, Gross asset		684
Asset derivatives, Gross liability		(14)
Derivatives not designated as accounting hedging instruments | Foreign currency forward | Other liabilities and accrued expenses
Derivatives, Fair Value [Line Items]
Total liability derivatives, Notional amount	17,984
Total liability derivatives, Fair value, net	683
Liability derivatives, Gross asset	771
Liability derivatives, Gross liability	(88)
Derivatives not designated as accounting hedging instruments | Structured settlement annuities | Other assets
Derivatives, Fair Value [Line Items]
Total asset derivatives, Notional amount	0	0
Total asset derivatives, Fair value, net	231,491	169,386
Asset derivatives, Gross asset	231,491	169,386
Asset derivatives, Gross liability	0	0
Derivatives not designated as accounting hedging instruments | Equity-indexed options in life product contracts | Contractholder funds
Derivatives, Fair Value [Line Items]
Total liability derivatives, Notional amount	43,855	36,265
Total liability derivatives, Fair value, net	(14,239)	(400)
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	$ (14,239)	$ (400)

Schedule of Gross and Net Amoun

Schedule of Gross and Net Amount for Company's OTC Derivatives Subject to Enforceable Master Netting Arrangements (Detail) - OTC derivatives - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Offsetting Assets [Line Items]
Gross amount	$ 846	$ 1,078
Derivative Asset,Counter-party netting	(846)	(391)
Derivative asset, offset under cash collateral (received) pledged	0	(590)
Derivative Asset, Net amount on balance sheet	0	97
Derivative Asset, Securities collateral (received) pledged	0	0
Derivative Asset, Net amount		97
Gross amount	(88)	(14)
Liability derivatives, Gross asset	846	391
Derivative liability offsets under cash collateral pledged	(831)	(380)
Net amount on balance sheet	(73)	(3)
Securities collateral (received) pledged	0	0
Net amount	$ (73)	$ (3)

Summary of Gains and Losses fro

Summary of Gains and Losses from Valuation and Settlements For Derivatives Not Designated As Hedges (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	$ 58,350	$ 865	$ 56,176
Interest rate contract
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	(200)	65	(54)
Equity and index contracts
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	1,988	(768)	1,289
Foreign currency forward
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	364	887	(697)
Embedded derivative financial instruments
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	(2,724)	995	2,381
Structured settlement annuities
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	58,922	(314)	53,257
Realized capital gains and losses
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	59,087	638	52,506
Realized capital gains and losses | Interest rate contract
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	(200)	65	(54)
Realized capital gains and losses | Equity and index contracts
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	1
Realized capital gains and losses | Foreign currency forward
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	364	887	(697)
Realized capital gains and losses | Structured settlement annuities
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	58,922	(314)	53,257
Contract benefits
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	987	(326)	2,937
Contract benefits | Embedded derivative financial instruments
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	987	(326)	2,937
Interest credited to contractholder funds
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	(1,724)	553	733
Interest credited to contractholder funds | Equity and index contracts
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	1,987	(768)	1,289
Interest credited to contractholder funds | Embedded derivative financial instruments
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	$ (3,711)	$ 1,321	$ (556)

Derivative Financial Instrume_3

Derivative Financial Instruments and Off-balance sheet Financial Instruments - Additional Information (Detail) $ in Thousands	Dec. 31, 2019USD ($)
Derivative [Line Items]
Pledged cash to counterparties as collateral	$ 831
Cash and securities pledged in the form of margin deposits	$ 291

Summary of Counterparty Credit

Summary of Counterparty Credit Exposure by Counterparty Credit Rating (Detail) - A+ $ in Thousands		12 Months Ended
		Dec. 31, 2019USD ($)Entity	Dec. 31, 2018USD ($)Entity
Counterparty Credit Concentration Risk [Line Items]
Number of counter -parties | Entity	[1]	2	2
Notional Amount	[1],[2]	$ 30,670	$ 30,191
Credit exposure	[1],[2]	770	1,064
Exposure, net of collateral	[1],[2]	$ 0	$ 97
[1]	Allstate uses the lower of S&P or Moody's long-term debt issuer ratings.
[2]	Only OTC derivatives with a net positive fair value are included for each counterparty.

Derivatives Financial Instrumen

Derivatives Financial Instruments and Off Balance Sheet Financial Instruments -Summary of Fair Value of Derivatives (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Gross liability fair value of contracts containing credit-risk-contingent features	$ 83	$ 0
Gross asset fair value of contracts containing credit-risk-contingent features and subject to MNAs	(70)	0
Maximum amount of additional exposure for contracts with credit-risk-contingent features if all features were triggered concurrently	$ 13	$ 0

Derivatives Financial Instrum_2

Derivatives Financial Instruments and Off Balance Sheet Financial Instruments - Schedule of Contractual Amounts of Off Balance Sheet Financial instruments (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Limited partnership interests
Derivative [Line Items]
Contractual amounts of off-balance-sheet financial instruments	$ 127,515	$ 153,719
Mortgage loans
Derivative [Line Items]
Contractual amounts of off-balance-sheet financial instruments	13,000	10,000
Private Placement [Member]
Derivative [Line Items]
Contractual amounts of off-balance-sheet financial instruments	$ 15,000	$ 0

Schedule of Reserve for Life-Co

Schedule of Reserve for Life-Contingent Contract Benefits (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Liability for Future Policy Benefit, by Product Segment [Line Items]
Reserve for life-contingent contract benefits	$ 2,411,809	$ 2,232,136
Structured settlement annuities
Liability for Future Policy Benefit, by Product Segment [Line Items]
Reserve for life-contingent contract benefits	2,051,363	1,882,914
Other immediate fixed annuities
Liability for Future Policy Benefit, by Product Segment [Line Items]
Reserve for life-contingent contract benefits	61,039	63,774
Traditional life insurance
Liability for Future Policy Benefit, by Product Segment [Line Items]
Reserve for life-contingent contract benefits	265,971	258,336
Accident and health insurance
Liability for Future Policy Benefit, by Product Segment [Line Items]
Reserve for life-contingent contract benefits	32,261	25,360
Other
Liability for Future Policy Benefit, by Product Segment [Line Items]
Reserve for life-contingent contract benefits	$ 1,175	$ 1,752

Schedule of Key Assumptions Use

Schedule of Key Assumptions Used In Calculation Reserve for Life-Contingent Contract Benefits (Detail)	12 Months Ended
	Dec. 31, 2019
Other | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Life contingent contract benefits, interest rate assumptions (as a percent)	2.00%	[1]
Other | Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Life contingent contract benefits, interest rate assumptions (as a percent)	5.80%	[1]
Structured settlement annuities | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Life contingent contract benefits, interest rate assumptions (as a percent)	3.80%
Structured settlement annuities | Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Life contingent contract benefits, interest rate assumptions (as a percent)	7.00%
Other immediate fixed annuities | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Life contingent contract benefits, interest rate assumptions (as a percent)	0.60%
Other immediate fixed annuities | Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Life contingent contract benefits, interest rate assumptions (as a percent)	5.40%
Traditional life insurance | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Life contingent contract benefits, interest rate assumptions (as a percent)	3.00%
Traditional life insurance | Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Life contingent contract benefits, interest rate assumptions (as a percent)	8.00%
Accident and health insurance | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Life contingent contract benefits, interest rate assumptions (as a percent)	3.50%
Accident and health insurance | Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Life contingent contract benefits, interest rate assumptions (as a percent)	6.00%
[1]	In 2006, the Company disposed of its variable annuity business through a reinsurance agreement with The Prudential Insurance Company of America, a subsidiary of Prudential Financial, Inc. (collectively "Prudential").

Reserve for Life-Contingent C_3

Reserve for Life-Contingent Contract Benefits and Contractholder Funds - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Insurance [Line Items]
Premium deficiency reserve	$ 231,357	$ 80,628
Variable annuities
Insurance [Line Items]
Account balances of separate accounts with guarantees, invested in equity, fixed income and balanced mutual funds	222,200	202,200
Account balances of separate accounts with guarantees, invested in money market mutual funds	$ 21,700	$ 21,500

Schedule of Contractholder Fund

Schedule of Contractholder Funds (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds	$ 2,547,968	$ 2,681,300	$ 2,874,884	$ 3,018,733
Interest-sensitive life insurance
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds	756,995	740,694
Investment contracts | Fixed annuities
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds	1,741,488	1,896,222
Investment contracts | Other investment contracts
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds	$ 49,485	$ 44,384

Schedule of Contract Provisions

Schedule of Contract Provisions Related to Contractholder Funds (Detail)	12 Months Ended
	Dec. 31, 2019
Other investment contracts
Policyholder Contract Deposits By Product [Line Items]
Interest rate, low end	1.70%	[1]
Interest rate, high end	10.30%	[1]
Minimum | Equity-indexed life
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds, interest rate assumptions (as a percent)	0.00%
Minimum | Other Life Insurance [Member]
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds, interest rate assumptions (as a percent)	2.00%
Minimum | Immediate annuities
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds, interest rate assumptions (as a percent)	0.60%
Minimum | Other fixed annuities
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds, interest rate assumptions (as a percent)	1.00%
Maximum | Equity-indexed life
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds, interest rate assumptions (as a percent)	10.00%
Maximum | Other Life Insurance [Member]
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds, interest rate assumptions (as a percent)	5.10%
Maximum | Immediate annuities
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds, interest rate assumptions (as a percent)	7.00%
Maximum | Other fixed annuities
Policyholder Contract Deposits By Product [Line Items]
Contractholder funds, interest rate assumptions (as a percent)	5.00%
[1]	In 2006, the Company disposed of its variable annuity business through a reinsurance agreement with Prudential.

Schedule of Contractholder Fu_2

Schedule of Contractholder Funds Activity (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Insurance [Line Items]
Balance, beginning of year	$ 2,681,300	$ 2,874,884	$ 3,018,733
Deposits	104,850	107,606	103,107
Interest credited	86,338	91,430	97,355
Benefits	(104,681)	(114,006)	(108,819)
Surrenders and partial withdrawals	(152,898)	(190,873)	(166,388)
Contract charges	(75,879)	(75,483)	(74,733)
Net transfers from separate accounts	88	256	54
Other adjustments	8,850	(12,514)	5,575
Balance, end of year	$ 2,547,968	$ 2,681,300	$ 2,874,884

Summary of Variable Annuity Con

Summary of Variable Annuity Contracts with Guarantees (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
Guaranteed death benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Separate account value		$ 243,833	$ 223,651
Net amount at risk	[1]	$ 4,392	$ 16,137
Average attained age of contract holders		68 years	67 years
Liability for guarantees related to income benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Separate account value		$ 18,849	$ 16,873
Net amount at risk	[2]	$ 1,750	$ 2,898
Weighted average waiting period until annuitization or guarantee date		0 years	0 years
Withdrawal benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Separate account value		$ 15,173	$ 13,989
Net amount at risk	[3]	421	485
Guaranteed accumulation benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Separate account value		24,033	25,272
Net amount at risk	[4]	$ 224	$ 849
Weighted average waiting period until annuitization or guarantee date		3 years	3 years
[1]	Defined as the estimated current guaranteed minimum death benefit in excess of the current account balance as of the balance sheet date.
[2]	Defined as the estimated present value of the guaranteed minimum annuity payments in excess of the current account balance.
[3]	Defined as the estimated current guaranteed minimum withdrawal balance (initial deposit) in excess of the current account balance as of the balance sheet date.
[4]	Defined as the estimated present value of the guaranteed minimum accumulation balance in excess of the current account balance.

Summary of Liabilities for Guar

Summary of Liabilities for Guarantees (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019		Dec. 31, 2018
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	$ 34,647	[1]	$ 31,464	[2]
Less reinsurance recoverables	5,721		4,872
Net balance	28,926		26,592
Incurred guarantee benefits	4,411		2,584
Paid guarantee benefits	(388)		(250)
Net change	4,023		2,334
Net balance	32,949		28,926
Plus reinsurance recoverables	3,936		5,721
Gross balance	36,885	[3]	34,647	[1]
Liability for guarantees related to death benefits and interest-sensitive life products
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	30,674	[1]	27,927	[2]
Less reinsurance recoverables	1,752		1,340
Net balance	28,922		26,587
Incurred guarantee benefits	4,412		2,585
Paid guarantee benefits	(388)		(250)
Net change	4,024		2,335
Net balance	32,946		28,922
Plus reinsurance recoverables	1,189		1,752
Gross balance	34,135	[3]	30,674	[1]
Liability for guarantees related to income benefits
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	572	[1]	462	[2]
Less reinsurance recoverables	568		457
Net balance	4		5
Incurred guarantee benefits	(1)		(1)
Net change	(1)		(1)
Net balance	3		4
Plus reinsurance recoverables	333		568
Gross balance	336	[3]	572	[1]
Liability for guarantees related to accumulation and withdrawal benefits
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	3,401	[1]	3,075	[2]
Less reinsurance recoverables	3,401		3,075
Plus reinsurance recoverables	2,414		3,401
Gross balance	$ 2,414	[3]	$ 3,401	[1]
[1]	Included in the total liability balance as of December 31, 2018 are reserves for variable annuity death benefits of $1.8 million, variable annuity income benefits of $0.6 million, variable annuity accumulation benefits of $3.0 million, variable annuity withdrawal benefits of $0.4 million and other guarantees of $28.8 million.
[2]	Included in the total liability balance as of December 31, 2017 are reserves for variable annuity death benefits of $1.3 million, variable annuity income benefits of $0.5 million, variable annuity accumulation benefits of $2.8 million, variable annuity withdrawal benefits of $0.3 million and other guarantees of $26.6 million.
[3]	Included in the total liability balance as of December 31, 2019 are reserves for variable annuity death benefits of $1.2 million, variable annuity income benefits of $0.3 million, variable annuity accumulation benefits of $2.0 million, variable annuity withdrawal benefits of $0.4 million and other guarantees of $33.0 million.

Summary of Liabilities for Gu_2

Summary of Liabilities for Guarantees (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2019		Dec. 31, 2018		Dec. 31, 2017
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	$ 36,885	[1]	$ 34,647	[2]	$ 31,464	[3]
Liability for guarantees related to income benefits
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	336	[1]	572	[2]	462	[3]
Liability for guarantees related to income benefits | Variable annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	300		600		500
Guaranteed death benefits | Variable annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	1,200		1,800		1,300
Guaranteed accumulation benefits | Variable annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	2,000		3,000		2,800
Withdrawal benefit | Variable annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	400		400		300
Other guarantees | Variable annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Gross balance	$ 33,000		$ 28,800		$ 26,600
[1]	Included in the total liability balance as of December 31, 2019 are reserves for variable annuity death benefits of $1.2 million, variable annuity income benefits of $0.3 million, variable annuity accumulation benefits of $2.0 million, variable annuity withdrawal benefits of $0.4 million and other guarantees of $33.0 million.
[2]	Included in the total liability balance as of December 31, 2018 are reserves for variable annuity death benefits of $1.8 million, variable annuity income benefits of $0.6 million, variable annuity accumulation benefits of $3.0 million, variable annuity withdrawal benefits of $0.4 million and other guarantees of $28.8 million.
[3]	Included in the total liability balance as of December 31, 2017 are reserves for variable annuity death benefits of $1.3 million, variable annuity income benefits of $0.5 million, variable annuity accumulation benefits of $2.8 million, variable annuity withdrawal benefits of $0.3 million and other guarantees of $26.6 million.

Reinsurance - Additional Inform

Reinsurance - Additional Information (Detail) $ / Person in Thousands, $ in Thousands	1 Months Ended	12 Months Ended
	Jul. 31, 2013$ / Person	Dec. 31, 2019USD ($)$ / Person	Dec. 31, 2018USD ($)$ / Person	Dec. 31, 2017USD ($)
Effects of Reinsurance [Line Items]
Maximum percentage of mortality risk ceded		90.00%	90.00%
Maximum coverage per life before ceded | $ / Person	250	2,000	2,000
Reinsurance recoverables		$ 229,759	$ 234,733
Gross life insurance in force		43,090,000
Life insurance in force ceded to affiliated reinsurers		482,900
Life insurance in force ceded to unaffiliated reinsurers		8,100,000
Ceded premium related to structured settlement annuities		10,600	11,054	$ 11,481
settlements receivable		13,687	11,016	8,055
Allstate Life Insurance Company
Effects of Reinsurance [Line Items]
Ceded premium related to structured settlement annuities		4,200	3,400	3,500
settlements receivable		1,000	0	$ 0
Prudential
Effects of Reinsurance [Line Items]
Reinsurance recoverables		166,900	170,600
Triton Insurance Company
Effects of Reinsurance [Line Items]
Reinsurance recoverables		$ 579	$ 722

Reinsurance - Schedule of Reins

Reinsurance - Schedule of Reinsurance ceded amount (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Effects of Reinsurance [Line Items]
Interest credited to contractholder funds	$ 4,307	$ 4,533	$ 4,805
Prudential
Effects of Reinsurance [Line Items]
Premiums and contract charges	4,797	5,189	5,401
Contract benefits	(890)	1,459	(3,251)
Interest credited to contractholder funds	4,307	4,533	4,805
Operating costs and expenses	$ 867	$ 868	$ 943

Schedule of Effects of Reinsura

Schedule of Effects of Reinsurance on Premiums and Contract Charges (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Effects of Reinsurance [Line Items]
Direct premiums and contract charges	$ 203,614	$ 199,289	$ 185,875
Total premiums and contract charges	185,766	180,641	167,112
Non-affiliate
Effects of Reinsurance [Line Items]
Assumed premiums and contract charges	697	685	672
Ceded premiums and contract charges	(16,359)	(17,361)	(17,705)
Affiliate
Effects of Reinsurance [Line Items]
Ceded premiums and contract charges	$ (2,186)	$ (1,972)	$ (1,730)

Schedule of Effects of Reinsu_2

Schedule of Effects of Reinsurance on Contract Benefits (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Effects of Reinsurance [Line Items]
Direct contract benefits	$ 272,200	$ 248,008	$ 237,998
Contract benefits, net of reinsurance	259,013	237,578	230,493
Non-affiliate
Effects of Reinsurance [Line Items]
Assumed contract benefits	500	586	550
Ceded contract benefits	(11,333)	(10,961)	(7,173)
Affiliate
Effects of Reinsurance [Line Items]
Ceded contract benefits	$ (2,354)	$ (55)	$ (882)

Schedule of Effect of Reinsuran

Schedule of Effect of Reinsurance on Interest Credited to Contractholder Funds (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Effects of Reinsurance [Line Items]
Direct interest credited to contractholder funds	$ 90,758	$ 96,002	$ 102,164
Ceded interest credited to contractholder funds	(4,307)	(4,533)	(4,805)
Interest credited to contractholder funds, net of reinsurance	86,464	91,482	97,377
Non-affiliate
Effects of Reinsurance [Line Items]
Assumed interest credited to contractholder funds	13	13	18
Ceded interest credited to contractholder funds	$ (4,307)	$ (4,533)	$ (4,805)

Schedule of Deferred Policy Acq

Schedule of Deferred Policy Acquisition Costs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Movement Analysis of Deferred Policy Acquisition Costs
Balance, beginning of year	$ 155,887	$ 146,333	$ 137,358
Acquisition costs deferred	16,771	19,577	24,522
Amortization charged to income	(30,396)	(16,299)	(16,992)
Effect of unrealized gains and losses	(18,144)	6,276	1,445
Balance, end of year	$ 124,118	$ 155,887	$ 146,333

Schedule of Deferred Sales Indu

Schedule of Deferred Sales Inducement Activity (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Movement in Deferred Sales Inducements
Balance, beginning of year	$ 2,391	$ 2,278	$ 2,265
Sales inducements deferred	125	128	167
Amortization charged to income	(251)	(181)	(188)
Effect of unrealized gains and losses	(489)	166	34
Balance, end of year	$ 1,776	$ 2,391	$ 2,278

Guarantees and Contingent Lia_2

Guarantees and Contingent Liabilities - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Guarantor Obligations [Line Items]
Obligations of insolvent insurance companies	$ 759	$ 759
Premium tax offsets	$ 916	$ 1,100

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Income Taxes [Line Items]
Unrecognized tax benefits	$ 0	$ 0	$ 0
Unrecognized tax interest accrued	0	0	0
Unrecognized tax penalties accrued	0	0	0
Income taxes paid	$ 1,000,000	$ 16,000,000	$ 6,800,000

Components of Deferred Income T

Components of Deferred Income Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Deferred tax assets
Unrealized foreign currency translation adjustments on limited partnerships	$ 317	$ 0
Accrued liabilities	25	25
Other assets	20	5
Total deferred tax assets	362	30
Deferred tax liabilities
Investments	(78,081)	(75,864)
Unrealized net capital gains	(33,151)	(15,178)
Life and annuity reserves	(29,048)	(32,450)
DAC	(14,447)	(18,713)
Other liabilities	(484)	(858)
Unrealized foreign currency translation adjustments on limited partnerships	0	(573)
Total deferred tax liabilities	(155,211)	(143,636)
Net deferred tax liability	$ (154,849)	$ (143,606)

Components of Income Tax Benefi

Components of Income Tax Benefit Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Components Of Income Tax Expense Benefit [Line Items]
Current	$ 36,766	$ 11,257	$ 12,837
Deferred	(5,840)	1,570	(59,572)
Total income tax expense (benefit)	$ 30,926	$ 12,827	$ (46,735)

Reconciliation of Statutory Fed

Reconciliation of Statutory Federal Income Tax Rate to Effective Income Tax Rate (Detail)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Tax Rate Reconciliation [Line Items]
Statutory federal income tax rate	21.00%	21.00%	35.00%
State income taxes	1.80%	5.40%	0.70%
Tax Legislation benefit		(3.90%)	(65.10%)
Adjustments to prior year tax liabilities	1.40%	(0.10%)
Other	(0.10%)	(0.30%)	(0.30%)
Effective income tax rate - expense (benefit)	24.10%	22.10%	(29.70%)

Statutory Financial Informati_2

Statutory Financial Information and Dividend Limitations - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statutory Accounting Practices [Line Items]
Statutory net income (loss)	$ (34)	$ 68	$ 50.8
Statutory capital and surplus	614.2	$ 644.5
Deficit position used to determine payment of dividends	373.7
Maximum dividends company can pay during 2019 without regulatory approval	61.4
Adjusted Statutory capital and surplus	639.3
Authorized control level RBC	$ 88.9

Benefit Plans - Additional Info

Benefit Plans - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Allocated Cost (Credit)	$ 609,000	$ 439,000	$ 1,200,000
Cost of Allstate Plan	$ 953,000	$ 1,000,000	$ 895,000

Schedule of Components of Other

Schedule of Components of Other Comprehensive Income on Pre-Tax and After-Tax Basis (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Pre-tax
Unrealized net holding gains and losses arising during the period, net of related offsets	$ 86,980	$ (65,379)	$ (89,152)
Less: reclassification adjustment of realized capital gains and losses	1,395	(1,359)	12,710
Unrealized net capital gains and losses	85,585	(64,020)	(101,862)
Unrealized foreign currency translation adjustments	(3,963)	124	3,706
Other comprehensive (loss) income	81,622	(63,896)	(98,156)
Tax
Unrealized net holding gains and losses arising during the period, net of related offsets	(18,266)	13,730	31,203
Less: reclassification adjustment of realized capital gains and losses	(293)	285	(4,449)
Unrealized net capital gains and losses	(17,973)	13,445	35,652
Unrealized foreign currency translation adjustments	832	(26)	(1,297)
Other comprehensive (loss) income	(17,141)	13,419	34,355
After-tax
Unrealized net holding gains and losses arising during the period, net of related offsets	68,714	(51,649)	(57,949)
Less: reclassification adjustment of realized capital gains and losses	1,102	(1,074)	8,261
Unrealized net capital gains and losses	67,612	(50,575)	(66,210)
Unrealized foreign currency translation adjustments	(3,131)	98	2,409
Other comprehensive (loss) income	$ 64,481	$ (50,477)	$ (63,801)

Schedule I - Summary of Investm

Schedule I - Summary of Investments Other Than Investments in Related Parties (Detail) $ in Thousands	Dec. 31, 2019USD ($)
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	$ 5,643,724
Amount at which shown in the Balance Sheet	6,095,981
U.S. government and agencies
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	43,280
Fair value	52,814
Amount at which shown in the Balance Sheet	52,814
Municipal
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	433,038
Fair value	552,280
Amount at which shown in the Balance Sheet	552,280
Foreign government
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	133,635
Fair value	140,166
Amount at which shown in the Balance Sheet	140,166
Public utilities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	601,930
Fair value	673,843
Amount at which shown in the Balance Sheet	673,843
All other corporate bonds
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	2,798,541
Fair value	3,001,402
Amount at which shown in the Balance Sheet	3,001,402
Mortgage-backed securities (MBS)
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	12,683
Fair value	13,857
Amount at which shown in the Balance Sheet	13,857
Fixed income securities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	4,023,107
Fair value	4,434,362
Amount at which shown in the Balance Sheet	4,434,362
Public Utilities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	3,117
Fair value	4,172
Amount at which shown in the Balance Sheet	4,172
Banks, Trust and Insurance Companies
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	16,061
Fair value	21,053
Amount at which shown in the Balance Sheet	21,053
Industrial, miscellaneous and all other
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	211,902
Fair value	246,529
Amount at which shown in the Balance Sheet	246,529
Nonredeemable preferred stocks
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	2,038
Fair value	2,379
Amount at which shown in the Balance Sheet	2,379
Equity securities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	233,118
Fair value	274,133
Amount at which shown in the Balance Sheet	274,133
Mortgage loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	733,258
Fair value	764,201
Amount at which shown in the Balance Sheet	733,258
Policy loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	38,583
Amount at which shown in the Balance Sheet	38,583
Derivative instruments
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	5,237
Fair value	5,237
Amount at which shown in the Balance Sheet	5,237
Limited partnership interests
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	386,310
Amount at which shown in the Balance Sheet	386,310
Short-term investments
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost/amortized cost	224,111
Fair value	224,098
Amount at which shown in the Balance Sheet	$ 224,098

Schedule IV - Reinsurance (Deta

Schedule IV - Reinsurance (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Premiums and contract charges, Gross amount		$ 203,614	$ 199,289	$ 185,875
Premiums and contract charges, Ceded to other companies	[1]	18,545	19,333	19,435
Premiums and contract charges, Assumed from other companies		697	685	672
Premiums and contract charges, Net amount		$ 185,766	$ 180,641	$ 167,112
Premiums and contract charges, Percentage of amount assumed to net		0.40%	0.40%	0.40%
Life insurance in force, Gross amount		$ 42,654,371	$ 42,502,450	$ 41,866,862
Life insurance in force, Ceded to other companies	[1]	8,581,710	8,914,558	9,142,525
Life insurance in force, Assumed from other companies		436,841	455,594	467,937
Life insurance in force, Net amount		$ 34,509,502	$ 34,043,486	$ 33,192,274
Life insurance in force, Percentage of amount assumed to net		1.30%	1.30%	1.40%
Life insurance
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Premiums and contract charges, Gross amount		$ 156,192	$ 154,016	$ 149,811
Premiums and contract charges, Ceded to other companies	[1]	17,595	18,322	18,316
Premiums and contract charges, Assumed from other companies		697	685	672
Premiums and contract charges, Net amount		$ 139,294	$ 136,379	$ 132,167
Premiums and contract charges, Percentage of amount assumed to net		0.50%	0.50%	0.50%
Accident and health insurance
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Premiums and contract charges, Gross amount		$ 47,422	$ 45,273	$ 36,064
Premiums and contract charges, Ceded to other companies	[1]	950	1,011	1,119
Premiums and contract charges, Net amount		$ 46,472	$ 44,262	$ 34,945
[1]	No reinsurance or coinsurance income was netted against premiums ceded in 2019, 2018 or 2017.

Schedule V - Valuation Allowanc

Schedule V - Valuation Allowances and Qualifying Accounts (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
SEC Schedule, 12-09, Allowance, Reinsurance Recoverable [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance as of beginning of period	$ 0
Additions charged to costs and expenses	34
Other additions	0
Deductions	0
Balance as of end of period	34	$ 0
Allowance for estimated losses on mortgage loans
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance as of beginning of period	0	0	$ 0
Additions charged to costs and expenses	0	0	0
Other additions	0	0	0
Deductions	0	0	0
Balance as of end of period	$ 0	$ 0	$ 0